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I. RESEARCH REPORTS 
TUMOUR AGENTS AND TUMOUR DIAGNOSIS 
1. Distribution Behaviour of 3-LT~ethyl~-['~fl~1~0ro-L-3,4-Dihydroxyphenylalanine 
in Wistar Rats, Normal Mice and Tumour-Bearing Nude Mice 
R. Syhre, P. Brust, D. 2ips1, F. Füchtner, J. Steinbach, B. Johannsen 
'TU Dresden, Klinik und Poliklinik für Strahlentherapie 
lntroduction 
3-0~eth~l-6-[~~~]fluoro-~-3,4-dihydroxyphenylalanine (OMFD) is known as a non-toxic metabolite of 
6-~8~]fluoro-~-3,4-dihydroxyphenylalanine (FDOPA). OMFD itself has proved to be a promising PET 
tracer for tumour imaging, especially for tumour visualization and localization [I]. 
The synthesis of OMFD is easy and produces the tracer in a high yield afier a relatively short 
preparation time [2]. This synthetic amino acid was found to be largely metabolically stable and not 
involved in the biosynthesis of proteins [3J. 
The airn of this study was to investigate the uptake and retention behaviour of OMFD in Wistar rats, 
normal BALBfC mice and tumour-bearing nude mice. The suitability of OMFD as a tumour-detecting 
agent is supported by a competition study using L-phenylalanine as a substrate for the amino acid 
transport system L. 
Materials and Methods 
The animal studies were carried out in accordance with the relevant national regulations. 
The experiments were performed in Wistar rats (male; 5 - 6 weeks old), BalblC mice as well as nude 
mice bearing human squamous cell carcinoma (male and female; 5 to 6 weeks old). The tumours 
were transplanted 15 to 20 days prior to the animal studies. At the time of the study the tumour weight 
was 0.7 I 0.4 g. 
The animals were injected into the tail vein under a light ether anaesthesia. OMFD solution (- 5 MBq 
OMFDIml; saline ; pH 4.5 - 5.0; radiochemical purity 2 90 %). The injection volurne was 0.5 rnl for rats 
and 0.2 ml for mice, respectively. 5 to 120 min p.i. the animals were sacrificed by heart puncture (ether 
anaesthesia). Selected Organs, including tumour, were isolated for weighing and counting. The 
accumulated radioactivity in the tissue was calculated as a percentage of the injected dose per organ 
and per gram tissue. 
To evaluate the uptake of OMFD by a specific amino acid transport systern present in the brain and in 
various tumours, the distribution pattem was studied 5 minutes after intravenous CO-injection of 0.5 rnl 
OMFD and L-phenylalanine (100 mg/kg body weight). 
The effect of L-phenylalanine as a competitive agent on the tumour uptake was investigated in L- 
phenylalanine-loaded nude mice. For this test 0.2 ml of L-phenylalaninelsaline (25 mg/1üQ g BW) was 
intraperitoneally injected into the animals 30 minutes prior to the OMFD injection. The biodistribution 
was determined 60 minutes after radiotracer injection as described before. 
Results and Discussion 
Table 1 shows the tracer distribution Pattern of the animal species studied as a percentage of the 
injected dose per organ. 
It is shown that OMFD is able to Cross the blood-brain-barrier of rats and mice. The injtial radioactivity 
uptake in the brain, heart and lungc was similar low (< 1 % IDlorgan) and even decreased clowly with 
the time in all of animal species studied (Table 1). 
The renal path shows the main elimination part (approx. 50 % ID up to 120 rnin pi.1 of OMFD among 
the animals investigated. However, the retention behaviour of OMFD in the kidneys suggests that the 
rate of renal cleamnce may differ between the animal species, In addition to the high kidney a~tiviiy of 
OMFD, a significant uptake in BalblC and in nude mice was measured in $he pancreas (6 % 113 
corresponding to -30 % lDlgram ticsue) followed by the iiver, whereas in rats the upIake in the Tier 
was significantly higher than in the pancreas (Table 1). This prominent accumulatirsn in the pancreas 
of mice was also observed afier the injection of various ['8~jiluoro-~-irmino acid derivatives, such as 
FDOPA, fluoro-L-prulines and fluoro-L-tyrosines, respectively 14 - 61. Ths results ot distribution studies 
in rats (Table 1) as well as ot clinical studies lndicate that the high pancreas uptake is specific for mice 
and negligible for the clinical use of these compounds [I, 5, q. 
Table 1. Biodistribution of OMFD in Wistar rats, BalbIC mice and nude mice as a percentage 
of the injected dose per Organ (mean I SD; n = 6). 
Wistar rats 
min p.i. 5 30 60 120 
Brain 0.64 I 0.06 0.51 10.10 0.42 I 0.05 0.39 I 0.03 
Pancreas 1.26 10.18 0.69 I 0.13 0.47 I 0.06 0.44 I 0.02 
Spleen 0.31 10.04 0.20 I 0.02 0.15 I 0.02 0.14 I 0.03 
Kidneys 7.40 r 0.41 5.21 I 0.66 4.21 I 0.38 4.74 I 0.68 
Lungs , 0.38 I 0.05 0.21 I 0.02 0.19 I 0.01 0.15 r 0.02 
Heart 0.74 I 0.17 0.39 I 0.08 0.29 I 0.02 0.27 I 0.04 
Femur 0.70 I 0.10 0.77 I 0.08 0.76 I 0.03 0.74 I 0.06 
Liver 5.41 I 1.03 3.64 I 0.26 3.03 I 0.24 2.87 I 0.44 
Brain 
Pancreas 
Spleen 
Kidneys 
Lungs 
Heart 
Femur 
Liver 
BalbIC mice 
0.84 I 0. 18 0.57 1 0.14 
3.21 I 0.67 2.29 I 0.74 
0.29 I 0.05 0.21 I 0.04 
6.52 r 0.38 7.39 I 0.25 
0.28 I 0.05 0.18 I 0.04 
0.35 I 0.05 0.28 I 0.05 
0.78 I 0.22 0.58 I 0.14 
3.17 I 0.62 1.72 1.13 
Brain 
Pancreas 
Spleen 
Kidneys 
Lungs 
Heart 
Femur 
Liver 
Nude mice 
0.79 r 0.14 0.66 I 0.26 
3.22 I 0.67 1.54 r 0.34 
0.34 t 0.12 0.42 r 0. 1 1 
3.26 1.27 1.93 r 0.35 
0.24 r 0.06 0.25 I 0.14 
0.39 r 0.22 0.47 I 0.12 
0.69 r 0.20 0.64 r 0.18 
3.63 r 1.27 2.67 r 0.59 
Nude miceV5; 45; 60; 120 min p.i. 
During the interval of investigation (5 min to 120 min) up to 16 % of the injected dose was retained in 
the skeleton (% 1D femur*20) of the animals. The in vivo stability of this "F-labelled compound without 
significant defiuorination within the organism was indicated by the fact that no increase against time 
was observed. 
The blood clearance of OMFD was faster for rats than for mice (Fig. 1). 
- 9 -  . 
0 30 60 90 120 min p.i. 
+Nude mice - c B a l b  C mice +Wistar rats 
Fig.1. Blood clearance of OMFD ailer injection in Wistar rats. 
BalbIC mice and nude mice (% lDlg I SD; n = 6) 
Fig. 2 shows the time Course sf tumour accumulation after injection of OMFD in tumour-bearing nude 
mice. It is apparent that a peak of the tumour uptake occurred at 60 min p.i. At this time 12.4 t 1.6 % 
of the injected dose per gram turnour was accumulated. The turnour activity slowly decreased with the 
time to ieach 9.8 I 1:7 % lDlg at 120 rnin p.i. 
0 30 60 90 120 
min p.i. 
Fig. 2. Time-dependent tumour uptake of OMFD in nude mice 
(% lDlg f SD; n = 6; tumour weight 0.45 I 0.37 g). 
These good tumour uptake values result in representative tumour-to-blood and tumour-to-tissue ratios 
as shown in Fig. 3. 
Interestingly, no significant changes in uptake were obsetved afkr CO-injecfion of OMFD and L- 
phenylalanine cornpared with the OMFD distribution data in most Organs sf rals (Table 2). However, 
the presence of L-phenylalanine signrficantly reduced the initial uptake of OMFD in the brain and in fhe 
heart. It was especially the signifieantly dirninished brain uptake (-70 %) &er L-phenylalanine CO- 
injection which confirrned that the compound crosses the blood-brain barrier through the arnino acid 
transport system L [8,9j. 
Btood Brain Muscle Liver 
I DCotumn 1 - 15 min p,i, CJCoturnn 2 - 45 min p.1. 
I DColumn 3 - 60 min p.i. EJColurnn 4 - 120 min p.i. i 
Fig. 3. Time Course of tumourlnon-tumour ratios after injection of OMFD in nude mice 
(ratio: % IDIg 1 % IDIg i SD; n = 6; tumour weight 0.45 i 0.37 g) 
Furthermore, the competition according to the tumour uptake of OMFD was demonstrated by 
investigating L-phenylalanine-loaded nude mice. The comparison of the tumour uptake as weil as of 
the tumourlnon-tumour ratios (Fig. 4) indicates that L-phenylalanine influences the distribution of 
OMFD in vivo. These results suggest that tumour uptake of OMFD was clearly reduced (approx. 20 %) 
by inhibition of the system L transporter. 
Table 2. Comparison of the distribution Patterns of OMFD in rats with and without 
L-phenylalanine as a competitive agent of the amino-acid transport system L 
(Wistar rats; 5 min p-i.; mean rt SD; n = 8). 
OMFD OMFD + L-~henvlalanine 
% IDIOrgan % IDlg %ID/Organ % IDIg 
Blood 0.69 0.05 0.79 r 0.15 
Brain 0.63 I 0.06 
Pancreas 1.1 1 10.22 
Spleen 0.39 r 0.05 
Kidney 6.49 t 0.38 
Muscle 0.37 I 0.10 
Heart 0.49 I 0.05 
Lung 0.81 I 0.12 
Femur 0.48 I 0.05 
LNer 6.77 I 0.73 
In sulmmary, the biodistnbution Pattern of 3 - 0 - m e t h y 1 - 6 - [ ' ~ ~ ] f 1 u o r o - ~ - 3 , 4 - d i h y d r o ~ i n e  
(OMFID) obtained in normal and tumour-bearing animals suggests that this compound is a useful 
tracer for tumour imaging, with a high tumour uptake as weil as a good tumourlnon-tumour contrast. 
Fig. 4. Tumour uptake and tumour/non-tumour ratios of OMFD in nude mice compared with the values 
obtained after injection of OMFD in L-phenylalanine-loading animals (ratio: % ID/g 1 % ID/g I SD; 
60 min p.i.; L-phenylalanine injection 30 min prior to OMFD) 
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2. "F-~abelled Neurotensin Receptor Ligands: Functional Studies 
R. Bergmann, M. Scheunernann, P. Mäding, H. Rodig, P. Brust 
The development of novel and sophisticated rnolecular probes for peptide receptors has provided new 
tools for the early diagnosis and potential therapy of malignant disease. Neurotensin (NT) receptors 
have been frequently detected in tumour cells of Ewing's sarcoma, meningioma, astrocytorna, 
rnedulloblastoma, rnedullary thyroid cancers and small-cell lung cancers. However, these receptors 
are rarely expressed in non-small-cell lung cancer and breast carcinoma; and are absent in prostate, 
ovarian, renal-cell and hepatocellular carcinorna, neuroendocrine tumours of intestinal origin, pituitary 
adenoirna, schwannorna, neuroblastorna and lyrnphoma [I]. The cell-line selective high expression of 
neurotensin receptors in ductal pancreatic adenocarcinoma rnight constitute the rnolecular basis for 
future clinical investigations, such as in vivo neurotensin receptor scintigraphy for early turnour 
diagnosis, radiotherapy with radiolabelled neurotensin analogues, and chemotherapy with neurotensin 
receptor antagonists [2]. 
The present work deals with the developrnent and initial evaluation of radiolabelled [ 1 8 ~ ] ~ ~  derivatives
as probes for the scintigraphic localization of NT receptor-positive turnours and their rnetastases in 
vivo. To this end, NT analogues of improved biological stability to enzyrnatic degradation were labelled 
with "F [3]. We are currently employing in vitro tests to verify the suitability and effectiveness of these 
modifications. In vivo experiments in healthy and in turnour-bearing anirnals will be used to screen the 
labelled peptides for later clinical oncology trials. 
In vitro binding studies 
The neurotensin-derived peptides were labelled with no-carrier-added N-succinimidyl-4- 
[18~]flworobenzoate ( [ 1 8 ~ ] ~ ~ ~ )  at high specific activity (5 - 15 TBqIrnrnol, 100 - 400 Cilrnmol) 131. To 
verify that the additional fluorobenzoyl group on the N-terrninus of the peptide does not alter the 
binding kinetics to the neurotensin receptor 1 (NTRI), we tested the in vitro accurnulation of the 
labelled peptides in a colon adenocarcinorna cell line HT-29 (ATCC No. HTB38) which expresses the 
NTRI. This bioaccumulation results frorn a sequence of events beginning with the binding of the 
ligands to the receptor, followed by internalization of the receptor ligand cornplex and nonspecific 
binding and distribution of the ligand within the cells. 
Fig. 3 .  Displacernent curves for '*F arid 'H-labelled analogue of NT in the presence of 
unlabelled peptide. 
We carried out competition studies with [ ' 8 ~ ] ~ ~ - ~ ~ ( 8 - 1  3), [ ' 8 ~ ~ ~ -  UNT(8-1 3) and [ 3 ~ ] ~ ~  as 
radioligands and with NT(8-13) as a cornpetitor. The apparent IC5~s (Fig 1) were 8 I: 3 nM, 3 + 2 nM 
and 6 + 2 nM, which cornes close to NT(8-13) (1 nM ). The nonspecific binding of the tracers was 38 
% of the total binding at an NT(8-13) concentration of 1 pM. 
The accumulation of fB~]F~-NT(8-13) and I'~F]FB-oNT(~-I~) in the cells was rneasured at 37 "C and 
4 "C in order to distinguish between saturable and reversible receptor binding which is not energy 
dependent and the subsequent internalization mediated by receptor endocytosis. More than 70 % of 
the [ ' 8 ~ ~ ~ - ~ ~ ( 8 - 1 3 )  and [ 8 ~ ] ~ ~ n ~ ~ ( 8 - 1 3 )  receptor complexes were intemaiiied &er 30 min at 37 
"C. At 4 "C about 26 % of the cell bound radioactivity remained within the cells after acid washing. 
To evaluate the binding of [I8FI~5NT(8-13) and [78FJ~5!J~~(8-13) to brain tissues expressing 
significant amounts of the high affinity NT receptor (NTR1) distribution we studied the in viao binding 
of these tracers using autoadiography. The [ 8 ~ ~ ~ - ~ ~ ( & 1 3 )  and [<'F]FB-UNT(~-13) biiding in rat 
brain slices (1 0 - 20 prn) was comparable to earlier reports [4]. The specific binding of [ QFB-NT(& 
13) and [ ' 8 ~ ] ~ ~ - ~ ~ ~ ( 8 - ~ 3 )  was highest in the mesencephalon and in descending order, in the frontal, 
parietal, temporal, and occipital cortices and in the cerebellum. 
Table 1. Tissue distribution (% lD/organ I SD) of radioactivity derived from ~'F]FB-NT(~-I~) and 
[ ' 8 ~ ~ ~ - y ~ ~ ( 8 - 1 3 )  in nude mice bearing human colon adenoc?f3noma HT-29 30 minutes,$fter 
simultaneous administration of saline or 2 pg NT(8-13) and 4-[ FIFB-NT(8-13) (n = 4) or [ FJFB- 
yNT(8-13) (n = 4) 
4-f8F]FB-NT(8-13) 4 - f 8 q ~ ~ - y ~ ~ ( 8 - 1  3) Tissue 
Control NT(8-13) P valuei Control NT(8-1 3) P values' 
Brain 0.01 * cO.01 0.02 I 4.01 0 .n  0.00 I 0.02 0.06 s 0.02 0.77 
Pancreas 0.12 & 0.03 0.14 a 0.03 0.1 6 0.09 I 0.04 0.1 1 s 0.07 0.77 
Spleen 0.04 t 0.02 0.04 I 0.01 1.00 0.1 1 * 0.05 0.10 ;t 0.05 1 .OO 
Kidney 1.89 I 0.91 2.30 I 0.68 0.29 4.1 1 * 1.24 6.92 & 3.94 0.39 
Stomach 0.28 i 0.1 9 0.49 I 0.36 0.29 011.3 I 0.15 0.66 X 0.32 0.25 
Heart 0.03 i <0.01 0.04 I 0.02 0.29 0.16 I 0.07 0.16 .;t: 0.09 0.77 
Lung 0.24 I 0.08 0.34 I 0.18 0.72 0.76 I 0.19 0.82 Y 0.67 0.56 
Liver 9.31 -t 3.78 20.81 I 7.06 0.03 32.54 I 9.24 38.14 a 10.05 0.1 4 
Tumor 0.06 I 0.05 0.14 I 0.07' 0.1 6 0.12 I 0.15 0.29 Y 021 0.08 
Intestine 1.92 I 0.52 2.08 i: 0.99 1 .OO 5.94 I 2.72 3.27 a 1.44 0.08 
'P vaiues (2-tailed P corrected for ties, Mann-Whiiy-Test) for 30 min V8fl~i3-~~(8-13) or 
[IsFJ~~-y~~(g13) in mice with and without NT(8-13) (2 pg) pretreatment. 
% IDlogan = percentage injected dose per ogan 
In vivo evaluation 
The biodistribution and biokinetics of the f8FJF&labelled compounds wer@ evaiuated in separate 
experiments with and without simultaneous injection of NT(8-13) in WisW mts and in nude mice 
bearing the solid human cobn adenocarcinoma HT-29 on the right kg. Radieracziuity concentrations 
were measured by gamma-counting of tissue samples and by Positron Emission Tomgraphy (PES). 
We calcuiated the distributiian sind Wwücs of the [ ' 8 ~ ~ ~ - ~ ~ i & 1 3 )  and af f'B~jf=B--.~NT(8-33) relative 
to the tissue radioactivity concentration, assuming that ihe tracer was untransfonned in vho. The 
verification d 's~-labelled meZabolite formation will be the subjeet of a later study. 
The biodistribution and biokinetics of f ' s ~ ~ & . ~ ~ ( 8 - 1 3 )  and of ~ s ~ ~ B - ; l ~ ~ ( 8 - 1 3 )  in rats and nude 
mice beafing a solid HT-29 celt tumour were qua5itia.tIvely simifar: the apparent bfoad clearance ef the 
' 8 ~  radioacWi after injection 01 [ ' 8 ~ ~ ~ - ~ ~ ( 8 - 1 3 )  and p 8 ~ ] ~ & 3 ~ ( 8 - 1 3 )  was rapid in tho mntrol 
group. The co-injeciion of NT(8-$3) resulted in a slowrvr clearance of the radi-tctjviw ffam the blood. 
The biodistribution data from the experiments in mice are shown in the Table 1. The kidneys were the 
main excretory Organs of [ ' 8 ~ ] ~ ~ - ~ ~ ( 8 - 1 3 )  and of [ ' 8 ~ ] ~ ~ - o ~ ~ ( 8 - 1 3 ) ,  with a maximum of accumulated 
radioactivity occurring after 8 to 10 min post injection. The urine (collected 30 min ost injection) of the 13 animals contained 61 %ID "F radioactivity of [ ' 8 ~ j ~ ~ - ~ ~ ( 8 - 1 3 )  and 43 % ID of [' FIFB-oNT(8-13). A 
high net uptake of both compounds was also measured in the liver and the intestine. 
Fig. 2. Static PET 30 min. p.i. of the [ ' 8 ~ ] ~ ~ - ~ ~ ~ ( 8 - 1 3 )  accumulation in two animals 
bearing HT-29 tumours of 0.5 cm diameter in the right leg 
The ex-vivo autoradiography (Fig. 3) of the tumours demonstrated a non-homogeneous distribution of 
radioactivity in the tumours, with the highest radioactivity found in the growing zones. No necrotic 
regions were detected in these tumours by histology. 
autoradiogram histology 
Fig. 3. Ex vivo autoradiography: Distribution of [ ' 8 ~ ] ~ ~ - ~ ~ ~ ( 8 - 1 3 )  in an HT-29 tumour from tumour 
bearing mice 
Conclusion 
In conclusion it was demonstrated with PET that tumour tissue can be visually detected with the 
stabilized '8~-labelled neurotensin derivative [ ' 8 ~ ] ~ ~ - [ 3 ~ ~ ( 8 - 1 3 ) .  This compound may be used as a 
lead substance for the development of an '8~-fluorobenzoylated stabilized neurotensin derivative for in 
vivo studies. 
This work is supported by the European Union (BMH4-CT98-3198). 
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3. PET for Evaluation of the Tumour Metabolism in Malignant Lymphomas - Cost - 
Benefit Optimization 
R. ~aumann', B. 5euthien-~aumann~, L. schirme?, C. ~iepolt~, J. ~ropp', W.-G.  ranke', 
G. ~hninger' 
'~edizinische Klinik und Poliklinik I, '~linik und Poliklinik für Nuklearmedizin, f U Dresden 
Introduction 
Positron Emission Tomography (PET) has the special advantage compared with conventional imaging 
techniques (ultrasonography, X-ray, CT, MRT) that it uses tumour metabolism to demonstrate the 
tumour location and to differentiate necrosis, vital tumour tissue and tumour recurrence [I]. 
Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) has been shown to 
improve the diagnostic accuracy in the staging an$ follow-up of malignant lymphomas 12 - 41, based 
on the metabolic signal of the vital lesions. 
At present PET is oniy avaiiable in a few places. It is an expensive method due to the elaborate 
technology. Recently it has becorne possible to extend the conventional double head gamma camera 
wideiy used in nuclear medicine to the coincidence mode (MCD system) and thus use this 
investigation more widely and more cost-effectively. For technical reasons, the resolution of the double 
head gamrna carnera is less than with the modern dedicated PET scanner. 
In a prospective investigation this method was to be compared with the dedicated PET method with 
regard to its diagnostic accuracy. 
Materials and Methods 
Patients: 
13 patients with Hodgkin's disease (7 female, 6 male, age 17 - 47 years) and 2 patients wi?h high- 
grade NHL (1 fernale, 1 male, age 21 and 54 years) were investigated. 
Blood glucose levels at the time of investigation were within physiological limits, none of the paa'ents 
was diabetic. 
lmaging procedures: 
45 - 60 minutes after injection of 300 - 370 MBq "F-FDG, the patients were first investigated with 
dynamic positron emission tomography using a dedicated full-ring PET scanner (ECAT EXACT-HR+, 
Siemens) and afterwards with the double head gamma camera modiiied for coincidence detection 
(Solus EPIC, ADAC) for primary, recurrence and residual staging. 
Results and Discussion 
Whereas in the investigation of residual staging after chernotherapy and/or radiotherapy the resuks 
were consistent (715 cases), 3/10 patients were staged too low with the double head gamma mmera 
according to the Ann Arbor classification (Table 1). 
Table 1. Prirnary staging and restaging based on FDG imaging with 
the dual head wincidence system or the dedicated PET scanner 
Stage Dedicated PET MCD systern 
I 0 0 
Wih the dedicated PET, 60 affected regions (lymph node regions or Organ maniiestations) were 
detected as cornpared 10 46 with the double head gamma camera (Table 2, Fig. 1). 
Table 2. Comparison of lesion detection with the dual head coincidence system 
and the dedicated PET Scanner in various body regions. 
Reaion Dedicated PET MCD system 
cervical, supra-, infraclavicular 
mediastinal, hilar 
axilla 
splenic hilum, porta of the liver 
paraortal, iliacal 
inguinal 
spleen 
bone marrow 
skeleton 
Fig. 1. A 20-year-old woman with recurrence of Hodgkin's disease. Several lymphomas were 
visualized with FDG. Pathological accumulation in the mediastinum and right parahilar region 
was only visualized with dedicated PET. 
To summarize, the conventional double head gamma camera extended by the coincidence mode 
without attenuation correction cannot yet be recommended at least for primary staging. 
Recentiy Zimny and colleagues investigated patients with suspected or known malignant diseases in a 
comparable setting. He summarized that MCD cannot yet replace dedicated PET in all oncological 
FDG studies [5]. Further technical refinement of the MCD method such as the introduction of 
attenuation correction is required to improve the image quality. 
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BRAIN BIOCHEMISTRY 
4. Is the Lumped Constant a Real Conatant? 
H. ~uwabara', P. Brust 
1 Departrnent of Neurosurgery, West Virginia University Morgantown, USA 
lntroduction 
['8~]~luoro-deoxyglucose (FDG) is widely used for the measurernent of glucose utilization in the brain with 
positron ernission tornography (PET). The FDG-PET rnethod requires a factor in order to correct for using 
FDG in place of native glucose in the rneasurernent. The factor is often referred to as the "lurnped 
constanl' (LC) because the factor is a lumped effect of two constants of two independent systerns, narnely 
the transport ratio (2 or K1./Kl) and the phosphorylation ratio (cp or &/k3) [I]. (See Theory for the definitions 
of symbols.) In the brain, the value of T is considered to be greater than one while the value of <p is 
considered to be significantly lesa than one (-0.3) [2, 3, 41. This difference givec rise to a valid theoretical 
reason to expect that LC is a function of glucose concentration in plasrna as described below. Thus, we 
exarnined the effects of glucose concentration in plasrna on the value of LC in this project. 
Theory 
In the FDG-PET method, the regional glucose utilization, rCMR„, is given by: 
where K is the net clearance rate constant of FDG rneasured with PET, and C, the concentration of 
glucose in plasrna. Using 2 and cp, LC is given by Kuwabara et al. [4]: 
where 2 is the transport constant which is given by the unidirectional blood-brain clearance rate constant 
of FDG, K,', over that of glucose, K, , and cp is given by the phosphorylation rate constant of FDG, 6, 
over that of glucose, k. The equation indicates that LC is a real constant only when 2 is equal to rp. It is 
reasonable to expect that K,' is rnore influenced by the plasrna g l u c o ~  concentration than K because ~ 1 '  
is related directly to the blood-brain transport of glucose while K is related botk to transport and 
phosphorylation. Thus, it is likely that LC is influenced by the plasrna glucose concentration [4]. 
In order to achieve our goal, it is necessary to obtain &MBgIC with an independent rnethod. Unfortunately, 
rCW&,, is only accessible by the tracer method. However, the whole brain glucose utilization, wCMRg,c, is 
directly accessible. According to the Fick principle, ~Cbl&,~of a steady state is given by: 
- 
wCMR„ = F .  (C, - C,) 
where F is the mean global blood flow, CO and C, are the rnean glucose concentrations in the arterial 
and venous plasrna. C' can be replaced by C, rneasured in plasrna obtained frorn the femoral artery, and 
- C, by C, rneasured in plasma obtained frorn the Superior sagittal sinus, assuming blood frorn various brain 
regions is rnixed well by the time it reaches the sarnpling site. F can be estirnated in individuafs in the 
Same study as the glucose utilization measurernent. When the Fick principle is applied to FDG, the rate of 
change in the whole brain radioactivity is given by: 
where ~ ' ( t )  is the whole brain radioactivity. When the equation is integrated from time 0 (FDG injection 
time) to T, the left hand side of the equation is given by A *(T) - V, . Ca (T) where Ä* (T) is the rnean 
whole brain radioactivity measured with PET, vo the rnean vascular volume in the tissue, and cae(f) the 
radioactivity in arterial plasma. C:(t) can be replaced by ca.(t) because there is little regional variation in 
ca.(t). C,:(t) is not accessible because it is the rnean radioactivity at the venous ends of capillaries. 
Assurning tiny tissue units, <(t) is related to the radioactivity at the venous ends of capillaries, C, (t), 
as follows: 
We chose to sarnple venous blood at the distal end of the superior sagittal sinus. Let C,; (t)denote the 
portion of the radioactivity due to C,: (t) in plasma sampled at the site. C,; ( t )  not only delays by Ati in 
timing relative to C; (t) due to the travel frorn the tissue to the sampling site but also is smeared (i.e., 
dispersion). According to the equation proposed by lida et al. [5], C; ( t )  is related to C, (t) as follows: 
Cl; (t) = Cl: (Y) + W; - dz; (U) 
du 
where U is equal to t+Ati, and w i  is the dispersion constant for the smearing of the radioactivity due to 
the travel. By integrating Equation 6 from time 0 to T, we obtain: 
It is likely that both At,and mi have normal distributions because the distances frorn the individual units 
to the sarnpling sites are likely to be distributed norrnally. Under these assumptions, C,:@) is related to 
C,: (t) as follows: 
T+A$ - T+& -* 
c(r )d t  = Cf, (Io C: (ir)du + (T + Ati )) = I C,. (u)dir + (T + At) (8) 
0 
By substituting c:(t) by ~ , * ( t )  , and C,* (t) by Equation 8 in the integration of Equation 4, we obtain: 
There are three variables to estimate by Hie least Squares method, namely F ,  At, and o in Equation 9, 
whiie A*(T) and Ca*(f) are measured in experirnents, and vo is sei to 0.035 mVg. 
Method 
Data obtained in 22 pigs in a preceding paper were used [6]. Briefly, three rate constants of FDG, K~', k,',
and kc, and vo were estimated in 12 ROls on each pig. The rCMRdC were calculated by Equation 1 where 
K of FDG was calculated as K ~ *  . k*/(k2*+ k*). The value of LC was set to 0.46 which was reported for the 
rat brain [I]. 
We estimated the whole brain blood flow using Equation 9 in 13 of the 22 pigs from which venous blood 
was taken successfully at the Same schedule as arterial blood. 
Results and Discussion 
The rCMßglc averaged 19.7 f 3.1 ymoV100g/min (mean I SD) among 12 R01s of 22 pigs. Individual 
rCMRg~C were plotted against the mean concentrations of glucose in arterial plasma (0 - 45 minutes), Ca, in 
Fig. 1. These rCMRgIC were not stable across C,. They (rCMRdC) were greater than the mean of all the 
ROls in the pigs whose Ca was less than 2 ymoVml. This sudden increase in calculated rCMRdC at low 
plasma glucose levels may or may not accompany an increase in the true rCMR&. For example, if the 
true rCMßglc remain unchanged, our obsewation should be an artifact due to using a fixed value for the 
lumped cons'tant while adjustment in the value is appropriate. In fact, Crane et al. reported a sudden 
increase in K of [3~]deoxy-glucose relative to K of ['4~]glucose when the brain glucose concentration 
was reduced below 0.5 pmollg (which corresponded to 2 pmoVml in plasma glucose concentration) [6]. 
The authors explained that, at a very low brain (and plasma) glucose level, the K~*-K ratio was close to 2 
because rCMRgfC an6 the net uptalce of f%f]deuxygtucose were iimited by blood-brain transport (i.e„ 
transported glucoce and fracer wem irnmediately phosphorjrfated). When brain gfucose content was 
above 0.5 yrnotlg, the authors found the &'-K rarjo invariant. Our finding was in contrasf to thfs. 
Calculated rCMRgfG increased as a funcsion of C, between 3.5 and 11 pmoltml (rCMR9iC = 1.14. C, +I *?, 
r2=0.600. The regression Iine is shown in Fig. 7). Alfhough Zhe sfope is close to unity, %he equation 
indicated %hat cabulated rCMRgiC at 10 yrnoVmt (23.1 ymol/l0ä&min) was about 42 % greaW %an 
~aiculated rCMROIC at 4 yrnol/ml (16.3 pmol/lOOgfmin) if a fixed value of LC was used. This finding 
indicated Ihat it is necessary to adjust LG according to pplasma glucoce tevefs even within commonly 
encountered ptasrna glucose levels. 
In the process of estirnating the whole brain blood flow, calculated radioactivity in the brain using Equation 
9 (Fig. 2, shown with the solid curve) was close to measured radioactivity (circles) in all 13 pigs. The 
whole brain blood flow averaged 35.5 t 10.6 mI/lOOg/rnin. We found a relatively large coefficient of 
variation in the values (30 %). There are several explanations for the large variance. First, arterial blood 
was sampled not frorn the arterial end of brain capillaries but from the femoral artery. Measured Ca* was 
modified to account for this fact using two constants similar to At and m defined for the venous blood. The 
two constants were estimated for the whole brain. The error on the estimation rnay have propagated to the 
estirnation of the whole brain blood flow. Second, sampled blood from the superior sagittal sinus rnay not 
reget3 the average of the whole brain. Venous blood samples rnay have been contarninated by blood from 
outside the brain. The arterio-venous difference in glucose concentration was 0.64 f 0.21 prnol/rnl. It was 
our surprise to find a relatively large coefficient of variation also in this variable (%%). The rneasurements 
were made in duplication and values were in close agreernent among duplications. Again it was not 
certain whether venous blood obtained through the catheter reflects sarnples frorn the sarne brain regions 
among pigs, although we tried to place the tip of the catheter in a f ied  place (5 crn posterior to the 
bregrna). The product of the whole brain blood flow and the arterio-venous glucose concentration 
difference, wCMRdC by the Fick principle (Equation 3), was 23.2 f 11.9 prno11100g/rnin (coefficient of 
variation: 51 5%). The large variation precluded detailed exarnination of the relationship between wCMRg/c 
and the plasma glucose level. In the 13 pigs, the product of Fand Ca averaged 9.1 rt 2.2 prnoVlOOg/rnin. 
We found the value of LC to be 0.39 (ratio) in this experirnent to equate wCMRgIC by the Fick principle and 
wCMR* by Equation 1. 
Summary 
1. Calculated rCMRac increased as a function of Ca between 3.5 and 11 ymoVrnl (rCMßglc = 1.14 . C, 
+lt.7, ?=0.600) when a fixed LC was used. Thus, there is a need for adjusting LC according to 
plasrna glucose levels. 
2. When plasrna glucose was below 2 yrnoYrnl, there was a sudden increase in calculated rCMRglc. This 
phenornenon suggested that rCMRsrC and the net uptake of FDG were lirnited by the transporl at very 
low glucose levels. 
3. We demonstrated that the whole brain blood flow could be estimated with the FDG-PET rnethod. 
However, a iarge variance in calculated wCMRsrc by the Fick principle precluded detailed comparisons 
of wCMRgIc with plasrna glucose levels. 
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Blood-Brain Transport of Glucose Studied with ["~]3-GMethylglucose and 
['8~~luorodeoxyglucose 
<uwabaral, P. Brust, R. Bergmann, P. Mäding, J. Steinbach 
1 Departrnent of Neurosurgery, West Virginia University Morgantown, USA 
lntroduction 
The blood-brain transport of glucose may be involved in the pathophysiology of sorne neurological 
diseases including Aizheirner's disease [I]. The transport makes it possible for glucose, the brain's sole 
energy source, to enter the brain. In this project, we examined which tracer was rnore suitable for 
investigating blood-brain glucose transport, ['8~]fluoro-deoxyglucose (FDG) or ["~]3-(rmethylglucose 
(OMG). FDG is widely used for rneasurernents of glucose rnetabolisrn in the brain. FDG has two fates in 
the brain, narnely being phosphorylated and trapped in the brain or being transported back to the 
circulation. This dual-fate feature rnade the estirnates of the unidirectional blood-brain clearance of FDG, a 
rneasure of glucose transport, uncertain [2]. In contrast, OMG has only one fate in the brain because it is 
not metabolized [3,4]. Thus, OMG is expected to yield accurate estirnates of glucose transport. 
Theory 
The unidirectional blood-brain clearance rate constant of FDG and OMG (K,') is relevant to the blood- 
brain transport of glucose because glucose and tracer cornpete for the saturable transport. It was 
dernonstrated repeatedly by several authors that the Michaelis-Menten equation describes the facilitated 
transport of glucose in anirnal experiments [5,6]. Accordingly, (K,*) is related to the maximal transport of 
OMG or FDG (f„), the half saturation constants of glucose and OMG or FDG ( 4  and F ) ,  and the 
concentration of glucose in plasma (Ca) by the following equation [7] (Symbols with stars are of radio- 
tracer and those without stars are of glucose throughout the text): 
In the derivation of the equation, the concentration of OMG or FDG in plasrna was considered negligible 
cornpared to C,. The equation can be rearranged as follows: 
T *  
where T „  is equal to f„, . K&. The two constants T& and K, can be estirnated using a plot of K,- 
versus Ca. It is not practical to repeat rneasurernents of K,* in one individual an adeqyate nurnber of times 
to estirnate the constants (at least at six concentrations). Therefore, we rneasured Kl in a group of pigs at 
varying concentrations of plasrna glucose and estirnated the constants, assuming that the constants are 
cornrnon arnong individuals. 
The ratio of K,' to the brain-blood clearance rate constant (k2*) is another variable which is relevant to the 
blood-brain transport of glucose. According to the Michaelis-Menten equation, the ratio, denoted by V„ is 
comrnon between glucose and the radiotracer and given by 181: 
where M, is the content of free glucose in a brain region. (Strictly speaking, we need to differentiate the 
content as M, and the concentration as C,. We will treat thern equally for the sake of sirnplicity in this 
paper). Separately, the glucose utilization of the region is given by: 
Eliminating kz ' Me using Equations (3) and (4), we obtain the following equation: 
V, = 1 
l+cl[K, - K,] 
Complete derivation of the equation can be found in a paper under preparation. Substituting KI with 
T„d (K, + C,) we obtain the following equation: 
Thus, we can estirnate [Tma, ' Kdc] and [Tmm ' Klc] + K, from a plot of V, versus Ca, assuming common 
values among individual pigs for the two constants. 
Methods 
We studied 22 pigs (-6 weeks old, body weight -20 kg) in this project. Under isoflurane anesthesia, each 
pig underwent one OMG-PET scan and, 4 hours later, one FDG-PET scan. All pigs were on a fast at least 
one day prior to the study. Concentrations of glucose in plasma were reduced in 6 pigs by subcutaneous 
injection of insulin (-5 I.U.) and increased in 9 pigs by means of intravenous bolus injections of 20 % 
glucose, which were followed by a continuous infusion of 5 - 20 % glucose. In the remaining 7 pigs, no 
attempts were made to modify the plasma glucoae concentration. In all pigs, plasma glucose levels were 
monitored at intervals ranging between 5 and 10 minutes. In experiments in which plasma glucose levels 
were modified, glucose levels were maintained starting 30 rninutes before tracer injection throughout the 
PET experiments by rneans of additional subcutaneous insulin or adjustments of glucose infusion rates. 
PET studies started with a slow-bolus injection of OMG (465 t 146 MBq, in 5 ml saline) or FDG (998 9 
167 MBq in 5-10 ml saline) over 30 seconds or one minute into the vein. PET data acquisition was also 
started at the start of the injection (time 0). A total of 26 frames were recorded with the Siemens EXAGT 
HR+ PET across 60 rninutes. There were 6 thirty-second frames, followed by 7 one-minute frames, 5 two- 
minute frames, and 8 five-minute frarnes. Arterial blood was sampled from the femoral artery and venous 
blood was sampled from the superior sagittal vein. Both arterial and venous blood was withdrawn with 
pumps at a constant speed for the first 20 rninutes. Blood samples wer@ collected into test tubes every 20 
seconds for the first 6 minutes and every minute thereafter. Blood samples were taken rnanually every 5 
minutes after 20 minutes. Sarnples were immediately placed on ice. Concentrations of glucose in arterial 
and venous plasma were determined every 5 minutes by the EGA PD 10 automated glucose analyzer. 
Th@ radioactivity in plasma was determined with the Wallac 1480 Witard 3 automated gamma counter 
which was cross-calibrated with the PET. 
We obtained the radioactivity in brain regions as functions of time, A'(T), as follows: first, templates 0f 
regions of interest (ROIs) were defined for left and right frontal, temporal, parietal, and occipital fobf2S, 
basal ganglia, and cerebellum on magnetic resonance images of a pig (12 ROls). Then, the templates 
were modified in space for the orientation and sizes of the individual pi$s brain. The individualized 
templates were repeatedly applied on individual PET frames to obtain A (T). A (Q was expressed in 
nCi1ml after being corrected for physical decay of the isotope to time 0. The radioactivity in arteiial plasma, 
c;(t), was expressed in nCiml with decay correction. Also prepared were glucose concentrations in 
arterial blood, which were the means of the five samples taken during the first 20 minutes- It is known that 
the estirnates of i(; were determined largely by the data obtained during the first 20 minutes {l. 
The regionat rate constants of OMG were estimated by the mean of the teast Squares method using the 
following equation: 
A* (T )  = K; f C,' ( t )  . e-*;"-T'dt + V. . C: ( T )  . . .(7) 
where V, is the effective vascular volume of the region. The regional rate constants of FDG were 
estimated using the following equation: 
A* (T)  = K ' f  C,' (t)dt +(K; - K *) . C: ( t )  . e-(k;+ki'"-T'dt +V, - C: ( T )  
0 
where k i  is the phosphorylation rate constant of FDG and K is the net clearance rate constant of FDG, 
which is equal to K,' . &I( k2'+ k'). 
Results and Discussion 
Estimates of K,* of OMG (leit panel) and FDG (right panel) were plotted against plasma glucose level in 
Fig. 1, for the right parietal lobe. The curves indicate the best fit to the data by Equation (2). Among 12 
ROls, estimates of T A ,  of OMG averaged 0.79 tr 0.04 pmol/g/min (mean tr SD, range: 0.74-0.86 
pmol/g/min), and Tm, of FDG averaged 2.2 I 0.22 pmoVgimin (range: 1.9-2.6 pmol/g/min). Recently, Van 
Zijl et al., reported a value of 0.83 + 0.19 pmol/g/min for T '  of [I-13C]glucose in the cat brain with a 
fixed K, (5 pmol/ml) using magnetic resonance spectroscopy [9]. According to Crane et al, Th, of FDG 
was calculated as1.06 pmol/g/min in the rat brain [IO]. These values were in agreement with our value for 
OMG. Estimates of Kt of glucose averaged 7.1 tr 0.8 pmol/ml (range: 6.2 - 9.0 pmoVml) in OMG 
experiments, and 15.6 f 2.1 pmol/ml (range: 13.0-18.7 pmol/ml) in FDG experiments. Crane et al. 
reported a value of 1 1.0 pmollml for the rat brain which is in agreement with our values by OMG [I 01. The 
corrected residual square sums (residual square sum over mean K,*) were significantly greater for FDG 
experiments than for OMG experiments (t=-11.7, paired t test). This finding confirmed that estimates of K, 
by FDG suffered uncertainty. lt was speculated that the uncertainty, especially in lower glucose levels, 
explained the differences between T& as well as between K, obtained by the two tracers, as discussed 
later. Assuming the values obtained by OMG were correct, 6 of glucose obtained in OMG experiments 
was greater than those reported for human and animal experiments (-4.8 mM). There are several reasons 
to explain the differences. In previously published experiments, solutions of varying glucose 
concentrations were injected into the carotid artery as boluses together with reference markers to obtain 
plots of K,~versus glucose concentration [4, 51. In this project, we chose to maintain plasma glucose level 
constant throughout the measurements of K, of OMG or FDG with PET in order to make the experimental 
conditions close to the physiology. 
In Fig. 2, estimates of V, of OMG (left panel) and FDG (right panel) were plotted against plasma glucose 
levels. The lines indicate the best fit to the data by Equation (6). Regional estimates of [T„: Kdc] 
averaged 7.1 o 0.29 pmollml (range: 6.6 - 7.5 pmol/ml) in OMG experiments, and -0.48 f 0.81 pmol/ml 
(range: -1.5-0.30 pmoVml) in FDG experiments. Regional estimates of [T„ . Kdc] + K, averaged 14.5 f 
0.58 ymoVml (range: 13.6 - 15.3 ymoVml) in OMG experiments, and 4.9 f 3.5 pmollml (range: 1.6 - 10.9 
pmollml) in FDG experiments. The estimate of K, which was given by the difference of the two estimates 
was 7.4 f 0.3 pmoüml (range: 6.9 - 7.8) by OMG, and -G!& 1.8 pmsl/ml (range: -7.0 - -2.4) by FDG. The 
regional values of K, yielded by the V, - Ca plots were very close to K, given by the K,'- C, plots with OMG. 
In contrast, K, given by the two plots of FDG were incomparable. Values of Ve were greater by several 
folds obtained by FDG than when obtained by OMG at lower C, (c4 pmoVml). The finding confirmed the 
uncertainty of rate constants obtained with FDG. Our results indicated that Ve of OMG may be used to 
characterize blood-brain transport of glucose. For example, changes in Kt due to a pathophysilogy may be 
detected by this method. However, it is questionable whether changes in T„ can be detected because 
the other constant, [Tm, ' Kt/c], also includes other two variable which are subject to changes in 
neurological conditions. The advantage of this method is that Ve may be estimated as the ratio of the 
radioactivity in brain regions to the radioactivity in plasma when OMG is in a near steady state (some 
times after OMG injection) without arterial blood sampling. This feature makes the method especially 
useful to studying elderly, diseased subjects. 
Summary 
1. Blood-brain transport of glucose was described by the Michaelis-Menten equation when it was studied 
with f1c]3-~methylglucose and PET. 
2. Estimates of K1* and V, of FDG suffered uncertainty when tested by the Michaelis-Menten equation. 
Thus, ["~]3-0-methylglucose should be used to investigate blood-brain glucase transport. 
3. K,' itself does not give infomiation on the blood-brain transport of glucose because K, is a function of 
plasma glucose level. It requires two Michaelis-Menten constants to characterize the blood-brain 
transport sf glucose. 
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6. Regional Estimation of Michaelis-Menten Constants of Blood-Brain Glucose 
Transport in Single Subjects with ["C]3-0-Methylglucose 
H. ~uwabara', P. Brust, P. Mäding, R. Bergmann, J. Steinbach 
'~epartment of Neurosurgery, West Virginia University Morgantown, USA 
lntroduction 
It is generally believed that the unidirectional blood-brain clearance rate constant of [18Fjfluoro- 
deoxyglucose (FDG) (Kl ) is a usable index of blood-brain glucose transport [I]. In a preceding-study [P], 
we demonstrated )hat [' C]3-0-methylglucose (OMG) yielded more accurate estimates of K1 than did 
FDG, and that Kl is a function of plasma glucose level with two constants, namely relative maximal 
transport of OMG ( T h )  and the half-saturation constant of glucose (K,) of the Michaelis-Menten 
equation. In that study, the two constants were estimated in a group of pigs with different plasma glucose 
concentrations, assuming common values for the constants among individuals. 
In this study, we examined whether the two constants could be estimated regionally in a single subject 
with acceptable accuracy when subjects are sscanned with OMG twice at different glucose levels. It is 
expected that such a method is useful to detect changes in blood-brain glucose transport in pathologiml 
conditions. 
Theory 
According to the Michaelis-Menten equation for blood-brain glucose transport, K~' of OMG is given by 
[2,31: 
where C, is the glucose concentration in plasma. By rearranging this equation, we obtain: 
T:, = K~* - (Kr + C,) 
When K~ '  is measured at two plasma glucose concentrations, T& and K, are given as solutions of the 
following equations: 
where [I"'] and [2M1] are to denote that variables are obtained in the 1'' and 2"d OMG-PET studies, 
respectively. 
Methods 
We studied 6 young pigs (-6 weeks old; body weight -20 kg) under isoflurane anesthesia in this study. 
Each pig was studied with OMG and PET twice, at iow and high pfasma glucose levels, Prior to the first 
OMG experiment, blood glucose level was iowered by subcutaneous injection of insulin (-5 !,U.) and 
maintained throughout the experiment. Then, blood glucose level was increasd by means of an 
intravenous bolus injeetion of 20 % glucose, sind maintained by a continuous infusion of 5 - 25 % glucoce 
throughout the second OMG experiment. PET procedures which were identical for the Wo stubles, can be 
found elsewhere[2]. Briefly, at time 0, a slow bolus injection of OMG, over one minilte, was adrninistered 
and PET scanning was ctarted. A total of 26 PET frames w e  taken across 60 rninutes. Arteriai b l o d  
was sampled frequentiy at the beginning and at prolonged intenrals toward the end .Bf the study. 
Standard ROI templates were adjusted in locations arid sizes to individual pigs. The radioactivity was 
obtained as a function of time in 12 brain regions by applying modified standard ROI templates on 
successive PET frames. The ROls included left arid right frontal, temporal, parietal, and occipital lobes, 
basal ganglia, and cerebellum. 
The unidirectional blood-brain and brain-blood clearance rate constants (K,* and k2', respectively) of OMG 
were estimated by least Squares optimization using the following equation: 
where A*(T) is the radioactivity in a brain region measured with PET, ca'(t) the radioactivity in arterial 
plasma, and vo the effective vascular volume in the region. The product of v6Ca (0 is used to subtract the 
radioactivity in the vascular space. 
In one analysis, we estimated regional values of Tm, and K, by Equation 1, assuming common values 
across individual pigs. In the other analysis, we estimated the constants by Equation 3 for individual 
regions in each pig. 
Resuits and Discussion 
Regional estimates of TL, by Equation 3 averaged 0.83 + 2.6 ymol/g/min and K, averaged 7.7 f 36 
pmollml. We found that one pig was responsible for the large variance. In this pig, plasma glucose 
concentrations were 4.7 ymoUml in one experirnent and 3.8 ymoUml in the other experirnent while the 
differences ranged from 7.7 to 8.9 ymoVml in the remaining experiments. Thus, this pig was excluded 
from the calculation of T I „  and K, when Equation 3 was used. Regional estimates of the two constants 
are shown in the Table below together with the vallues obtained by Equation 1 [2]. 
Table 1. Regional estirnates of T- and K, obtained by one OMG-PET study 
Regions 
Frontal lobe 
~emporal lobe 
Parietal lobe 
Occipital lobe 
I I 
Values by Equation 3 are greater than values by Equation 1 (paired t-test, p ~0.001). 
Basal ganglia 
Cerebellum 
Mean 
Regional estirnates of T'„, by Equation 3 (=Y) correlated with the estimates by Equation 1 (=X) (y = 
1 .l6-X-0.08, i!= 0.721), although the estimates by Equation 3 were significantly greater than the estimates 
by Equation 1 (t = 9.63, p~0.001, paired t-test). We found a range of coefficients of variations (COVs) 
among individual pigs between 17 and 37 %. Witlh a 17 % COV, 9 subjects are needed b detect a 30 % 
change in T'„ at a power of 0.8, a commonly accepted level[4]. With a 37% COV, such a change cannot 
be detected with that 0.8 coniidence level, and 16 pigs are needed to detect a 50% change in T'„,. 
Regional estimates of K, by Equation 3 (=Y) correlated with the estimates by Equation 1 (=X) (y = 1.1 5-x- 
0.45, 8 = 0.975). The estirnates by Equation 3 were significantiy greater than the estimates by Equation 1 
(t = 7.94, p 0.001, paired t-test). Regional COVs among individual pigs ranged from 20 % to 46 %. With 
a 20 % COV, 12 pigs are needed to detect a 30 % change in K, at the 0.8 confidence level. With a 46 % 
COV, even 50 % change cannot be detected. Thus, the proposed mettiod may not be used to compare K, 
between Wo groups unless the differente beWeeln the groups is expected to be greater than 50 %. 
G, (ymoi/g/min) 
1.05 
1.06 
1-00 
Equation 1 
1.01 
K, (pmoVml) 
1.06 
1.01 
1.03 + 0.03 
Equation 3 
1 .09 f 0.21 
Equation 1 
9.3 
1.16 k0.34 
t .12f 0.19 
1.07 + 0.20 
Equation 3 
10.2 I 2.4 
1.18It0.45 
1.12 t 0.36 
1.12 f 0.04* 
12.5 
10.5 
10.4 
13.8 f 4.4 
1 1.2 f 2.2 
11.3 f 2.3 
13.1 
9.9 
10.9+ 1.5 
14.8 + 6.8 
11.3k4.7 
12.1 t- 1.8* 
We found that both T A  and Kt of this study were significantly greatter than those estimates obtained 
using Equation J in the preceding study. In order to understand the reason for the differences, regional 
estimates of K1 of OMG were plotted against plasma glucose concentration in Fig. 1. The curve in the 
figure demonstrates K1' caiculated by Equation 1 using the mean estimates of T"„ (0.79 pmol/g/min) and 
Kt (7.1 pmoVml) of the preceding study. Estimates of K1* of this study distributed across plasma glucose 
levels in a similar manner to K1. of the preceding study. However, K,' values of this study were below the 
curve in a majority of regions at lower plasma glucose levels (c3 pmoVml) and above the curve in a 
majority of regions at higher glucose levels.(>8 pmoVml). In short, K,* values of this study changed less 
with plasma glucose concentration than Kl values of the preceding study, which made both-estimates 
greater. Fig. 2 illustrates this phenomenon for the right parietal lobe. In the figure, individual Kl values of 
this study were plotted agaiqst the plasma glucose concentration with Open circles together with a solid 
curve indicating predicted Kl by Equation 1 (T, and Kt in Table), and K, values of the preceding study 
with crosses with a dotted curve for predicted K1* (T"„ = 0.78 pmollgimin and K, = 6.7 pmol/ml). There 
are two possible explanations for the differences in the estimates between the two studies. First, the range 
of plasma glucose concentrations jn the preceding study was about 510 % larger than the range of this 
study. Second, the variations in K1 values were relatively large in each study at lower glucose Ievels (<3 
pmol/ml). K ~ "  values ranged between 0.065 and 0.113 ml/g/min for this study and between 0.061 and 
0.128 mllglmin for the preceding study. In order to cope with potential errors caused by the large K~' 
variance at low plasma glucose levels, 
Equation 1 was modified as follsws: 
This equation may be less sensitive to the variations in K,' values at lower glucose leveis because the 
contributions by high K, values on the residual Square Cum decrease when inverted. Using Equation 5, 
we obtained 1.05 i 0.06 pmoVg/min for Tm, and 1 1.3 ir 1.8 pmoVml for K, in this $tu&, and 1.09 k 0.10 
ymol/g/min for T, and 12.3 -F 1.8 ymoVml for K, in the preceding study. There wer6 no signiiicant 
diierences between the Wo studies for both constants. It 1s premature to mnclude which equatjon is more 
accurate at this point. 
Summary 
1. Two Michaelis-Menten wnstants of blood-brain glucose transport T, and Kt can be estimated in 
individual subjects with two ~ ~ ] 3 - 0 - m e t h ~ l ~ l u c o s e - ~ ~ ~  studies at high and low plasma glucose 
levels. 
2. Due to relatively large variances among individual regional estimates of T, and Kt, it is important to 
consider sample sizes when planning experiments. 
3. An alternative linear equation (Equation 5) may be robust against a large Variance in K,. at lower 
glucose levels. 
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7. Relationship between Brain Tissue p02 and Dopamine Synthesis of the Basal Ganglia 
R. Bauer1, P. Brust, B. walterl, G. Vorwieger, R. Bergmann, F. Füchtner, J. Steinbach, E. EI-~allag', A. 
~ritz', U. zwienerl, B. Johannsen 
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lntroduction 
It is now firmly established that both excitotoxicity and oxygen radical-mediated processes contribute 
prominently to the pathophysiology of perinatal hypoxic-ischemic brain injury [I, 21. The striatum, 
innervated with interacting corticostriatal glutaminergic and nigrostriatal dopaminergic projections, is a 
structure particularly susceptible to ischemic/hypoxic neuronal damage during perinatal period [3]. This 
may be caused by early hyperactivity of both transmitter Systems due to O2 lack. The dopaminergic 
System in immature brains is obviously sensitive to changes in brain tissue oxygen tension (krainp02) 
because even small decrease of fbminpo2 will cause significant increase in ctriatal extracellular dopamine 
concentration 141. The reason behind this phenomena remains quite unclear. From findings in studies on 
newborn rats it was postulated that hypoxia may increase the releasable dopamine pool [SI. However, 
other data suggested that mild hypoxia-induced extracellular dopamine increase resulted from inhibition of 
re-uptake [6]. 
Until now no in vivo measurements were made of dopamine metabolism in the newborn brain. Therefore, 
we estimated the activity of the aromatic amino acid decarboxylase (AADC), the ultimate enzyme in 
dopamine synthesis, in relation to fbrainp02, regional cerebral blood flow (CBF) and cerebral metabolic rate 
of oxygen (CMR02) during normal conditions and asphyxia in newborn piglets. We postulate that the 
changes in brain oxidative metabolism may induce profound effects on striatal dopamine synthesis in 
newborn brain. 
Material and Methods 
The animal experiments were performed according to the German Law on the Protection of Animals. The 
study was approved by the committee of the Saxon state government for animal recearch (75-9185.81- 
4.6195). Methods were described in detail elsewhere 17-10]. 
Table 1. Hemodynamic values, arterial blood gases, acid-bace balance, metabolic and regional 
cerebral blood flow values for newborn piglets during normoxia and asphyxia. 
Normoxia Control2 Asphyxia 
MAP (mm Hg) 72 I 6 66 rt 24 78 a 14 
Heart rate (min-') 241 i 45 240 r 43 293 a 75 * 
Arterial pC02 (mm Hg) 37 I 2 38 * 3 73 I 2 ** 
Arterial pH 7-48 rt 0.03 7.47 k 0.01 6.98 ~t 0-09 ** 
Arterial p02 (mm Hg) 121 A 32 120 & 29 39 rt 6 ** 
Arterial base excess (mmol fl) 4 r 2 4 t l  -13 a 4 * *  
Arterial glucose (mmol T') 7.5 I 1.0 7.6 t 1.2 9.0 a 4.4 
Arterial lactate (mmol * il) 2.4 I 1.5 2.4 t 3.2 13.5 I 3.9 ** 
Cortical CBF (ml 100 g' D min') 73 +: 24 61 r 15 191 r 88 ** 
Striataf CBF Cm1 * 100 g" * min-') 48 r 1 0 56 * 20 211 I $1 ** 
(Values are means I SD for 8 piglets. MAP: mean arterial blood pressure; <;BE cerebral blood 
flow; * p i 0.05, "* p < 0.01 * indicate significant differentes to stage "li2ormoxia*). 
Table 1 summarizes the values for mean arterial blood pressure (MAP), heart rate, arterial blood gases, 
acid-base balance and energy fuels during normoxia and asphyxia, when blood flow measurements were 
made. The values obtained during the first PET-study and asphyxia (control 2) are within the physiological 
range in both groups studied and consistent with other data obtained from mildly anesthetized and 
ariificially ventilated newborn piglets 111, 121. Similarly, there was no changed in the values for regional 
cerebral hemodynamics and Parameters of cerebral oxidative metabolism during the first PET scan 
measurement and control2 period (Tables 1 and 2). 
Table 2. Forebrain hemodynamic and variables of forebrain oxidative metabolism during normoxia 
and hypoxidhypercapnia. 
Normoxia Control2 Asphyxia 
Forebrain CBF 70 121  61 I 15 203 I 94 ** 
(ml 100 g-' min-') 
Forebrain CVR 1.1 I 0.3 1.1 I 0.5 0.5 I 0.3 ** 
(mmHg 100 g * min mrl) 
Forebrain 02-delivery 321 190  284 I 48 335 I 190 
(pmol 100 g-' min-') 
CMRO2 167 I 49 139 I 39 143 I 38 
(pmol 100 g -'* min-') 
(Values are means I SD for 8 piglets. (CBF: cerebral blood flow, CVR: cerebrovascular resistance, 
CMR02: cerebral metabolic rate of oxygen; ** p E 0.01 * indicate significant differences to Stage 
"Normoxia"). 
Asphyxia resulted in a reduction of arterial pO2 by about one-third and doubling of arterial pC02, an 
increase in heart rate but no change in arterial pressure. There was combined respiratory and metabolic 
acidosis with increased arterial lactate concentrations. Although cerebral blood flow increased due to 
reduced cerebrovascular resistance (CVR, p E 0.01), brain oxygen delivery as well as CMR02 remained 
unchanged. Despite this, brain tissue pO.2 was markedly reduced (Fig. 1, p < 0.01). Furthermore, the rate 
of FDOPA decarboxylation which reflects dopamine synthesis was markedly increased during asphyxia 
(Fig. 1; p 0.01). 
Normoxia Asph yxia Normoxia Asphyxia 
Fig. 1. Effect of moderate asphyxia on brain tissue p02 and striatal "F-DOPA decarboxylation (indicated 
DOPA decarboxylase (DDC) activity rate constant k j )  in newborn piglets (n = 8; mean + SD, ** p E 0.01, 
* indicate comparison between normoxia and asphyxia). 
Discussion 
Our results show that brain tissue p02 is reduced due to hypoxernia while cerebral O2 delivery and also 
CMR02 remains rnaintained. Indeed, systernic hypoxialhypercapnia induces a circulatory redistribution 
even in immature marnmals which favors the blood flow towardc the heart, brain and adrenals at the 
expense of the other Organs and tissues. This is rnainly effected by an increase in syrnpathoadrenal 
activity. However, in contrast to older anirnals, cardiovascular response in newborns is mainly caused by 
circulating catecholarnines because of delayed central syrnpathetic rnaturity [13]. Direct stirnulation of 
adrenal rnedulla and extrarnedullar chrornaffin cells by reduced arterial p02 is mainly responsible for 
increased catecholarnine release in newborn rats early after birth [14]. Neurogenic acüvation via increased 
efferent syrnpathetic tone appears to be rather unlikely since peripheral chernoreceptors remain 
insensitive for a certain time after birth. Resetting takes several days even in precocial animals like 
newborn larnbs [15]. 
Under such conditions of reduced brain tissue p02 a rnarked increase of extracellular dopamine content 
occurs in newborn piglets 1163. The hypothesis that increases in extracellular doparnine during hypoxic 
insult play an irnportant role in the pathogenesis of neuronal injury in newborn brain is supported by 
nurnerous findings from different injury rnodels. Direct neurotoxic effects of doparnine on cultures were 
shown [17, 181. Furtherrnore, doparnine can play an irnportant role in ischemia-reperfusion injury through 
over-stirnulation of the glutarnatergic receptors during ischemia, resulting in an increase in neuronal 
darnage in the striaturn [I9 - 211. Another proposed rnechanisrn for the neurotoxic effect of dopamine is 
through an increase the production of free radicals. There are several pathways for free radical generation 
in the brain, where doparnine rnay contributes. Oxidation of the excess doparnine released during 
ischernia by rnolecular oxygen rnay occur during reperfusion could result in the forrnation of superoxide 
anion radicals, which further rnay oxidize doparnine and rnay form covalent bonds with sufhydyl- 
containing cellular components [22]. Dopamine can react with hydroxyl radicals to form the dopaminergic 
neurotoxin, 6-hydroxydoparnine, which generates free radicals during ist spontaneous rapid autooxidation 
[23]. Furtherrnore, the enzyrnatic oxydation of doparnine by rnonoamine oxidase results also in the 
forrnation of hydrogen peroxide, a hydroxyl radical precursor 1241. A further contributing factor to 
neurotoxicity of doparnine may be due to an increase in cerebral rnetabolisrn of glucose by an uncoupling 
of flow and rnetabolisrn of the striatum after forebrain ischernia [25]. This increase of extracellular 
doparnine content is deterrnined by the balance of its active uptake, release and washout frorn the brain. 
Previous in vitro studies have suggested that hypoxia per se increased the release af dopamine [26], 
whereas synaptosomec obtained from rat cerebral cortex after a hypoxic period exhibited a unaffected 
rate of doparnine efflux although re-uptake appeared to be impaired [27]. Our results indicate for the first 
time that the striatal doparnine synthesis rate is markedly increased by about 1.8 fold during moderate 
asphyxia. Reasons for short-terrn AADC upregulation, however, rernained unclear. 
In Summary, our findings indicate that a marked increase in dopamine synthesic is associated with 
rnoderately reduced brain tissue p02. However, an asphyxia-induced CBF increase irnpedec an alteration 
of brain oxidative rnetabolism. 
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8. Mapping the Serotonin Uptake Site in Swine Brain with [3~]~italopram 
Radioluminography 
P. ~urnrning', M. Kretzschrnar, R. Bergmann, D. srnith', P. Brust 
'PET Center, Aarhus Kornrnunehospital, Aarhus, Denrnark. 
lntroduction 
Plasma rnernbrane transporters for serotonin are rnarkers for the pre-synaptic terrninals of serotonin fibres 
throughout the rnarnrnalian brain. Changes in the serotonin uptake site density have been irnplicated in 
the pathophysiology of Parkinson's disease [ l ]  and the neurotoxicity of psychostimulants [2]. We have 
ernployed living swine for investigations of serotonin uptake sites by positron ernission tornography [3]. 
However, the distribution of serotonin uptake sites in pig brain in vitro has not been reported. In order to 
facilitate the interpretation of positron ernission tornograms obtained in vivo [4], we have used 
radiolurninography to rnap the binding in vitro of [3~]citaloprarn to serotonin uptake sites in cryostat 
sections from swine brain. 
Experimental 
Three female pigs (40 kg, Danish Landrace) were killed by overdo~se with ketarninellorazeparn. After rapid 
rernoval, the brains (100 g) were frozen at -20' C, and stored for one week at - 80' C. Sagittal sections 30 
rnicron thick were cut frorn the whole brains, and thaw-rnounted to polylysine-coated glass slides. Series 
of adjacent sections were collected at four positions in the sagittal plane: 18, 12, 6, and 0 rnrn lateral to the 
rnidline. After a brief pre-incubation for 15 rnin in 50 rnM Tris-HCI buffer (pH 7.4) , containing 120 rnM 
NaCl and 5mM KCI the sections were covered with a solution (2 rnl each) containing the Same buffer and 
[3~]citaloprarn (specific activity 82 Cilrnrnol, New England Nuclear) at one of six concentrations ranging 
frorn 0.1 nM to 10 nM. For deterrnination of the non-specific binding, some sections were incubated in the 
incubation medium rnodified by the addition of fluoxetine hydrochloride (Research Biochernicals) at a final 
concentration of 20 PM. After incubations for 120 rninutes at roorn temperature, the slides were placed in 
ice-cold Tris buffer for 20 rninutes (2x), dipped in cold de-ionized water, and quickly dried under air at 
roorn ternperature. 
Slides were placed on tritium-sensitive radiolurninography plates (Raytest), along with calibrated 
standards (Arnersharn) for a period of ten days, and then quantified using cornrnercial irnage analysis 
software AlDA 2.1 1 (Raytest). 
Resu Rs 
The non-specific binding in all regions of the brain in the presence of excess fluoxetine at the highest 
radioligand concentration was less than the specific binding present in cerebellar cortex, the gray matter 
brain region with the lowesi density of serotonin uptake sites. An exarnple of the pattern of total and non- 
specific binding for 5 nM [ Hlcitaloprarn in a sagittal brain sectio~n is illustrated in Figure 1. The linear 
Scatchard analysis was used to estirnate the Saturation binding pararneters in vjtro. The apparent affinity 
of [3~]cjtaloprarn binding was close to 5 nM in all brain regions. Typical values for the binding site density 
in sorne regions of particular interest, in descending order of concentration, were as follows: Basolateral 
arnygdala (250 frnoilrng tissue), substantia nigra Pars reticulata (200 frnoilrng tissue), superficial layer of 
the superior colliculus (150 fmol/rng tissue), Corpus striaturn (50-100 fmoVrng tissue), dorsolateral 
thalarnus (60 fmoilrng tissue), entorhinal cortex (60 frnoilrng tissue), anterior cingulate cortex (40 frnollrng 
tissue) hippocarnpus (20 fmoilrng tissue) occipital cortex (15 frncaVrng tissue), and cerebellar cortex (10 
frnoilrng tissue). 
The specific binding of citaloprarn in swine brain was highly heterogenous, consistant with the pattern of 
distribution reported in man and rodent [5]. The binding site density was 25-fold higher in the region of 
high concentration (basolateral arnygdala) than in the region of lowest density (cerebellurn), validating the 
use of cerebellum as a non-binding reference region in positron emission tomographic studies of serotonin 
uptake sites. The absolute binding site densities were comparable with those obtained in pig brain 
membranes [6]. In general, the highest concentrations of binding sites were found in limbic brain regions 
and in small structures of the mesencephalon. Within the thalamus, the specific binding was observed in 
boundries of the specific thalamic nuclei. 
Fig. 1. In vitro autoradiograms (above and middle), radioactivity scale and histological image {below) of 
sagittal brain sections of the swine showing the total binding (above) and ünspecific binding (middle) of 
L"~]citalopram in several brain regions . 
The fine structure of the distribution of serotonin uptake sites in pig brain is scaled smailer than the 
resolution of most available positron emission tomographs. Therefore, the binding h specific regions On 
anatomical in'terest must necessarily be blurred extensively due to eHects of partial vdurne. We contencl 
that statistical parametric mapping of binding in a population of swine may provide a route fot quantitative 
assay of serotonin binding sites in vivo. This approach may be faclitaled by the recent appeasirance of a 
sterotaxic atlas of the swine brain 17'1. 
References 
Chinaglia G., Landwehrmeyer B., Probst A. and Palacios J. M. (1993) Serotoninergic terminal 
transporters are differentially affected in Parkinson's disease and progressive supranuclear palsey: 
an autoradiographic study with [3~]citalopram. Neuroscience 54,691 -699. 
McCann D. U., Szabo Z., Scheffel U., Dannals FR. F. and Ricaurte G. A. (1998) Positron emission 
tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in humans 
beings. Lancet 352, 1433-1 437. 
Smith D. F., Gee A. D., Hansen S. B., Moldt P., Nielsen E. O., Scheel-Kruger J. and Gjedde A. (1999) 
Uptake and distribution of a new SSRI, NS2381, studied by PET in living porcine brain. 
Eur. Neuropsychopharmacol. 9,351 -359. 
Brust P., Scheffel U. and Szabo Z. (1999) Radioligands for the study of the 5-HT transporter in vivo. 
IDrugs 2,129-1 45. 
Duncan G. E., Little K. Y., Kirkman Ji A., Kaldas R. S., Stumpf W. E. and Breese G. R. (1992) 
Autoradiographic characterization of [ Hlimipramine and [3~]citalopram binding in rat and human 
brain: species differences and relationships to seratonin innervation patterns. 
Brain Res. 591,181 -1 97. 
Erreboe I., Plenge P. and Mellerup E. T. (1995) Differences in brain 5-HT transporter dissociation 
rates among animal species. Pharmacol. Toxicol, 7'6,376-379. 
Felix B., Leger M. E, Albe-Fessard D., Marcilloiux J. C., Rampin 0. and Laplace J. P. (1999) 
Sterotaxic atlas of the pig brain. Brain Res. Bull. 49, 1-1 37. 
9. Correlation of the Capacity for Continuous Selective Attention and Eye Movement 
Disturbances with rCMR,i, in Patients with Spasmodic Torticollis 
J. Pinkert, I. Gerdsen, B. Ripke, R. Fötzsch, L. Oehme, J. Missimer, N.Galley and W.-G. Franke 
lntroduction 
ldiopathic spasmodic torticollis is a subtype of adult-onset focal dystonia causing abnormal head posture. 
Apart from clinical signs recent studies on torticollis patients have shown a reduced perforrnance of tasks 
related to temporal processing as an indicator of a probable affection of higher cognitive functions such as 
strategy use and working rnemory [I J and disturbances in voluntary eye movernents with the intrusion of 
macro saccades during the smooth tracking paradigm [2, 31. Elevated saccadic intrusions were observed 
by electronystagrnographic recordings from the rnajority of torticollis patients of out neurological outpatient 
clinic. 
Basal ganglia dysfunction with abnormal basal ganglia ou ut has been suggested to underiie this clinical f0 syndrome. Previous activation studies with PET and ~ 2 '  0 on idiopathic torsion dystonia have shown 
overactive striatal and frontal accesEoty areas and an underactivity of the primary motor Cortex and caudal 
supplernentary rnotor area, while F-FDG studies confirrned the bilateral hypermetabolism of nucleus 
lentiformis in spasmodic torticollis. Recent neuropsychological studies on torticollis patients revealed an 
impaired visuospatial function, suggesting the involvement of complex cortical functions [4]. It is not yet 
understood, however, how characteristic patterns of the disease are related to the underiying neural 
networks on cortical and subcortical levels. 
18 F-FDG-PET can be used to analyse metabolic activity as an indicator of affected network 
representations in torticollis. 
The airn of the present study was to investigate the relationship between regional cerebral metabolic rates 
of glucose (CMRgIu), the number of saccadic intrusions during the srnooth eye tracking paradigm and the 
level of continuous selective attention based on rather complex visuo-motor functions, including working 
memory, to analyse the metabolic activity as an indicator of affected network representations in torticollis. 
Material and Methods 
16 patients with spasmodic torticollis (7 female and 9 male, age 24 - 71 years, median age 56.4 years) 
undenivent "F-FDG PET imaging using a 32-ring ECAT EXACT HR+ scanner (FWHM = 4 rnm, axial fietd 
of view (FOV) = 15.5 Cm, Siemens / CTI Inc., Knoxville, TN). All patients had normal MRI scans. For 
comparison data Sets from 11 age matched normal volunteers were obtained fron the PSI, 
Before the examination the patients gave their written informed wnsent after thorough explanation of the 
procedures. The clinical symptoms of the torticollis patients were assessed on the TVVSTR sind TSUl 
scales by two independent raters. All subjects were strictly right handed. The torticollis pa2ients had their 
last botulinum injection 4 - 10 weeks before the scanning. 
Patients were prepared by fasting for at least 12 h before the PET examination. PET irnages wer@ 
acquired with the patients in a resting state, with their eyes Open in a darkeneci PET scanner room, ears 
unplugged and with a rninimurn arnbient noise, The head was placed in a speciai head holder to rninimize 
movernent during scanning. The scanning plane was parallel to the cantho-meatal Bne. 
After a 15-min transmision scan (three 68~a l "B~e  rod sources), dynamic PET emission scans were 
performed in 2D mode. About 300 MBq "F-FDG was intravenousiy injected within 1 min. A time 'frame 
schedule of 10 X 120 and 7 X 240 s was used. Once during each time frame an arterialized blood sampie 
was manualiy drawn from an indwelling catheter placed in the cubitai vein for the rneasurement 05 piasma 
activity. The radioactivity concentration was measured with an automated gamma counter (341K) Wzard 
T, Wallac Inc„ Turku, Finland), cross-calibrated to lhe PET scanner. 
PET images were reconstructed in a 128x128 matrix using a Hanning filter (C&-off frequency 0.5) and 
corrected for measured photon attenuation and decay. 
Images of the cerebral metabolic rates for glucose (GMR#,J were cakulated by a voxet-based grapfiical 
analysis using rneasured input function and tissue radioactivity concentration (Patlak plot) in 1DL on a 
SUN workctation and smoothed with a boxcar filter. 
The absolute glucose consumption rate was catculated for each pixel using maps of CMRd„ blmd 
glucose concentration and a iumped constant of 0.42. 
These irnages were spatially transforrned to a standard atlas (Talairach and Tournoux) and globally 
norrnalized, using proportional scaling. Differences between the scans of the patients group and those of 
11 healthy controls were statistically analysed using SPM95, setting the threshold to p C 0.01. 
A multi-subject design with covariates was chosen to scan for a correlation between regional CMR,, 
changes with covariates. 
Attentional functioning connected with the ability to differentiate visual stirnuli and translate thern into 
adequate rnotor responses was rneasured by rneans of the d2 test [5, 61. In this exercise subjects are 
given a sheet of paper with lines consisting of the letters "p" and "6" in a random sequence and points of a 
various nurnber (minirnum one, rnaxirnurn four) above and below thern belonging to each letter. 
The subjects are asked to Cross out all "d's" with two points as quickly and accurately as possible. They 
are asked to start at the beginning of the first line and to continue frorn the beginning of the next line after 
20 seconds or when the experirnenter teils thern to. 
The error rate as a rneasure of accuracy and the difference between the total nurnber of checked letters 
and the error rate as a measure of selective attention in the D2 test as well as the nurnber of saccadic 
intrusions counted during the srnooth pursuit were used as covariates in the SPM analysis. 
Electronystagrnographic exarninations were carried out using a Nicolet Nystar nystagrnograph. The 
nurnber of saccadic intrusions during the srnooth eye tracking paradigm were counted automatically by 
the Nicolet sofhvare. 
ResuRs and Discussion 
SPM analyses for torticollis patients in comparison with age matched controls dernonstrated a significantly 
elevated bilateral glucose rnetabolisrn in the basal ganglia (p C 0.01). The stereotactic coordinates were in 
strict accordance with the nucleus lentiforrnis. This finding was supported by sirnilar results obtained by 
Magyar-Lehmann et al. [7]. They also found a higher glucose rnetabolism in the nucleus lentiforrnis in 
patients with dystonia. 
No relations were found to exist between the glucose rnetabolisrn and the clinical syrnptorns of torticollis 
patients measured on the TWSTR and TSUl scales or the duration of the disease. 
The SPM covariate analyses with the nurnber of saccadic intrusions during the srnooth eye tracking 
paradigm confirrned a significant correlation with the glucose rnetabolism in the visual cortical areas and 
extrastriatal association areas with an increased nurnber of saccadic intrusions (p C 0.01, See Fig. 1). In 
contrast to our previous results obtained in torticollis patients with SPECT and an increased perfusion 
during srnooth tracking in the posterior parietal cortex, the frontal eye field and cerebellurn, the elevated 
glucose rnetabolisrn under resting conditions in the visual cortex rnay indicate a higher basal neuronal 
activity in the visual cortex in torticollis patients. 
A subgroup of the subjects show a d2 perforrnance which Scores below the age-related average while 
there is a significant correlation between the extent of dirninution of the selective attention score in the d2 
test and the glucose rnetabolisrn in the prefrontal coriical areas (see Fig. 2) in the torticollis patients. 
An affected accuracy score in the d2 test was found to be associated with a reduced glucose rnetabolisrn 
in the anterior cingulate (see Fig. 3). 
This study confirrns previous data On bilateral nucleus lentiforrnis hypermetabolisrn in spasrnodic 
torticollis. In sorne cases it also suggests the invoivernent of irnpaired associative functions, visuo-rnotor 
capacity and working rnernory which are necessary to achieve a sufficient perforrnance in the continuous 
selective attention exercise. The extent of affection is assurned to be connected with the degree to which 
there is a diminution of glucose rnetabolisrn in the prefrontal cortex and the anterior cingulate. These 
areas are parts of the System which controls processes of continuous selective visual attention connected 
with corresponding motor responses as a rather cornplex cognitie function. 
Thus we conclude that the pathology of spasrnodic torticollis rnay not only be based on basal ganglia 
dysfunction. 
Fig. 1. Positive correlation of rCMR,,, with the total number of saccades in patients with spasmodic 
torticollis, SPM projections (left) and areas with significant correlation (search threshold p <O.Dl) 
matched with the MRI T1 template (right) 
Fig. 2. Positive correlation of rCMR,,, with the accuracy in the d2 test in patients with spasrnodic torticollis, 
SPM projections (left) and areas with significant correlation (search threshold p 4l.01) 
matched with the MRI T1 template (rightf 
Fig. 3. Negative correlation of rCMR,l, with the error rate in the d2 test in patients with spasmodic 
torticollis, SPM projections (left) and areas with significant correlation (search threshold p <0.01) 
matched with the MRI T1 template (right) 
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RADIOPHARMACEUTICAL CHEMISTRY 
10. Two-Step Synthesis of 1 6a-['8F]~luoroestradiol-Disulphamate 
J. Römer, F. Füchtner, J. Steinbach 
lntroduction 
The developrnent of new specific oncological '8~-labelled tracers for the positron ernission tornography 
(PET) is an emerging area [I], especially for diagnosing endocrine-dependent breast cancer [2] and breast 
cancer rnetastases [3], 16a-['8F]fluoroestradiol ([18F]~ES) has proved to be the PET tracer of choice [4]. 
In order to make the new PET tracer accessible to the nuclear physicians at our location, a synthesis, 
elaborated in the USA [5], was modified at our PET centre [6] and integrated into an automatic module r/l. 
Thus, ["FIFES can be reliably produced in GBq arnounts of high specific radioactivity. 
Recently, we have found that estradiol6,17ß-disulpharnate and first of all 16a-halogen-estradiol-3,178 
disulpharnates are highly active steroid sulphatase inhibitors. Estrogen sulphatases in vivo are responsible 
for the deconjugation of estrogen sulphates. This deconjugation is necessaty because only free estrogen 
can exercise its biological function. Free estrogens are rnitogens and promote the growth of endocrine- 
dependent tumours. As steroid sulphatase is particularly prevalent in breast cancer tissue [8], sulphatase 
inhibitors that prevent the formation of free estrogen should be suitable for chemotherapeutic intervention 
in breast cancer [9]. When using 16a-['8~]fluoroestradiol-3,17ßdisulpharnate ( [ ' 8 ~ ~ ~ ~ ~ ~ )  on the other 
hand, there should be the chance to image sites of high sulphatase activity. For such studies [ ' 8 ~ ~ ~ ~ ~ ~  
had to be rnade available. The access to [18F ]~~S by a rapid and reliable production rnethod [71 was a 
good starting point to accornplish such a project. 
In this paper we describe the conditions which are suited to convert [18qF~s successfully into chernically 
and radiochernically pure [18~]~ESDS. 
Results and Discussion 
A simple phase-transfer rnethod for the preparation of unsubstituted sulpharnate esters , H2N-S02-OR, 
where R can be aliphatic or aromatic, was described by Spillane et al. [10]. These authors were the first 
to use solid sodiurn carbonate as a deprotonating medium. We transferred this successful rnethod for the 
first time to steroid alcohols [ l  I]. 
Sulpharnoyl chloride (H2N-SO2-CI, SCI) 1121, a solid moisture-sensitive cornpound, was used as reagent. 
It forrned three sulpharnates with 1 Ga-fluoro-estradiol (FES). These new cornpounds - 16a-fluoro-estradiol- 
3-sulphamate (FES3S), 1 Ga-fluoro-estradiol-17ß-sulphamate (FES1 7S), and 1 Ga-fluoro-estradiol-3,17ß- 
disulphamate (FESDS) - were first synthesized and characterized in our laboratory [I 11. 
The sulpharnoylation reaction of FES or other 3,175-diols yielded mixtures of sulpharnates but in all the 
cases investigated the forrnation of the 17c-sulphamate was favoured. When using excess SCI, alrnost all 
the diol could be converted into diol-3,176-disulphamate. 
To separate a sulphamoylation mixture, preparative reversed-phase (RP) HPLC was used. Usually, pure 
acetonitrile was the eluent [ l l ] .  But, 55 % aqueous ethanol proved to be a better eluent capable of 
separating FES and all the sulphamates of FES in an excellent manner. Because the diol-rnonosulphamate 
is rnore polar than the diol, and the dioldisulpharnate is rnore polar than a monosulpharnate, FESDS was 
eluted frorn an RP column before the rnonosulpharnates. The retention tirnes of FES, FESSS, FES17S, 
and FESDS are listed in Table 1. 
The new sulphamates were characterized by melting point, rnass, UV, and '=C NMR SpeCtroscopy, and 
by thin-layer chromatography (TLC) [ I  I]. TLC was also used in the radioactive experirnents described 
here. Therefore, Rf values were also noted in Table 1. 
An autornated synthesis should be straightionvard. Liquid-liquid extractions and the addion of solids are 
dicult in a module-acsisted procedure. Therefore, we tested the usefulness of the coiuble 2,6-ditert.butyl-4- 
methyl pyridine (DBMP) instead of sodiurn carbonate as a base. 
Table 1. Retention tirnes and Rf values of FES, FES-monosulphamates 
and FES-disulpharnate 
Cornpound a' Retention Time [rnin] Rf Value C' 
FES 30.5 0.32 
FES3S 22.5 0.17 
FES1 7s 21 .O 0.27 
FESDS 17.0 0.21 
a) Abbreviations see text 
b) SP 250/10 NUCLEOSIL 100-7Cm frorn Macherey & Nagel; 55% ethanol 
as eluent at a flow of 1.5 rniirnin 
C) Silica gel; toluenelethyl acetate (3:l) as solvent 
The usefulness of DBMP had already been established in non-radioactive experirnents [ I  11. DBMP worked 
even if used in sub-stoichiometric arnounts in relation to FES. Milligram amounts of FES in absolute 
acetonitrile were converted into FESDS at room temperature by using a twentyfold excess of SC1 in the 
presence of sub-stoichiornetric arnounts of DBMP, the reaction being cornplete in a few rninutes. 
Conversion o~P'F]FES in the presence of DBW 
In the radioactive experirnents, solutions Of DBMP (1 rng) and SC1 (1 0 rng) in acetonitrile were added to 
columnpurifii dry r8F'JF~S. The solution was stirred at roorn ternperature. Samples were taken frorn time 
to time and analysed, using analytical radio-HPLC. But contrary to the optirnum non-radioactive conditions 
mentioned above, no conversion of ['8F'JFES was detected. Only sorne negligible conversion was obsewed 
after the ternperature had been increased. 
However, complete conversion of the [ ' 8 ~ ] ~ ~ ~  was shown by analytical radio-HPLC when the reaction 
batch was evaporated to dryness at 70 "C and ethanol was added to the residue. Mainly polar products 
(about 75 %), but only about 25 % of the desired [ 1 8 ~ ] ~ ~ S ~ ~  were found in the analytical radio- 
chromatogram. Further experirnents confirrned these results and proved that cornplete conversion of 
[18F'JFES had taken place in the process of evaporation. 
1 
polar products 
fl 
reteniion time [rnin] 
Fig. 1. The semipreparative radiochromatograrn of a reaction rnixture prepared by 
sulphamoyiation of [I8F]FES in the presence of DBMP 
H a reaction batch treated in this way was injected into a serni-preparative RP column and then eluted with 
55 % aquwus ethanoi, a typical radiochrornatograrn was obtained as shown in Fig. 1. Peak collection, 
radioactivity rneasurernent and decay correction provided precise data on the radioactivity distribution: 
polar products (69.6 %), [18~]~ESDS (25.9 %), and another product with a retention time of 21 min, 
probably [18F]FES17S (4.5 %). A check of the collected eluate of the [ ' 8 ~ ~ ~ ~ ~ ~  peak showed a radio- 
chernical purity of >99 %. 
Contrary to non-radioactive experirnents, in radioactive experirnents DBMP cannot be used in sub- 
stoichiometric arnounts. We tried to reduce the formation of polar by-products by lowering the arnount of 
DBMP to 0.1 rng. Even with this small arnount, r8F]FE~ was cornpletely converted without increasing the 
yield of [18FIFESDS. Further reduction of DBMP finally led to [l8F]FEs not being converted at all. 
Conversion of [ 1 8 ~ ] ~ ~ ~  in the presence of other bases 
Dimethyl forrnarnide was recornmended in the literature [13] as a good solvent for sulphamoylation 
because it also acts as a base. We investigated the sulpharnoylation reaction of ["F]FES in a solvent 
mixture of acetonitrile and dirnethyl fomiarnide, first at room ternperature, then at 60 "C. No conversion of 
[l8FIFEs occurred. Rernoval of the solvent at 100 "C and adding ethanol to the residue resulted in the 
quantitative conversion of [18F]FES into polar products. No trace of [ 1 8 ~ ] ~ ~ ~ ~ ~  could however be de- 
tected. 
Quantitative conversion of ["FIFES into polar products also occurred when only srnall arnounts of codiurn 
carbonate or potassiurn carbonate were used. This result showed that the occurrence of undesirable by- 
products in the previously described experiments cannot be attributed to any special property of DBMP. 
It was surprising, on the other hand, that in the non-radioactive experiments forthe preparation of FESDS 
[ I  11 no polar product was forrned in the presence of excess sodiurn carbonate. 
Conversion of [18Fj'F~S in the presence of Kryptofix 2.2.2 / K2C03 
Mixtures of Kryptofix 2.2.2. (K222) and potassiurn carbonate in absolute acetonitrile have proved to be 
useful in nucleophilic fluorination reactions [14-161. For preparing ["QFDG [17] and ~ F J F E S  171, we have 
made use of a solution containing 40 pnol K222 and 20 prnol K2C03 per rnL (K222/K2C03). Now we 
exarnined whether this rnoderately basic solution can be also successfully appiied in the sulpharnoylation 
reaction of ["FIFEs. 
K222/K2C03 solution (1.5 mL) was added to colurnn-purified ["FIFES. After careful evaporation of the 
solvent to dryness, a solution of SC1 in acetonitrile was added, and this reaction mixture was stirred at 
70°C. Surprisingly, a sarnple taken after 5 rnin already showed a 75 % conversion of ["F]FES. After work- 
up, ["FIFESDS and polar products were present in a ratio of about 1 : 1 as dernonstrated by analytical 
HPLC. The sarne ratio was found after separation on a serni-preparative RP column. A radiihromatograrn 
is shown in Fig. 2. The reproducible preparation of ["QFESDS was confirrned by further experirnents. The 
conversion level was between 50 and 60 %. 
Fig. 2. The sernipreparative radiochromatogram of a reaction rnixture prepared by 
sulphamoylation of rgFjFES in the precence of @ 2 m C a 3  
The method with K222/K2C03 was then transferred into an autornatically operating module. The experi- 
rnents were carried out at a higher radioactivity level. The Same module was used as for preparing 
['8~]FES. After synthesis and purification of ["F~FES according to [7], the rnodule had to be cleaned and 
prepared for the sulphamoylation reaction which was then carried out as described above. Finally, the 
reaction rnixture was separated on a semipreparative RP-HPLC column. 
The results of three typical rnodule-assisted experirnents are surnmarized in Table 2. The decay-corrected 
yield of [18~]~ESDS related to [ ' 8 ~ ~ ~ ~  was about 50%. The maximum yield of [ 1 8 q ~ ~ s ~ ~  related to the 
starting radioactivity at t = 0 was 6% (real yield) and 20% (decay-corrected), respectively. The total time 
for producing [ 1 8 ~ ] ~ ~ ~ ~ ~  was about 3 h. At the end of the synthesis [ ' 8 ~ ] ~ ~ ~ ~ ~  was available in a 
quantity of up to 1000 MBq. 
Table 2. Results of three rnodule-assisted experirnents 
Expt. Irradiation time Starting activity -------_-----[ 18 - !TS - - - - -- -- - ----ss -- - -- - -1- 18F --J-- FESDS - -- - -- --- - -- - - - -. 
[rnin] [MBql Time [min] Y „,. [%I Time Emin] Y mrr. ["L] 
a) b) C) b) C) 
3 20 22150 62 37.0 190 19.2 
a) Radioactivity at the Start of the synthesis (t = 0) 
b) Time between t = 0 and the rnornent of availability of the radiotracer 
C) Meld of the radiotracer related to t = 0 
Chemical and radiochemical purity, specific radioactivity 
The high chemical and radiochernical purity of ['*F]FES and its high specific radioactivity had already been 
shown by analytical HPLC [7]. Now, the purity of the ["F]FESDS had to be determined. 
Some results frorn Expt. 2 (Table 2) are represented in Fig. 3. There are four analytical chrornato-grarns; 
a UV chromatograrn of a reference solution containing FES and FESDS (Fig. 3A), a radio-chromatograrn 
of the raw product before it was injected into the serni-preparative RP column to be separated (Fig. 3B), 
a radiochrornatogram of the collected eluate of ihe [ ' 8 ~ ~ ~ S ~ S  peak (Fig. 3C), and a UV chromatogram 
of the sarne solution (Fig. 3D). 
According to Fig. 3A the retention tirnes of FESDS and FES were 15.7 rnin and 19.0 min, resp. When the 
raw product was analysed (Fig. 3B), a peak representing polar products (30 %) was found at 10.6 rnin, a 
large peak (58 %) was eluted at 16.0 rnin, and a srnall peak (7 %) at 19.2 rnin,. In Fig. 3C, the successful 
HPLC separation was dernonstrated with the peak at 16.0 min representing [ ' 8 ~ ~ ~ ~ ~ ~  of high chemical 
and radiochemical purity (>99 %). 
The named distribution and the radiochernical purity of [18F]FESDS were confirrned by radio-TLC. The 
irnpure product showed three spots and the following radioactivity distribution: polar products (29 %), 
[ ' 8 q ~ ~ ~ ~ ~  (65 X), ["F]FES (6 %). The Rvalues found were 0.18 for [ 1 8 F ] ~ ~ s ~ S  and 0.32 for [ ' 8 ~ ~ ~ ~ .  
The pure [18F'jFESDS solution showed one and only peak (Rf = 0.18) with a radiochemical puri i  of >99 %. 
The specific radioactivity of the '8~-labelled compound was higher the greater the starting radioactivity 
used [7]. Only solutions of pure [18F]FESDS frorn the experiments in Table 2 were investigated. We 
injected 100 pl into the analytical HPLC system. A srnall peak due to FESDS was found at 21 6 nrn (Fig. 
30). The peak mass was deterrnined, and values for the specific radioactivity of between 150 and 200 
GBqfpmol were obtained. The identity of reference FESDS and the product synthesized in the rnodule was 
confirmed by mass spectroscopy ( d z  448). 
Experimental 
Chemicals 
Sulphamoyl chloride was synthesized according to a modified procedure of Appel and Berger 1121. The 
synthesis of FESDS is described in [I I]. Kryptofix 2.2.2 and DBMP were purchased frorn Merck. 
Fig. 3. Analytical HPLC chrornatograms 
3A - UV chromatogram of a reference solution containing FES and FESDS 
38 - Radiochromatogram of the irnpure product of Expt. 2 in Table 2 
3C - Radiochromatogram of the column-purified [ 1 8 F ] ~ ~ ~ D S  
3D - UV chromatogram of the column-purified [ ' 8 F ] F ~ ~ ~ S  
Preparing the no-carrier-added (n.c.a.) f 8 9 H F  
The Roscendorf PET Centre is equipped with an IBA CYCLONE 1W cyclotran, ["F~HF is producd by 
the '80(p,n)'8~ reaction using enriched [180~H20 (15 mL, 95 %) as target. For the optirniration experi- 
ments only limited amounts of ~*F]HF were necessary, Therefore, the fallowing irradiaan condifions were 
usually uced: 
- Ion beam current on the target: 30 yA (18 MeV protons) 
- Irradiation time: 5 minutes 
After end of bombardment, the irradiated water was transferred from the target to the module, arid here 
the starting radioactivity at t = 0 was measured 
Preparing the n.c.a. ["F]FES 
The synthesis was carried out in a rnodule (Nuclear Interface, Gerrnany) which was rnodified in terrns of 
program and hardware F]. A semi-preparative RP colurnn (SP 250110 Nucleosil 120-7 C18, Macherey & 
Nagel, Gerrnany) served for separation of [18F]FEs. Aqueous ethanol(55%) was used in order to transfer 
the irnpure radioactive product frorn the reaction vessel into the colurnn and then to elute [ 1 8 ~ ] F ~ S  
isocratically at a flow of 1.5 mUmin. 
Optimization experiments to synthesize ~*F]FESDS 
N.c.a.[18flFES (about 100 - 500 MBq) dicsolved in about 2 mL 55% aqueous EtOH was placed in a bulb. 
After adding a solution of a base (either DBMP: 0.1 mg in 0.5 rnL MeCN or K222/K2C03: 22.5 rng K222 
and 4.2 mg K&03 in 1.5 rnL MeCN), the solvent was rernoved on a rotary evaporator. A solution of 10 mg 
SC1 in 2 mL MeCN was added to the absolutely dry reaction batch. The bulb was stirred at room ternpera- 
ture or a higher ternperature (up to 70 'C). Samples of 10 p1 each were investigated in an analytical HPLC 
systern (Hewlett-Packard, series 1050, diode array detector 1040 M, radio-activity detector A 100 from 
Canberra Packard. Column: ET 1251814 NUCLEOSIL 120-5 C18 from Macherey & Nagel. EtOH-water 
rnixtures were the mobile phase at a flow of 0.5 mUrnin with a linear gradient: 0 rnin - 30 % EtOH, 20 rnin 
- 60 % EtOH, 30 rnin - 100 % EtOH). To work up the reaction batch, the solvent was rernoved on a rotary 
evaporator and 55 % aqueous EtOH (0.6 mL) was added. The clear solution (0.5 mL) was injected into a 
serni-preparative HPLC systern (Merck-Hitachi, pump L-6200A, a Rheodyne injector with a 0.5 mL loop, 
an RP colurnn SP 25O/lO NUCLEOSIL 100-7Cl8 (Macherey & Nagel, Gerrnany) and a diode array detector 
L-4500 DAD). The colurnn was eluted with 55 % aqueous EtOH at 1.5 mUrnin. After UV rneasurernent at 
A = 275 nm , the eluted solution was rneasured in a radioactiiity detector (Canberra Packard A 120). Each 
solvent peak was collected and the radioactivity measured in an ionisation charnber (Nuklear Medizintech- 
nik Dresden, Gerrnany). 
Module-assisted experiments to synthesize ~ . c . ~ . [ " ~ ~ F E s D s  
[18F]FES was synthesized as described above. After cleaning the rnodule, the collected eluate of [ 1 8 F ] ~ ~ s  
(1 - 3 GBq in 3 - 5 rnL of 55 % aqueous EtOH) was transferred into the reaction vescel of the rnodule in 
which the following four solutions were already stored in four vials: 
Solution I K222 (22.5 rng) and KzC03 (4.2 rng) in I .5 rnL 86 % aqueous MeCN 
Solution I1 SC1 (1 5 - 20 rng) in 1.5 rnL absolute MeCN 
Solution 111 22% aqueous EtOH (4 rnL) 
Solution IV absolute MeCN (12 rnL) 
The following operating steps were carried out: 
Addition of solution I and 4 rnL of solution IV and drying the reaction rnixture at 700 "C for 4 rnin. 
Addition of only 4 rnL of solution IV and drying the reaction rnixture at 100 "C for 4 rnin. 
e Repetition of the last drying process and ternperature reduction to 70 "C. 
e Addition of solution 11. The reaction mixture is stirred for 5 rnin at this ternperature. 
e Evaporation of the solvent within 1 rnin. Heating is switched off. 
Addition of solution III and waiting for 1 rnin. 
Transfening the solution into the injection loop. 
lnjection of the solution into the colurnn. Elution using 45 % aqueous EtOH, 
Collection of the eluate of the i ' 8 ~ ] ~ ~ ~ ~ ~  peak (RT = 25 rnin). 
Measuring the radioactivii of [ l 8 F ] F ~ ~ D ~ .  
Radio-TLC 
Samples of the impure product solution and the collected eluate of the [ ' 8 F ] ~ ~ ~ ~ ~  were developed on a 
silica-gel plate (MERCK) in to!uene/efhyl acetate (3:l). For visualizing the chrornatograrn, the TLC plate 
was contacted with an irnaging plate (IP-BAS-III, 20x25, Fuji) for 15 s . The distribution of radioactiiity on 
the plate was recorded by an imaging analyzer (BAS 2000, Fuji). 
Conclusions 
Sulpharnoylation of [ 1 8 F ] F ~ ~  in the presence of K222/K2COS is a rapid and reproducible procedure. It is 
also applicable as a module-assisted procedure. The whole synthesis of [ l B F J ~ ~ ~ ~ ~  In a rnodule-assisted 
way is cornposed of five steps: 
Moduloassisted synthesis of ["F]FES according to ri]. 
Purifying ["FJFEs by RP-HPLC (see also m). 
Cleaning the rnodule. 
Moduloassisted synthesis of ["F]FESDS. 
Purifying ["FIFESDS by RP-HPLC. 
Starting with high levels of radioactivity, [ 1 8 ~ ~ E S ~ ~  can be prepared in arnounts up to 5 GBq using this 
way. 
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1 1. One-Pot Synthesis of 1 6a-['8F]Fluoroestradiol-~isulphamate 
J. Römer, F. Füchtner, J. Steinbach, H. Kasch ' 
l~ans-~nöll-lnstitut Jena 
lntroduction 
In the preceding paper [ I ]  the successful preparation of 16a-[18~]fluoroestradiol-disulphamate 
([18F]FES~S) in a two-step synthesis was reported. After elaborating the Wo-step synthesis [2], we tried 
to prepare [18F]FESDS in a rnodule-assisted one-pot procedure. The experiments were carried out with 
the intention of shortening the synthesis time and increasing the real yield of [ 1 8 ~ ] ~ ~ ~ ~ ~ .  Instead of five 
steps in the previous procedure [I], the one-pot procedure consists of in three steps: 
e Module-assisted synthesis of 1 6a-[18~]fluoroestradiol ([18F]FES) 
Module-assisted synthesis of [ 1 8 ~ ] ~ ~ ~ ~ ~  
Purifying [ 1 8 ~ ] ~ ~ ~ ~ S  by reversed-phase high performance liquid chromatography (RP-HPLC) 
Experimental 
The ['*F]FESDS module 
One of the modules (Nuclear Interface, Münster, Germany) for synthesis of 2-['8~]fluoro-2-deoxy-~-glucose 
( [ 1 8 ~ ] ~ ~ ~ )  was modified in terms of program and hardware. Designed as the [ 1 8 ~ ] ~ ~ ~ ~ S  module, it is 
shown in Fig. I .  
vented 
FES-DS VP.1 13/3998 
Fig. 1. Schematic diagram of fhe t 8 F J ~ ~ ~ ~ ~  rnodule for synthesizing 1 ~'~~]fluoroestradiol-3,17j3-disul~hamate 
The f 1 8 F j ~ E ~ D ~  rnoduie is an automatically operating, remote-controlled closed system. It is installed in 
a hot celt and make$ it possi~ble to process up to 200 GBq f8Fjfluoride. Evacuation is performed via a 
cooting Erap (blue in Fig. 1) with Iiquid nitrogen. Volatile radioactive substances are thus trapped. The 
reaction vecsel is made from glassy carbon and closed with a PEEK Cover. lt is connected via thin hose 
pipes (Teflon) and valves (V, -V8, VSO) with the Storage V ~ S S ~ I  for the target water (red in Fig. 1, the 
radioactivity & at the time O is measured) and further storage vesselc ( I  - 6, blue) for storing the reagent 
solutions os safvents. These resewoirs are closed by Septa. The solutions and solvents are moved within 
the moduie by vacuum or aoxiliary gas (nitrogen). The reacfion mixture in the reaction vessel can be 
stirred, heated or cooled. A radioactivity detector controls the radioactivity of the reaction mixture, The 
reaction veccel is connected to an HPLC system (JASCO) consisting of an injection loop (5 mL), a 
semipreparative column (SP 250110 Nucleosil 120-7 C18, Macherey & Nagel, Germany), a UVNIS 
detector, a radioactivity detector and a distribution system for the final solution (path 1, red), for other 
fraction collections (paths 2 - 5) and for waste (path 6, green). The column is eluted with ethanolic 
solutions at a flow of 1.5 mUmin. 
Chemicals 
The necessary precursor, 3-O-methoxymethyl-l6,17-O-sulphuryl-l6-epiestriol (I), was prepared amrding 
to the formula given in [3]. Sulphamoyl chloride (SCI) was prepared from commercial N-carbonylsulphamoyl 
chloride [4]. The synthesis of the reference substances FES and FESDS was described in [3] and 151. Soivents 
and reagents were products of Sigma-Aldrich and were used as supplied. Kryptofix 2.2.2 was purchased 
from Merck. 
Preparing the no-carrier-added (n.c.a.) P*F]HF 
The Rossendorf PET Centre is equipped with an IBA CYCLONE 1819 cyclotron. [18F]~F is produced by 
the 180(p,n)18F reaction, using enriched [ ' 8 0 ] ~ 2 ~  (1.5 mL, 95 %) as the target. To prepare ' 8 ~  for the 
[18F]F~SDS synthesis, the following irradiation conditions were used: 
- Ion beam current on the target: 30 pA (18 MeV protons) 
- Irradiation time: 30 or 60 minutes 
At 60 min irradiation time, a target yield of 75 GBq was achieved. After end of bombardment, the irradiated 
water was transferred from the target to the module by a pneumatic tralnsport system and measured there 
(Ao). 
Synthesis preparation 
Before starting the one-pot synthesis, the module was cleaned and supplied with all the solutions mentioned 
below. After storing the irradiated water in the reaction vessel of the mcrdule, the program was started. The 
program consisted of only four partial steps. Hydrolysis was followed by sulphamoyiation, As a result the one- 
pot procedure was significantly shorter than the two-step synthesis. 
The following solutions were needed in the one-pot synthesis of [18F]FESDS: 
Solution I K222 (1 5 mg) and K2C03 (2.77 mg) pro mL 86 % aqnieous MeCN (3 ml) 
Solution II 1 (2 mg) in 1 mL absolute MeCN 
Solution 111 0.1 M hydrochloric MeCN (6 mL) prepared by mixing 9 parts of MeCN with 
1 part of 1 M HCI 
Solution IV SC1 (10 - 15 mg) in 1.5 mL absolute MeCN 
Solution V 22.5 % EtOH (4 mL) 
Absolute MeCN (12 mL) was also required for drying processes. 
The procedurefor preparing [18qF~sDS ina one-pot synthesis is sholwn in FIG. 2. 
Measuring instruments and auxiliaries 
An HPLC syctem (Hewktt Packard) with a diocte anay detector, a radioacthrity detector and an analykal mlumn 
(ET 1251814 Nucleosil120-5 CI8 from Macherey & Nagel, Germany) was used to keep check On the purity 
of the final product. EtOH-water mixtures were the mobile phase (flow rate: 0.5 rnUmin) with a linear 
gradient ( 0 min: 30 % EtOH, 20 min: 60 % EtOH, 30 min: 100 % EKIH). The HPLC system was also used 
for determining 1 ' 8 ~ ] ~ E ~ ~ S  as an impure prMluct and the specific actilrjty of ~.'QFEsDS. 
ßadioacfivify measurements for detemination of yields and specifie! 1adioactN-ip 
In all experiments the starting radioactivity C&) at t = 0 and the radioactivity of ~F]FESDS after HPLC 
purification (A,('~F€SDS) ) were determiined.. These values were uced t6 waluate &e yield of tYsFjF~SDS, 
The yield was expressed as the real yield Yrd(OJo) and the decay-concected yieid YIXX$.(%) with thie calcu1;ti- 
ted value At„ being the measured value At relatt?d from the rneasuring time Z fio t = 0. 
Furthermore, the specific activity of ["FIFESDS was deterrnined. For this purpose the FESDS concentra- 
tion of the ["FlFESDS solution was measured, using the analytical HPLC systern (see [I]). 
\$ 
S=O 0-SO2-NH2 O 
I. nucleophilic iiuorioation 
2. hydrolysis 
3. sulphamoylation 
4. HPLC purification 
MOM 
> 
H2N-SO2-0 
Fig. 2.One-pot synthesis of 16a-[1eFlfluofoestradiolB,17b-disulphamate ([laFJFESDS) 
Explanation of the way of preparation of ["F]FESDS with reference to Table I 
All the individual steps included in the preparation of chemically and radiochemically pure ["FJFESDS are 
listed in Table 1. Twelve of these steps took place in the rnodule, three during HPLC puriiication. 
Table 1. Summary of Operations and Parameters in the Module-Assisted One-Pot Synthesis of 
[''~FESDS 
Step Operations and Parameters 
A a, Add solution 1 (13 mL) b, and cornpletely evaporate the solvent C) 
B Add solution I1 
C Fluorinate at 100 "C for 10 rnin 
D Remove the solvent 
E d, ~ d d  1,5 rnL of solution 111, and dry the reaction mixture at 100 "C for 3 rnin 
F d, Repeat step E twice 
G Add solution 1 (1.5 mL) and 2 ml MeCN and dry the reaction mixture at 100 "C for 4 rnin e, 
H Add only 2 mL MeCN and dry the reaction rnkture at 100 "C for 4 rnin e, 
J Repeat step H and lower the temperature to 70 "C 
K Add solution IV and keep the reaction vessel for 5 rnin at this ternperature 
L Evaporate the solvent within 1 min and switch the heating off 
M ') Add 4 rnL of solution V 
N Transfer the solution from step M into the injection lwp and inject into the HPLC systern g, 
0 h, Elute using 45 % EtOH; flow: 1.5 murnin; detection: UV (275 nrn), RA 
P 0 Collectthe radioactive peak of [~'FJFESDS, the retention time of which is 30 rnin. Measure the 
radioactivity of ['*F]FESDS 
Before starüng the one-Pot synthesis, the ~lt33ning Program had been carried out, arid ["F]HF in ['80]~2~ was placed in the 
module's reaction vessel and all the required sofutions had been stored in the vialc of the module. 
In this moment, the fed-in radioactivity was bound as ["FJKF. 
Careful drying is  necessary, Therefore, after the first drying (at 100 'C and reduced pressure), 2 ml MeCN were added, 
and a second drying procecs was performed. 
In the steps E and F, W b o W  "F, i.e., unconverted ['BQKF, was eliminated from the reaction vessel as ~'FJHF. The producer 
obtains a first inforrnation aboutthe yield to be expected (see [6]). 
The solvent was  removed by using vacuum and auxiliary g a s  (2 min), then by using vacuum alone (2 min). 
A sample of the solution from this step was checked in the analytical HPLC system. 
HPLC = high perfarmance liquid chromatography. 
EtOH = ethanol; UV = ultraviolet; RA = radioactivify 
Results and Discussion 
The results of the first five synthesis experiments carried out in the [18F]FES~S module are compiled in 
columns 4 - 9 of Table 2. The irradiation time and the resulting starting radioactivity are listed in columns 
2 and 3. 
We found that the starting radioactivity is linearly dependent on the irradiation time. A longer irradiation 
time proved to be advantageous for the speci~fic activity (Asp, column 9). For the results in [I] the Asp 
values at 30 min were found between 50 and 200 GBqipmol and at 60 min between 200 and 300 
GBqIl~mol. 
0 10 20 30 40 50 
retention time [min] 
Fig. 3. A typical column radiochromatogram of the 16a-['8flfluoroestradiol-3,17ßdisuIph~ 
Compared with the synthesis time of the two-step procedure [I], the spthesis time of the one-pol pr~edu- 
re was halved. Thus, the real yield (Le. the available after HPLC purification) was significantly 
higher. All the operations of the one-pot prqram (see Table 1, steps A - N) needed about 1 h. In the 
following HPLC purification (Table 1, steps 0 and P) was eluted after about 25 min in a 
volume of about 2.5 - 3 mL. Thus, the total synthesis time was about 1.5 h. 
The decay-corrected yield of about 20 % in th~e two-step procedure corresponds to a real yield of 6.5 %, 
But, the real yield of ['8F]FESDS found here is between 11 and 15 %. In terms of radioactivity, there are 
amounts of more than 10 GBq [18F]FESDS which can be made available to the ucers. 
In all the experiments between 10 and 30 mg of sulpharnoyl chloride dissolved in 1.5 mL acetonitrile was 
used. Increasing the reagent to rnore than 30 mg had no effect on the yieM. But fhe yieM of ~ ' ~ ~ F E S D S  was 
lower, when less than 10 mg SC1 was used for the sulphamoylation reaction, 
We were pleasanöy surprised at the good reproducibility of the one-pot procedure. This b m e s  evident 
frorn the values of real yield Yr4 or the decay-corrected yield Y, in Table 2, which afe ail to be %und 
within rather narrow lirnits. It also becomes evident from thefact that each successful experiment msulted 
in a column radiochromatogram as shown in Fig. 3. In thic radiochromatqram, there are WO pF!akc bf 
polar products with about 50 % of the tote1 radioactivity and the E''~~FEsE)S peak with about 45 %, sind 
only a small amount of unconverted [18F]~E~. The radiochemical purity of Zhe collected I"F]FESDS W k  
was >99 %. 
It is important to note that the sulphamoylation reaction in the one-pot procedure is hardly susceptible to 
any influences. This is due to the presence of kryptofix 2.2.2 [7]. The procedure worked weil even with 
sulphamoyl chloride which due to long Storage contained a distinct arnount of sulphamoyl acid. 
Conclusions 
Pure [18F]FESDS of high quality can also be prepared in a one-pot procedure. As this procedure is more 
rapid than the two-step synthesis larger amounts of radioactivii can be supplied to the Users. The specific 
activiiy found after 60 min irradiation time was between 200 and 300 GBqIpmol. In order to increase the 
specific activity, we will increase the irradiation time in the nearest future. 
Table 2. Results of five one-pot syntheses in the ["FJFESDS module 
1 2 3 4 5 6 7 8 9 
Expt. Irradiation Starting Synthesis A,(''FESDS) Y,d A~~~.("FEsDs) Y„ A , p ( ' 8 ~ ~ S ~ S )  
time activity time 
a) Really available Radioactivity of ["F]FESDS at that Time given in Column 4 
b) Real Yield of I'~F~FESDS 
cj Radioactivity Öf Column 5 at Time t = 0 
d) Decay-corrected Yield of [ ' ~ ~ F E S D S  
e) Calculated Specific Activity of ["F]FESDS 
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12. Steroidal 16,17-Cyclic Carbonates as Key Products for Cyclic Sulphites and Sul- 
phates 
~ . ~ a s c h ' ,  ~ .~ in tner ' ,  J.Römer, J.Steinbach 
' Hans-Knöll-Institut für Naturstoff-Forschung Jena 
Introduction 
We recently described the synthesis of the 16ß,l7ß-cyclic carbonates (1, cis-ß,ß), starting from 17ß- 
hydroxy,l6a-bromo-steroids of the androstane and estrane series [I]. The isomeric 16a,17a-cyclic 
carbonates (1 , cisa,a) can be similarly synthewized from the 17a-hydroxy, 16ß-bromo derivatives through 
the intra-molecular ring closure reactions to the intermediate l6a,l7a dioxoianimines [2] (Scheme 1). 
/U% ~r Scheme 1 
Cyclic carbonates are good tools for preparin~g cis-diols (2) which can be converted via the surprisingly 
stable cyclic sulphites (3) into cyclic sulphates (4) (Scheme 2). The reaction sequence 1 9 2 9 3 + 4 
described here is a new approach to the cis-l6<-O,l7<-0-sulphonyl steroids which are important precur- 
sors for nucleophilic fluorination reactions. 
1 
Scheme 2 
Experimental 
16a, 17a- or 16ß, I 7ß-diols (2) 
The corresponding 3-0-protected cyclic carbonate (1) (1 mmol) was suspended in methanol (15 ml) 
containing water (1 ml) and potassium carbonate (2 mmol). The solution was heated to 50 O"C: and stirred 
until the saponification was completed. The 3-0-protected diols (2) were precipitated by adding water to 
the methanolic solution. 
( R ) and ( S ) - 16a, 1 7a- or 16ß, 17ß-cycIic swlphites (3) 
Dry 3-0-protected-16<,17<-diol(2) (0.3 mmol) was dissoived in tetrahydrofuran. Pyridine (0.5 mmol) and 
thionyl chloride (0.5 mmol) were intermittantly added to the &irr& solution at temgmatures below O°C+ 
After stirring for 15 minutes, the solution was evaporated to drynesc and Zhe residue suspended in water. 
The mixture of the diastereomeric sulphites was separat& by colurnn chromatography on siliica gel, using 
toluene (estrane-series) or toluene / n-hexane (androstane-series), 
The minor unpolar components of the sulphites showed ,Ru- configuratpon of rtfre oxo%iodioxdan-hnction 
in the a,a- and $3" in the ß,ß-series, while the polar main components showed ,,Su-configuration in the a,a- 
and .Ru in the ß,ß-series. 
16a, 17a- or 16& f7ß-cyclc sulphafes (4) 
The above rnixture of sulphiie preparations (0.3 mmd) was die;sOtved in a two ph;tse ma@nchtonWwater 
colution containing potassium permanganate i(Q.5 mmot) and tetrab~-amm~nium&om5& (0,"lmmd). The 
solution was \riwously stirred und1 the oxidatisn was cwnpk!t% can2rdW byHn&w chroma~raphy VLG) 
on silica gel using toluene. After adding sodiurn sulphite, the steroid was extracted with methylene chloride 
and recrystallized after evaporating the solvent. 
Structure determination 
MS, 'H NMR, 2D 13c NMR, IR, and UV were used for structure deterrnination. The absolute configuration 
of the cyclic sulphites was determined by circular dichroisrn (CD) and correlation with NMR data, chroma- 
tographic characteristics and MM2-calculations. 
Results and Discussion 
Cyclic carbonates are stable to acids, for exarnple, to diluted hydrochloric acid or hydrobrornic acid / acetic 
acid, but they are easily cleaved under basic conditions in protic and aprotic solvents. In this process cis- 
diols are quantitatively synthesized by saponification, using a diluted aqueous-methanolic potassium 
carbonate solution. The cyclic carbonates are easier saponified than the 3-acetates. Thus, the 3-protective 
group can be partially saved in the saponification process. 
The reaction 2 + 3 was optirnized. It was found that the cyclic sulphites (3) are best prepared by using 
thionyl chloride in tetrahydrofuran in the presence of pyridine as a proton-accepting base. The resulting 
sulphites were purified and characterized. The results are surnrnarized in Table 1. 
Table 1. Melting points and chrornatographic properties of sorne new cyclic sulphites 3 a 
Cyclic sulphites 3 prepared according to the reaction 2 + 3 RF-value Retention time [min] M. p. 
a) b) ["Cl 
a) n C  was perfonned using silica gd60 F254 aluminium sheets (Merck) and toluene (for estane derivatives) or toluene / n-hexane (androstane series) as eluents. 
b) HPLC was performed using a RP18 Purosphere C O I U ~ ~ ,  5 pm, 12514 (Merck) and acetonitrile : 1% aqueous diisopropylamine 
= 90 : 10 as eluent. 
In each reaction, no matter whether 16a,17a- or 16ß,17ß-dihydroxysteroid was used as a starting material, 
two isorneric sulphites were formed. These two sulphites (e-g. 3a and 3b in Table 1) were easily separated 
from each other by TLC and HPLC. 
The Valence Shell Electron Pair Repulsion Theory [3] offers a simple explanation for the forrnation of 
diastereomeric sulphites in the reaction 2 + 3. The electron pair on the sulphur of the cyclic sulphites is 
perceived to be functioning as substituents- Because of the various configuration possibilities of the 
electron pair, the sulphites are formed in two different ,Ru and „ S  configurations according to the rule 
stipulated by Cahn, lngold and Prelog [4]. 
MM2-calculations showed that sulphite is therrnodynarnically favoured, the more polar it is, which was 
indeed the case. The product relationships depended on the reaction conditions. Working at room tern- 
perature and using only small arnounts of pyridine, rnore of the thertnodynarnically unfavoured product was 
formed. 
TLG perforrnance and the NOE (NMR) method revealed the interactive effects of the oxothiodioxolane 
rings with the neighbouring substituents; thus proving the polarity of the diastereorners (R / S), and likewise 
the therrnodynarnically favourable connection. 
Additional confimtbn has been Seen in h s e  data through CD measurements in rnethanol. Within appropri- 
ate short wave pararneters, the CD cunres of the substance pairs of the 16ß,17ß (or 16a,17a) sulphites 
occurred ac epimeres, which means that the Cotton effects are reversed. Since the estratriene derivative of 
the CD curves are clearly Seen, due to the additional chromophors in the A-rings at 205 and 212 nm, the 
significant CD bands of the androstene deriiatives are at 205, or 195 nm. 
In Fig. I ,  the epimeric 16ß,l7ß-sulphites of the 16-epiestriol-3-methyl ethers are shown. On the right, the 
interaction of the sulphinyl group with the 13-methyl group in 3g is represented. But no interaction between 
sulphinyl and 13-methyl group exists in 3h on the left side. 
Fig. I. Three-dimensional structure of the epimeric 16ß,17ß-sulphites of the epiestriol-3-methylether 
In general, the reaction 3 + 4 is carried out according to the Sharpless method 151, in which the freshly 
prepared cyclic sulphites are oxidized with rhodium-111-chloride/NaJ04. But oxidation with permanganate 
under phase transfer conditions proved to be a better method, because it was able to overcome the 
intermittent solubility problems of the steroids. The epimeric sulphites can be used as a Substrate. This is 
because the asymmetric centre on the sulphur was removed by oxidation, forming the symmetric cyclic 
sulphates. This saves the purification of the epimeric sulphites and the resulting sulphates. 
Recently the cyclic cis-165-0,17<-0-sulphonyl steroids have played an important patt as precursors for 
preparing the vicinal trans-16-substituted 17-hydroxy steroids 161. Because of their electrophilic properties 
the cis-I 65-0,17<-0-sulphonyl steroids are more reactive than the corresponding cis-165-0,173-0-sulphinyl 
steroids. 
Conclusions 
Steroidal 16<,17<-cyclic carbonates which are available from 17-keto steroids are good tools for preparing 
cis-16<,17<diols. The following reactions Open up possibilities of synthesizing 16<,17~-cycIic sulphites and 
165,175-cyclic sulphates. The latter represent important precursors for the nucleophilic 18F-fluorinations. 
After successful preparation of 16a-['8~]fluoroestradiol ur investigations will be extended to the andro- 
stane-series. 
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13. In Vitro Selection of Sulphatase Inhibitors for Tumour Diagnosis with PET and for 
Tumour Therapy 
H. Kasch1, J. Römer, J. Steinbach 
lHans-Knöll-lnstitute für Naturstoff-Forschung Jena 
lntroduction 
Steroids play a significant role as mediitors in celluiar communication. As hormones which affect enzymes 
and components of cell membranes, they are Seen as responsible for a number of functions. Steroid hor- 
mones, especially estrogens, are frequently responsible for the development of breast Cancer [I, 21. 
Over the last 15 years various concepts of drug treatment of estrogen-dependent tumours (for example 
with Tamoxifen) have been successfully tested. The main focus was directed on the elimination of estro- 
gens such as estrone, estradiol and androstenediol. The estrogen action was minimized by application of 
receptor antagonists, on the one hand, and inhibiion of the transformation of steroid precursors, such as 
estrone sulphate, dehydroepiandrosterone (DHEA) sulphate or androstenedione, into estrogens, on the 
other. The targets to achieve these aims are enzymes, such as 17-steroid dehydrogenase, esterase, 
aromatase, estrone sulphatase, and estrogen receptors. All these enzymes and receptors are enriched 
in estrogen dependent tumour cells [3]. 
The combination of the estrogen receptor blockers and inhibiors of aromatase, 17-steroid dehydrogenase 
and estrone sulphatase hoids out gOOd procpects for the therapy of estrogen-dependent mammary 
tumours. 
We recentiy reported on synthesis of new sulphamates (2,3,4) of estradiol (la) and its 16a-compounds 
as potential inhibiors of sulphatase [41. In this Paper we describe the search for such sulphatase inhibiors, 
using human placenta microsomes [51. Our goal was to select suitable compounds which can be useful 
for tumour, utilizing ''~4abelled compounds and the PET-technique and also for therapy. For PET pur- 
poses we intended to image the sulphatase target in mamma tumours. 
Chemical and biological experiments 
General 
The sulphamates (2,3,4) were prepared by sulphamoylation of the 3,17diols (I) with sulphamoyl chloride 
in DMF or in rnethylenchloride / &C03 in the presence of tetrabutylammonium bromide. The sulphamoyla- 
tion reaction is not regioselective, i-e. all the sulphamates are formed. To determine their biological 
behaviour the sulpharnates have to be prepared in > 99 % purity. In order to ensure high purity a combined 
purification procedure using flach chrornatography on silicagel and HPLC was used. In this way contami- 
nation of the biologically weaker compound by traces of a more active 3- or 3,17-sulphamate was ruled 
out. 
In vitro - testing wjth human placenta microsomes 
Estrone sulphatase can release estrone or dehydroepiandrosterone (DHEA) frorn estrone sulphate or 
DHEA-sulphate. The enzyme is ubiquitously distributed within the body and is especially enriched in the 
leukocytes, macrophages, the brain, and the placenta. It can further be seen in the estrogen-dependent 
MCF-7 cell lines. 
For the in vitro analysis of the sulphataseinhibiing effect, placenta microsomes taken from a fresh 
placenta were used according to the Reed procedure [6]. At -20 "C the microsomes are presenred frorn 
any significant loss of activity for six months. Further experiments with rat her  microsomes yielded 
comparable results. 
The incubation experiments were carried out using [6,7-3~]estrone sulphate potassium sait. Free [6,7-%) 
estrone released by sulphatase was measured after extraction with toluene. 
Procedure 
In a 5 rnl test tube estrone sulphate potassiurn [6,7-3H], estrone sulphate ammonium salt (altogether 
20mM) as weil as a solution of the sulphatase inhibitors to be tested (1 - 2 mg / rnl basic colution, concen- 
tration between 0.01 and 5 FM) were rnixed in a tris-HCI buffer. In a second via1 human placenta microso- 
mes (0.1 - 0.5 mg protein, determined by Bradford's rnethod) were prepared in a tris buffer. 
The chilled enzymecontaining solution was added to the substrate solution. After warrning to 37 "C and 
incubation for 20 minutes, the enzyme was destroyed by adding 1.5 ml of toluene, and the steroid was 
extracted (Vortex, 1 min.). To rneasure the radioactivity in a liquid scintillation analyzer (Packard), 50 MI 
of toluene extract was withdrawn and mixed with 3 ml of scintillator soluüon (Vortex, 10 s). For comparison 
of the values, known cornpounds such as estrone sulphamate and dehydroepi-andrmerone sulphate 
were used as standards. This measurement was carried out two or three times. 
With new substances the initial experiment was geared towards accertaining the IC, values. In sulphatase 
inhibiting effects, the values ranged frorn 0.01 to 25 PM. 
Results and Discussion 
We were interested in finding substances with high sulphatase-inhibiting effects. Such substances are 
useful for diagnostic purposes, where the drug and tlle labelled compound are nearly identical in StrUckire 
and activity. In the present case of fluoroestradiol-3,17ßdisulphamate or bromoestradiol-3,17ß- 
disulphamate the diagnostics (18F- or 75~r,76~r-labelled cornpound) and therapeutics are fortunately 
identical. 
The sulphatase inhibition effect of all the sulphamates 2, 3, and 4 was determined. The ICW values 
obtained are compiled in Table 1. 
Table 1. !Cso values for sulphatase inhibition by estrone sulphamate and the sulphamates 2,3, and 4 
Substances 3-Monosulphamates (2) 17-Monosulpharnates (3) 3,17-Disulphamates (4) 
. . [PM] [FM] [UM] 
Estrone 0,07 
Estradiol (1 a) 0.09 (2a) 25 Pd 0.035 (4a) 
1 Ga-Bromoestradiol (1 b) 0.09 (2b) 7 {3ti) 0.020 (4b) 
1 Ga-Fluoroestradiol (1 C) 0.08 (2c) 2.5 (3c) 0.025 (46) 
Fig. 1 shows the relative values for sulphatase inhibiion by the 3-, 3,17- and 17-stftphamtes &h esttone 
sulphamate (activity = 1) being the reference compound. 
The results demonstrate that the disulphamates (4a, 4b, 4c) are essentially more a&e than eslrone 
sulphamate. The inhibior activities of estradiol-3-sulphamates (2a, 2b, 2c) are moderate in ~ 0 m p o f i ~ n  
with estrone sulphamate, those of estradiol-17-sulphamates (3a, 3b, 3s) are weak. 
ate 
Fig. 1. Sulphatase inhibition by 17-monosulphamates 3 (green), 3-monosulphamates 2 (red), and 3,17- 
disulphamates 4 (blue). The values are related to estrone sulphamate actity of which is set = 1. 
Fig. 2. Increase of the sulphatase inhibitory effect within the 17-monosulphamates 3a, 3b, and 3c. 
The values are related to estrone sulphamate activity of which is set = 1. 
Conclusions 
A series of novel sulphatase inhibitors which are more active than the well-known steroid sulphatase 
inhibitors were selected. The introduction of an additional sulphamate group in the 17 position was 
combined not only with a decrease in estrogenic activity, but also with an enorrnous increase in the 
inhibition of estrone sulphatase [7]. 
Because 16a-fluoroestradioldisulphamate belongs to the most active sulphatase inhibiors, there are good 
prospects of ist being used as a diagnostic in [''F] labelled form as well as for therapy, 
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14. One-Pot Synthesis of N-Succinimidy14-['8F]~luorobenzoate 
P. Mäding, M. Scheunemann, H. Kasper, J. Steinbach 
lntroduction 
We have been using N-succinimidyl 4-['8~]fluorobenzoate ( [ ' 8 ~ ] S ~ ~ )  for labelling peptides by [18~fluoro- 
benzoylation [I]. [18FJs~~ is prepared according to [2] by a three-step synthesis, which is a time- 
consuming and labour-intensive procedure. We are interested in a simplification and improvement of the 
synthesis of ['8F]SFB and therefore tried to produce the [18flS~6 in a one-pot process. 
Experimental 
Materials 
4-Dimethylaminobenzoic acid, trimethyloxonium tetrafluoroborate, Kryptofix 222 and dibenzo-18-crown-6 
were purchased from Merck and had for synthesis quality. Di-(N-succinimidyl) carbonate (purum, 97 %), 
ethylene carbonate (puriss., 99 %) and sulfolane (99.5 %) were obtained from Fluka, Bu4NOH (1 M 
solution in methanol) and methyl triflate (99 %) from Aldrich, and 18-crown-6 from Janssen Chimica. 
Analysis 
To determine the extent of conversion and the radiochemical purity and to identify the labelled products, 
an HPLC system (JASCO) was used, including a pump, a Rheodyne injector with a 20 p1 loop, a LiChro- 
spher WP300 RP-18 column (5 Pm, 250 mm X 3 mm, Merck) and a UV detector coupled in series with a 
radioactiiity detector FLO-ONEBeta 150TR (Canberra Packard). The HPLC analyses were carried out 
at a flow rate of 0.5 miimin with mixtures of MeCN and water containing 0.2 % TFA. The gradient of the 
eluents was: 0 min - 10 % MeCN/ 90 % water; 10 min - 60 % MeCN/ 40 % water; 14 min - 100 % MeCN/ 
0 % water; 20 min - 100 % MeCN/ 0 % water. 
Synthesis of the precursors 
N-Succinimidyl44-dimethyiaminobenzoate (I) 
Di-(N-succinimidyl) carbonate (2.56 g; 10 mm01) was added to a suspension of 4-dimethylaminobenzoic 
acid (1.05 g; 10 mmol) in 25 ml MeCN. After dropwise addition of NEk (1 .O1 g; 10 mmol) in MeCN (5 ml) 
a clear solution of the reaction mixture was obtained. The mixture was heated at 50 "C for 1 h and then 
evaporated. The residue was dissolved in CH2C1.2 (60 ml). The organic solution was washed with aqueous 
NaHC03 and then with HCI (0.01 M). The organic Phase was dried with Na2S04. Evaporation of the filtered 
extract left a soiii residue which was recrystallized from isopropanol. Light grey crystals, melting point: 205 
- 207 "C, yield: (1.5 g, 57 %)- 
Tetrafluoroborate salt of N-succinimidyl4-trimethylammonium benzoate (2) 
Trimethybxonium tetrafiuoroborate (0.19 g; 1.28 mmol) was dissolved in nitromethane (1 ml) under argon. 
A solution of 1 (0.33 g; 1.26 mmol) in nitromethane (4 ml) was added drop by drop to the oxonium salt The 
reaction mixture was stirred for 4 h. Then dry diethyl ether (20 ml) was added while stirring, with a pink oil 
separating. The ether was decanted off and the Procedure was twice repeated. In this way the oil slowly 
changed into a pink solid. It was recrystallized frorn a mixture of ethanol and isopropanol(4 : 7). Colourless 
crystals, melting point: 185 - 188 "C, yield: (0.18 g, 39 %). 
Triflate salt of N-s~1ccinimidyl4-frimethylammonium benzoate (3) 
A solution of methyi triflate (0.19 g; 1.16 mmol) in CH.&12 (1 ml) was added to a stirred solution of 1 (03 g; 
1.14 mmol) in Cf-f&12 (4 ml). The reaction mixture was stirred for 8 h with a pink oil separating. Then the 
solvent was decanted off. Addion of dry diethyl ether (10 ml) changed the oil into a colourless solid. After 
filtration of the hygroccopic solid through a frit glass filter it tumed pink. The product was recrystallized from~ 
a rnkture of THF clnd ethanet (2 : I). Colouriess crystals, melting point: 7 6 0  - 162 "C, yieId: (0.1 1 g, 22 X). 
Rad~ntheses 
Experiments folr the spthesis O~['~@SFB 
A Solution of a phase-transfer ~ak fys t  (15 mg Kryptofix 222 or 10.6 mg 18-crown-6 or 14.4 mg dibenzo- 
18-crown-6; 40 pmofJ and K2C03 (2.77 mg; 20 Crmof) in aqueous MeCN (1.5 ml; 86 %j or only Bu4NOH 
(I M, 40 ~ 1 ,  40 pmol) in MeCN [i ml) was added to a mixture of irradiated fY80]i-i2O containing n.c.a. 
[18F]HF. This reaction mixture was dried by means of a nitrogen stream at 90 - 95 "C using a cooled trap. 
The residue was carefully dried by repeated addition and evaporation of abs. MeCN (3 X 1 ml). After 
addition of the precursor 2 or 3 in a solvent, the reaction mixture was heated either at 90 - 95 "C or in a 
microwave oven. 
For detailed reaction conditions See Table 1. 
Resuits and Discussion 
Prerequisites for the one-step procedure of preparing ["F]SFB was a suitable precurcor which already 
included the activated ester funcüon of the benzoic acid and, in p-position, a leaving group for the nucleo- 
philic substitution. Such a precursor was prepared by a two-step synthesis according to Scheme 1 starting 
from 4-dimethylaminobenzoic acid. 
The esterification of the benzoic acid using di-(N-succinimidyl) carbonate yielded N-succinimidyl 
4-dirnethylaminobenzoate (1). The corresponding salt of N-succinirnidyl4-trimethylammonium knzoate 
(2 = tetrafluoroborate; 3 = triflate) was obtained by rnethylation of the dimethylamino group of (1) with tri- 
rnethyloxonium tetrafluoroborate or rnethyl triflate. 
r, 
O-N 
Scheme 1 
The structures of the cornpounds I, 2 and 3 were confirmed by their 'H and NMR data, 
The one-pot synthesis of ["FISFB by nucleophilic substiiution of ra~fluoride for the tnmethylammonium 
group of the precursors 2 or 3 according to Scheme 2 was tested under various reaction canditions: 
several phase-transfer catalysts, various sohrents, reaction ternperatures and rear;tion times @?e Table I). 
The phase-transfer cataiysts Kryptofix 222, 18-crown-6 and dibenzo-18-crown-6 were combinded wjth 
&Co3 in a molar ratio of 2 : 1. Tetrabutylammonium hydroxide was also tested as a phase-taansfer 
catalyst. 
for synthesizing ["FISFB under various reaction conditions 
Expt. Precur- Phase-transfer Solvent Reaction time Reaction ternpe- ["FISFB 
sor catalvst rature or rnicro- Total 
250 pl MeCN 
250 pI DMSO 
125 p1 MeCN 
125 pI MeCN 
150 pI MeCN 
150 p1 MeCN 
125 pI MeCN 
125 p1 DMSO 
150 p1 DMSO 
150 pI MeCN 
150 pI MeCN 
150 pl HMPT 
1 rnl MeCN 
1 rnl MeCN 
1 ml MeCN 
1 ml MeCN 
1 rnl MeCN 
1 rnl MeCN 
1 ml acetone 
0.5 rnl MeCN 
1 rnl MeCN 
300 pI MeCN 
500 pI ethylene 
carbonate 
10 min 
10 min 
10 rnin 
10 rnin 
2 rnin 
5 min 
5 min 
5 rnin 
10 rnin 
5 rnin 
5 min 
2 rnin 
3 rnin 
4 rnin 
6 min 
10 rnin 
10 rnin 
10 rnin 
10 rnin 
5 rnin 
10 rnin 
5 min 
10 rnin 
10 min 
10 rnin 
20 rnin 
10 rnin 
40 min3) 
10 rnin 
15 rnin 
10 rnin 
wave power 
90°C-950C 
90 "C - 95 "C 
90°C-95°C 
90°C-95°C 
600 W 
900 W 
900 W 
900 W 
90 "C - 95 "C 
900 W 
900 W 
900 W 
600 W 
900 W 
440 W 
600 W 
900 W 
90 "C - 95 "C 
90 "C - 95 "C 
600 W 
90 "C - 95 "C 
600 W 
90 "C - 95 "C 
140 "C 
90 "C - 95 "C 
90 "C - 95 "C 
90 "C - 95 "C 
90 "C - 95 "C 
90 "C - 95 "C 
600 W 
90 "C - 95 "C 
yield [%I 
0 
0 
0 
0 
0 
0 
0 
2 
0 
0 
0 
0 
2 
9 
2 
4 
21 
10 
15 
0 
14 
4 
21 
11 
1 
23 2 18-crown-6 500 pI sulfolane 10 min 90 "C - 95 "C 0 
''reduced amount of K2C4 (0.69 rng; 5 prnol) 
')double arnount of 18-crown-6 (21.2 rng; 80 prnol) 
3)while stirring and ultrasonicating 
It was shown that the Kryptofix 222/K&03 mixture, which is often used for nucleopilic substitutions, was 
unsu&&& for the one-pot synthesis of [''FISFB acwrding to Scherne 2. The best results (yields of 21 % 
[ 7 8 ~ S ~ ~ )  were obtained using an 18-crown-6/K2C03 mixture in 0.5 - 1 rnl MeCN (see Expt. 14 and 20). 
But the use of [18qSFB as a labelling agent requires a pure substance. Puriiication procedures which were 
not investigated increase the preparation time and decrease the yields. The advantage of the one-pot 
synthesis of [I'FJSFB over the three-step synthesis according to [2] cannot be assessed at the rnornent. 
Furüler investigations in this field are necessary. 
[ I ]  Scheunernann M., Mäding P., Bergmann R., Steinbach J., Johannsen B. and Tourwe D. (1999) 
Reacgon of neurotensin(8-13) and its partially reduced congener with unlabelled and "F-labelled 
N-succinimidyl4-flu0robenz0ate fSFB). Repotf January 1998 - June 1999, Institute of Bioinorganic 
and Radiopharmaceutical Chemistry, FZR-270, pp. 26-28. 
[2] Wester H.J., Hamacher U. and StÖcWin G. (1996) A cornparative study of n.c.a. fluorine-18 labeling 
of proteins via acylation and photochernical conjugation. Nucl. Med. Biol. 23,365-372. 
15. The Utilization of ['8~N-Succinimidyl 4-Fluorobenzoate ([''FISFB) for Labwelling 
Bombesin Derivatives 
M. Scheunemann, P. Mäding, R. Bergmann, J. Steinbach, B. Johannsen 
lntroduction 
Bombesin as well as its closely related congener, human gastrin-releasing peptide (GRP), are produced 
and secreted by human small-cell lung Cancers (SCLC) [I]. It was disclosed that both peptides act as 
autocrine growth factors for various cell lines of this turnour type 121. Moreover it was found that specific 
receptors for peptides related to GRP are expressed on the surface of various other tumour cell types as 
well, such as human prostate [3] and human breast Cancer [4]. The obvious physiological if not pharmacol- 
ogical role of bombesin in the proliferation of these tumour types has triggered a wide search for new 
antagonists with a high affinity and selectivity for the appropnate binding sites. In addition to these efforts, 
there is a general interest in the development of new radiopharmaceuticals for the visualisation and 
radiotherapy of bombesin receptor positive tumours. 
Pyr-Gln-Arg-Leu-Gly-A~n-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH~ bombesin, (three-letter code) 
pEQRLGNQWAVGHLM-NH2 (one-letter code) 
H-Ala-Pro-Val-Ser-VaI-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-ValGly-His-Leu-Met-NH2 
APVSVGGGTVLAKMYPRGNHWAVGHLM-NH2 human GRP 
Our motivation consists in the appropriate 'F labeliing of bombesin(6-14) derivatives, which represent the 
minimal structures associated with full biological activity [5]. 
Results and Discussion 
Because peptide structures bearing a variety of various H-acidic functions each attempt to introduce the 
[18F]fluoride anion directly by nucleophilic substitution would fail due to the high basicity of the fiuoride ions. 
The use of a prosthetic group is therefore a requirement for selective labelling of a peptide such as 
bombesin BN(6-14) or its analogues. As for the corresponding labelling procedures of several neuroten- 
sins, such as NT(8-13) [6], we chose again the 4-[1'~]fluoro benzoyl moiety as prosthetic group. N- 
~uccinimidyl-4-["~]fluorobenzoate (['*F]sFB), which in our experirnents serves as the molecule carrying 
the positron emitter fluorine-18, was prepared in a three-step procedure as described in the literaiture F]. 
In view of the fact that peptides derived from the bombesin(6-14) class might display a chemical behaviour 
widely differing from NT(8-13) derivatives, we started our expenments with smaller analogues of BN(6-14). 
Thus, we selected the dipeptide Phe-Trp (FW) as weil as the tetrapeptide Phe-Gln-Gly-Pro (FQGP). In 
each of these model peptides phenylalanine serves as the N-terminal amino acid. 
,Gln ,Al% ,Gq .,Lep+Et 
(~ )~he \Trp  Val HIS H (3) 
Studying the steric infiuence of the benzyl substituent of phenylalanine (Phe: F) on this reactivity with SFB, 
the absolute configuration of the N-terminal amino acid is expected to be of less importance due to the 
absence of a stereogenic centre in the labelling agent. 
For the synthesis of the nonradioactive analogues of 1, 2 and 3 we tested protic sobents, such as an 
aqueous buffered medium (borate-phosphate buffer, pH 8-31, as well as aprotic mixtures, such as DMF 
or acetonitrile, in each case with triethyl amine as the proton acceptor, Generaliy It can be said that an 
aqueous buffered system tends to provide more favourable reaction conditions for a complete and better 
chemoselective conversion of the starting peptide. But the addition of a small amount of DMF is advisable, 
especially for the synthesis of the nonradioactive analogues of 1 and 3, for complete dissolution of the 
highly lipophilic peptide precurcor. 
In the Course of our studies we turned our attention to experiments using [ 1 8 F ] s ~ ~  on the n.c.a. level. Thus, 
the two derivatives 2 and 3 were synthesised and biologically tested. The results of the radiolabelling of 
the tetrapeptide FQGP and the bombesin derivative (D)-FQWAVGHL-NHEt are listed in Table 1. 
Table 1. Results of '8~-fluoro-benzylation of two Phe peptides 
Peptide r.c.y. ' specific mol weight I (decay corrected) I radioactivity I of product 
I I [GBqIvmol] I 
Phe-Gln-Glv-Pro 2 65 % = 5 569.6 
': r.c.y. = radiochemical yield 
': starting from approx. 3.5 GBq ["VF 
3: as indicated by macs spectrometry of the unlabelled derivative (electro Spray, ES') 
To confirm the suggested structure of the labelled peptides we synthesised the nonradioactive analogues. 
The mass spectrum (electrospray, ES(+)) of each nonradioactive analogue indicates a compound showing 
a molpeak as calculated for the fluorobenzoylated cornpound. 
Both independently prepared unlabelled derivatives coelute fairly well with the '8~-labelled peptides. 
In order to determine the definite position of the 4-fluoro benzoyl group, we used the ninhydrin test, a 
standard method for identification of molecules bearing secondary or primary amino groups, such as amino 
acids or simple amino alcohols. By using this test system we obtained a negative result for the unlabelled 
analogues of 1, 2 and 3. Their parent peptides, on the other hand, show a positive result which clearly 
demonstrates the successful coupling of the prosthetic group to the a-amino group of the Nterminal amino 
acid. 
The authors wish to thank Dip1.-Chem. K. Fischer for recording the electrospray mass spectra. 
This work was supported by the European Union (BMH4-CT98-3198). 
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16. Co-Labelling Experiments for the Synthesis of [l-11~/13C]~henol 
P. Mäding, H. Kasper, M. Scheunemann, K. Fischer, J. Steinbach 
lntroduction 
The synthesis of [1-~~C]phenol(6a) is described in [I]. As the identity and the position of the labe1 of "C- 
labelled compounds cannot be directly determined, we carried out ' 3 ~ / ' 1 ~  cblabelling experirnents 
according to Scherne 1, making use of the opportunities provided by mass spectrometry and 13C NMR 
spectroscopy. Two HPLC Systems were used for analytical control. 
Scheme 1 
Experimental 
General 
Analytical HPLC was used to deterunine the extent of reaction conversion and the radiochemical purity of 
the reaction products and to identify the products. HPLC was performed with an HPLC system frorn Merck- 
Hitachi, including a gradient pump (L-6200A), a Rheodyne injector with a 20 p1 loop and a diode array 
detector (L-4500 DAD) coupled in series with a radioactivity detector FLO-ONRBeta A500 (Canberra 
Packard). Two analytical HPLC systerns were used: a gradient system [ l ]  and an isocratic system. 
Gradient systern: 
The column used was a Merck LiChrospher 100 RP-18 endcapped, 5pm, 150 mm X 3.3 mm. The mobile 
phase consisted of phosphate bu~ffer pH 7.0 (c[NaH,P04] = 0.26 rnM; c[Na2HP04] = 0.51 rnM) and 
acetonitrile at a flow rate of 0.5 rnllmin, with the following linear gradient of the eluents: 0 min - 100 % 
bufferIO % MeCN; 20 min - 0 % buffed 100 % MeCN. 
Isocratic system: 
These analyses were performed with a NUCLEOSIL 120 RP-I8 column (5 pm, 125 rnrn X 4 rnm, Ma- 
cherey-Nagel) isocratically eluted with isopropanol/water (20180) containing 0.1 M arnmonium formate at 
a flow rate of 0.5 rnllmin. Retention times: 22.77 min for 3,635 min for 4,7.81 min for 6. Reagent-grade 
nitrobenzene (Fluka, Switzerland), reagent-grade aniline (Fluka, Switzerland) and reagent-grade phenol 
(Berlin Chemie, Gerrnany) were used as reference substances. ~itro-['~~]methane (lb) (99 atom OJo 13C) 
was purchased frorn Aldrich. 
13c NMR spectra were recorded an a Varian INOVA 400 spectrometer at 160.6 MHz with CDCI, as an 
internal standard. 
Mass spectrometric analyses were carried out on a Micromass tandern quadrupofe rnass spectrometer 
(Quattro LC) operated in the MS mlode. Macs spectral data were recorded in the negative ES1 mode using 
a cone voltage of 35 V. A solution of phenol or fl-'3C]phenol (6b) in MeOH was infused at a fiow rate of 
5 pl/min. 
~itro-[I-" C/' 3C]benzene (M) 
~itro-[llc]rnethane (ja) was trapped in a cooled 2 ml vecsel (10 "C) mtaining HMPT (250 ~ 1 ) ,  
5-dimethylaminopenta-2,4-dienyli&ne-dimethylammoniu perchlorate (2) (8 mg, 32 prnol) and t-BuOK 
(3.5 mg, 31 pmol). ~itro-S3c]methane (lb) (1 pl, 18.5 pmol) was added. Cyclizationl aromatization into 
3alb was achieved by heating the well-sealed vessel at 170 "C for 7 min. 
[I- "C/' 3C]aniline (4alb) 
The reduction of 3alb to obtain 4aib was performed by adding an excess of Na2S.9H20 (28 mg, 1 17 pmol) 
in water (100 pl) to the above reaction mixture and heating at 170 "C for 30 min. 
Then the reaction mixture was diluted with water (1 ml) and passed through an activated polystyrene 
cartridge (LiChrolut EN, Merck). After washing the cartridge with water (20 ml) and with aqueous HBr (2 
ml, 10 %), 4alb was eluted with ethanol(2 ml). 
The acidic ethanolic solution of 4aib was diluted with water (8 ml) and passed through a cartridge filled with 
cation exchange resin DOWEX 50 WX 8 (SERVA, 100-200 mesh, H+ form, neutral). The resin was washed 
with water to make it neutral. Pure 4alb was eluted with ammonia (2 M). 
[1-'~C/'~C]Phenol(6a/b) 
The ammoniacal solution (3 ml) was acidified with HBr (1 ml, 40 %) and cooled to 0 "C, Compound 4alb 
was diazotized by adding NaNOa (10 mg, 145 pmol) in water (100 pl) to the cooled solution. After 5 min 
at 0 "C the reaction mixture was heated at 100 "C for 5 min. The [l-11~/'3~]benzenediazonium bromide 
(Salb) formed was then concentrated and 6ah was obtained. It was analysed by the two HPLC systems 
mentioned above. 
After decay of the "C radioactivity, the acid solution was passed through an activated polystyrene cartridge 
(LiChrolut EN, Merck). The cartridge was washed with water to make the resin neutral. Then the polysty- 
rene cartridge was dried by means of a nitrogen stream (3 Ilh). [1 -13C]~henol (6b) was eluted from the 
cartridge with CDCI3 (1 ml) and analysed by 13C NMR. Part of the CDC13 solution of 6b was evaporated 
for MS investigations in MeOH. 
Results and Discussion 
T he synthesis of nitro-[1 -1'C113C]benzene ( M )  by reaction of 5-dimethylaminopenta-2,4-dienylidene- 
dimethylammonium perchlorate (2) with la/b and the subsequent reduction of M to [1-"~l '~~]ani l ine 
(4alb) were carried out in a similar way as the "C procedure described in [2]. The amount of sodium 
sulphide and the reduction time had to be increased in comparison with the pure "C synthesis for a 
satisfactory reduction of 3alb to 4alb. [l-11Cl'3C]~henol (Wb) was obtained by diazotization of purified 
4alb and subsequent concentration of the [l-"~I'~~]benzenediazonium salt 5alb formed by analogy with 
[I]. Compound 6aib was identified by two HPLC systems using a reference standard. 
After decay of the "C radioactivity of 6a, [l-'3C]phenol (6b) was purified by solid-phase extraction on a 
polystyrene carbidge. The position of the labe1 was confirmed by analysis of the 1 3 ~ - ~ ~ ~  spectrum of 6b. 
The strong 13C signal of 6b at 6 = 156.0 ppm corresponded to the 13C signal of the C-1 of authentic phenol. 
Compound 6b was also analysed by MS, indicating a molecular ion peak at rn/z 94 (M-1), which corre- 
sponded to the molecular ion peak at mlz 93 (M-I) observed with authentic phenol. 
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[13C]rnethane (1 b) (2 pI, 37 prnol) was added. After addition of t-BuOK (1 M in t-BuOH, 38 PI, 38 prnol) and 
t-BuOH (250 PI), the well-sealed vessel was heated at 120 "C for 30 rnin. 
Using a syringe, the reaction rnkture was diluted with water (10 ml) and passed through an activated RP- 
18 cartridge (Chrornafix C1 8 ec, Macherey-Nagel). After washing the carbidge with water (1 0 rnl), Salb was 
eluted with acetonitrile (2 rnl) and analysed by HPLC. 
After decay of the "C radioactivity of 4-nitro-[4-"C]anisole (5a), the solvent was evaporated. 4-Nitro- 
[4-'3C]anisole (5b) was purified by flash chrornatography, using a silica gel colurnn (i.d. 1 crn, length 
4.3 crn) and a rnixture of petroleurn ether and ether (9 : 1). The separated fractions (each 1 rnl) of Sb were 
cornbined and evaporated. The purified solid product was dissohred in CDC13 (0.7 rnl) and analysed by 13c- 
NMR. Part of this CDCI3 solution was evaporated for MS investigations in MeOH. 
2,s-~imethyl-4-methoxy-nitrof l- Cf3C]benzene (6a/b) 
The gaseous l a  was trapped in a 2 rnl vessel containing t-BuOH (250 pl) and 2,6-dirnethyl-4- 
rnethoxypyryliurn perchlorate (3) (9 rng, 38 prnol). 1 b (2 PI, 37 prnol) was added. After addition of t-BuOK 
(1 M in t-BuOH, 40 pl, 40 prnol) the well-sealed vessel was heated at 120 "C for 30 min. The reaction 
rnixture was analysed by HPLC. 
After decay of the "C radioactivity of 2,6-dirnethyl-4-rnethoxy-nitro-[l-"C]benzene (&I), the reaction 
rnixture was evaporated. 2,6-Dirnethyl-4-rnethoxy-nitro+ -13~]benzene (6b) was purified by flash chrorna- 
tography, using a silica gel colurnn 0.d. 1 Cm, length 3.8 cm) and a rnixture of petroleum ether and ether 
(9 : 1). The separated fractions (each 1 rnl) of 6b were combined and evaporated. The purified solid 
product was dissolved in CDCI3 (0.7 rnl) and analysed by 13c NMR. Part of this CDC13 solution was 
evaporated for MS investigations in MeOH. 
2-~itro-12-" Cf  3C]mesitylene (7ah) 
The gaseous l a  was trapped in a 2 rnl vessel containing t-BuOH (250 pl) and 2,4,6-trimethylpyryliurn 
tetrafluoroborate (4) (8 rng, 38 prnol). I b  (2 PI, 37 prnol) was added. After addition of t-BuOK (1 M in 
t-BuOH, 40 pl, 40 pmol) the well-sealed vessel was heated at 120 "C for 30 min. The reaction rnixture was 
analysed by HPLC. 
After decay of the "C radioactivity of 2-nitro-[2-"Clrnesitylene (7a), the reaction rnixture was evaporated. 
2-~itro-[2-~~~]rnesityiene (7b) was purified by flash chrornatography, using a silica gel column (i.d. 1 crn, 
length 2.5 cm) and petroleurn ether. The separated fractions (each 1 rnl) of 7b were cornbined and 
evaporated. The purified solid product was d i i l v e d  in CDCI3 (0.7 rnl) and analysed by l 3 C - ~ ~ ~ .  Part of 
this CDCh solution was evaporated for MS investigations in MeOH. 
Results and biscussion 
The synthesis of the nitr~-[l-~~CC/'~C]benzenes Salb-7alb by reaction of the corresponding pyryliurn salts 
2-4 with I& was carried out in a sirnilar way as the "C procedures described in [I, 21. ~itro-[13C]rnethane 
(lb) was added irnrnediately after nitro-["Clrnethane (la) had been trapped in the reaction rnixture. 
Because of the molar ratios of the pyryliurn salb 2-4 and 1 b, the reaction tirnes had to be increased 
compared with the pure "C syntheses to obtain Salb-7alb in satisfactory yields. The cornpounds 5afb-7aib 
were identified by two HPLC Systems. An additional purification step using an RP-18 cartridge had to be 
carried out after the synthesis o l  Wb- In this way the high-boiling HMPT arid other impurities were 
rernoved. 
After decay of the "C radioactivity of 5a-7a, the '3C-ring-labelled nitrobenzenes 5b-7b were purified by 
flash chrornatography. 
The position of the labet was ~0nfirrTIed by analysis uf the ' 3 ~  NMR spectra of 4-nitr0-[4-'~C]anicole (Sb), 
2,~i-dime~y~4-mthoxy-n~~o-fl-~~C]benzene (W a d 2-nitr0-[2-'~C]rnes.3yIene (i'b). The strong 13C signal 
of Sb (6 = $442 -5 pprn), 6b (6 = 145.5 ppm) and 7b (6 = 149.7 pprn) corresponded to the ' 3 ~  signal of the 
a&henGc unlabefied compound. MS analyses of 5b (mlz = 155 (M+l)), 6b (m/z = 183 (M+1)) and 7b (m/z 
= f 67 ( M I J ) )  r'ndicated a motecular ion peak which differed from the correspon-ding rnolecular ian peak 
of the autheritic wnfabelled compound by 1. 
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18. Repeated Charging of Automated Synthesis Modules with Liquid Starting Materials 
for the Preparation of PET Tracers by an Ultrasonic Fill Height Sensor 
J. Zessin, F. Füchtner, J. Steinbach, B. Jung, P. Mäding, E. Will, E. Lösel, N. Dohn, H. ~ r u g '  
'~entralabteilung Forschungs- und Informationstechnik 
Introduction 
The synthesis of PET tracers requires a high level of starting radioactivity due to the short half-life of the 
radionuclides. The radiotracer preparation has therefore to be carried out in shielded hot cells with 
automated synthesis rnodules. The growing number of PET investigations requires the use of the synthesis 
rnodules several times a day. The residual radioactivity after radiotracer preparation makes it necessary 
to automate cleaning processes and fill-up procedures of starting materials. The latter can be performed 
with multiple dosing of liquids from a reservoir vessel. 
In this paper we described a device for multiple charging of synthesis rnodules with liquids based on fill 
height rneasurement by an ultrasonic sensor. 
Experimental 
Charging mit 
The charging unit was used for the addition of hydroiodic acid in the synthesis of [%]methyl iodide. The 
device is based on the ultrasonic sensor Sonometer 10 for filling level measurment (SONOTEC, HalleISa., 
Germany). The hydroiodic acid reservoir is a graduated glass cylinder (height: 180 mm, inner diameter: 
10 mrn) sealed with a silicone rubber Septum. The outer diameter of this vessel is sirnilar to the diarneter 
of the ultrasonic sensor. An improved contact between the sensor and the ground bottom of the reservoir 
is achieved by using of a coupling Paste. Teflon tubing is used for connecting the reservoir and the reaction 
vessel. 
Automated preparafion of [''~]methyl iodide 
[ " ~ I ~ e t h y l  iodide was prepared from ["Clcarbon dioxide in an automated synthesis module, which was 
described in a former report [I]. 
Results and Diccussion 
The device for repeated charging of the reaction vessel with liquid starting materials consists of a reservoir 
and an ultrasonic sensor for filling level rneasurement. The fill height was determined by rneasuring the 
running time of the echo from the liquid surface. Parameters to be adjusted at the sensor are the sonic 
speed in the liquid and a dead time for elirnination of troublesome echos both from the bottorn and the wall 
of the vessel. Due to this dead time the minirnum fill height was 30 mm. 
At first we checked the precision of the charging procedure for various volumes. The results are summa- 
rized in Table 1. 
T able 1. Precision and time required by the automated filling process 
I Set volume 1 Filled volurne I Time required by the filling process') I 
1 .O 1.2 + 0.1 16 
1.5 1.5 20.1 19 
2.0 2.1 + 0.2 21 
1) 8 s of this vatue was needed for switching the valves, the filling processes was canied out, using an 
optimized overpressure Vaiue 
The liquid was transported frorn the reservoir to the reaction vessel by overpressure. The transfer time 
depended on the level of the gas overpressure. In the tests the overpressure was optirnized to reach 
minimurn transfer tirnes cornbined with rnaxirnurn precision. Volumes frorn 0.1 up to several millilitres can 
be dosed with this charging device, which Covers all the volurnes cornmonly used in PET tracer syntheses. 
After these initial tests the described charging unit was used for the addition of hydroiodic acid in the 
synthesis of ["C]methyl iodide. The Set volume of hydroiodic acid for the conversion of lithium aluminium 
["Clmethylate into ['lC]rnethyl iodide was 1.7 ml. The volume rneasured by the charging unit was 1.8 t: 
0.1 ml. The whole charging process took about 30 s. 
The radiochernical yields and the synthesis times of ["C]rnethyl iodide preparation were not influenced by 
this charging device. Starting frorn 3.9 GBq (105 mCi) ["cICO*, 1.5 + 0.2 GBq ["Clrnethyl iodide (not 
decay-corrected) was obtained after synthesis, which corresponds to a decay-corrected radiochemical 
yield of 67 t: 4 %. The radiochernical purity of [71~]rnethyl iodide was greater than 98 %. Under these 
conditions the specific radioactivity at the end of the synthesis varied from 3.3 to 6.3 GBqiprnol(90 - 170 
mCi/l.imoI). 
We also tried to use such a charging unit for addition of the lithiurn alurniniurn hydride solution. The 
automated addition of this solution was not possible due to blockages in the valves, which may have been 
caused by hydrolysis of the lithium alurniniurn hydride. 
Conclusion 
We demonstrated that the charging unit based on an ultrasonic filling level Sensor can be used for repeated 
charging of reaction vessels with liquids in the synthesis of PET radiotracers. In this way synthesis modules 
can be used several times a day without filling up reagents. This was dernonstrated by the use of such a 
charging unit in an autornated synthesis rnodule for dosing of hydroiodic acid in the preparation of 
["Clrnethyl iodide. The reliability of this charging device was confirmed in more than 50 syntheses. 
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19. Installation of Surge Protective Devices for the "CYCLONE 18/9" PLC System 
St. Preusche, H. Ross, H. ~ r u g '  
'Forschungszentrum Rossendorf, Zentralabteilung Forschungs- und lnformationstechnik 
lntroduction 
At the Rossendorf PET Center the PET cyclotron and thle radiochernical laboratories are 500 meters apart. 
Due to this fact our CYCLONE 18/9 PLC configuration consists of two PLC modules. The main PLC unit 
(SIMATIC S135U) at the cyclotron site controls the cyclotron. The chemistry PLC unit (SIMATIC S95U) 
at the site of the radiochemical laboratories controls the chernistry rnodules. The two PLC units cornmuni- 
cate via a SlNEC L2 bus cable 500 rneters in length. 
Problem 
The control System worked without any problerns for more than three years. 
But after a heavy thunderstorm at the end of June 1999 we were unable to operate the cyclotron. The 
following problerns appeared in the control systern: 
- no cornmunication between PC/PLC (S135U) 
- PC login was not possible either at the cyclotron oir at the radiochernistry terminals 
- bus failure in the chemistry PLC (S95U) 
Solution 
The SlMATlC S95U was repaired at Rossendorf. The final Stage circuit was replaced and the bus failure 
thus overcome. 
An intervention by an IBA specialist was necessary to locate the problern of the SlMATlC S135U. It was 
impossible to deal with it at Rossendorf and thus the main PLC unit, the bus terminals RS485 and the two 
PC were shipped to IBA and were repaired there. The PLC cornmunication processor, which rnanages the 
comrnunication both between the PLC units and between the PLC units and PC was found to be rnalfunc- 
tioning. The problerns were obviously caused by excess voltage in the SlNEC L2 bus cable during the 
heavy storm. 
After reinstallation of the system at Rossendorf we additionally protected the entrances of the two bus 
terminals at either end of the SlNEC L2 bus cable with a so-called BLITZDUCTOR CT (DEHN + SÖHNE 
GmbH + Co. KG, EleMrotechnische Fabrik, Neumarkt, Germany), which is a wo-piece surge protective 
device for the protection of information technology Systems. It consists of a base (feed-through terminal) 
and the protection rnodule. 
To prevent the Same problerns occurring in the control System of the radionuclide transport system (RATS), 
the BLITZDUCTOR CT system was also inserted to protect the RATS bus cable. 
20. Operation of the Rossendorf PET Cyclotron "CYCLONE 18/9" in 1999 
St. Preusche, J. Steinbach 
Routine operation 
Our standard radionuclides produced in routine operation are [18F]~, [ 1 8 ~ ] ~ 2  and "C, which are applied 
for radiotracers, radiopharmaceuticals and for various experimental uses. 
Since November this year the cyclotron has been used for radiopharmaceutical production from Monday 
to Friday, reducing the initial service day per week to one per month. This is due to the great demand for 
the radiopharmaceuticals, both for the in-house use and for the distribution outside the institute. The daily 
operation time is two to four hours. 
Table 1 gives an overview of the 1999 radionuclide production and the typical irradiation conditions. The 
radionuclide 1 3 ~  was produced to optimize the irradiation and extraction conditions and to introduce 
[13N]ammonia as radiopharmaceutical. 
Table 1. Radionuclide production in 1999 
Radionuclide production 
RN 
Typical irradiation conditions 
Number of SumA~os Irrad. Time IT YieldEoe Sat. Yield 
Irradiations [GBql [min] [PA] [GBql ~ ~ C I A ]  
*) including pre-irradiations 
Fig. 1 shows the number of irradiations of our standard radionuclides and Fig. 2 the total amount of activity 
produced from 1997 to 1999. Due to the reconstruction of our radiopharmaceutical laboratories it has not 
been possible to work with "C-labelled compounds from late spring to the end of November. 
1997 1998 j 999 
Year 
Fig.1. Number of irradiations of standard radionuckies produced. 
1997 19% 1999 
Year 
Fig. 2. Total amount of activity produced 
lmprovements at the cyclotron 
Installation of surge protective devices for the 'CYCLONE 18B" PLC system 
Resulting from problems caused by a heavy thunderstorm at the end of June [ I ,  21, we decided to better 
protect the CYCLONE 1819 PLC system. The entrances of the two bus terminals at either end of the 
SlNEC L2 bus cable are now equipped with a so-called BLITZDUCTOR CT (DEHN + SOHNE GmbH + 
Co. KG, Elektrotechnische Fabrik, NeumarM, Germany). This is a two-piece surge protective device for 
the protection of information technology Systems. It consists of a base (feed-through terminal) and the 
protection module. 
To prevent the same problems occurring in the ~0ntr0l system of the radionuclide transport system (RATS), 
the BLITZDUCTOR CT system was also inserted to protect the RATS bus cable. 
Maintenance and service 
The cathodes of both ion sources, both puller electrodes and all the strippers were replaced during the half- 
yearly maintenance of the inner parts of the cyclotron in late summer. 
Preventive changes of the target and vacuum windows are carried out every 2500 pAh at each target [3]. 
For the [ 1 8 ~ ] ~ -  water target this is every five to six months. We changed the windows at the beginning of 
May and the end of September 1999. 
Radiation protection 
- Emission of radionuclides with the exhaust air 
The emission of radionuclides with the exhaust air is monitored. As shown in Table 1 it is far below the 
limit. 
Table 2. Emission of radionuclides 1999 with the exhaust air resulting 
from operation of the CYCLONE 1819 and U-120 cyclotrons 
Radionuclide Emission 
lBs/al 
4 1 ~ r  3.2E09 
'*F 2.3E09 
1 3 ~  6.9E09 
IIc 3.3E10 
Sum 4.6E10 
Percent of the annual limit 0.7 
- Exposure to radiation of the cyclotron staff 
The cyclotron staff belong to category A of occupational exposed persons. The average exposure to 
radiation was 1.8 mSv in 1997,2.9 mSv in 1998 and 2.7 mSv in 1999 (Jan. to Sep.). 
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21. Synthesis and Characterization of Novel Mixed-Ligand Technetium(lll) Complexes 
Containing Tridentatmonodentate Thiol Ligands and Monodentate Phosphines 
H.-J. Pietzsch, S. Seifert, A. Drews, P. ~eibnitz', H. Spies 
'~undesanstalt für Materialforschung- und prüfung, Berlin 
lntroduction 
"3+lU mixed-ligand oxotechnetium(V) complexes with tridentatelmonodentate thiolate coordination 
fTcO(SES)(SR)] (HS-CH2CH2-E-CH2CH,-SH, E = 0, S, NR'), constitute a welldocumented group of 
compounds which are used in radiotracer design [I, 21. Extensive studies have been carried out to 
add to the variety of such complexesin which a monodentate ligand is combined with a chelating agent 
as a tool for introducing technetium into biologically relevant molecules. 
Alternatively, coordination of the tripodal NS3-chelator 2.2l.2"-nitrilotris(ethanthiol) with technetium(lll), 
combined with a monodentate isonitrile or phosphine ligand, produces weakly polar "4+1 "-complexes, 
in which the metal is more strongiy shielded than in the square-pyramidal 0x0 complexes [3,4]. 
Here we describe the reaction of "311" complexes of the general composition [TcO(SES)(S-C6H4- 
COCH3)] (E = 0, N(CH3), S) with dimethylphenylphosphine to produce 0x0-free Tc(lll) species with 
SESISIP coordination. This reaction can be considered a protoiypical exarnple of the reduction of 
"3+lK oxotechnetium(V) complexes by tertiary phosphines. 
Results and Discussion 
Oxotechnetium(V) complexes as the starting material were prepared by the cornmon reaction of Tc(V) 
gluconate with mixtures of the appropriate tridentate ligand and 4-methoxybenzenethiol as described 
e~sewhere[~~. They were reduced by dimethylphenylphosphine in acetonelacetic acid (1:l) at ambient 
temperature, which was indicated by the change in colour of the reaction mixtures to a deep violet 
(Fig. 1). 
The products were isolated as microcrystalline powders and recrystallized from CHClJmethanol as 
violet crystals suitable for X-ray diffraction analysis. 
HS-E-SH 
+ HS-Ph-OCH, 
OCH, 
Fig 1. Reducüon of oxotechnetium{\l) mixed-ligand complexes by dimethyfphenyl phosphine 
The analytical data of the cornplexes correspynd to the general formula [Tc(Me2PhP)(SES)(S-C6H4- 
COCH3)]. This forrnulation was confirrned by H NMR spectroscopic data. The signal groups can be 
clearly assigned to the individual ligands. A ligand ratio in the complexes of 1:1:1:1 follows from the 
integrals. 
As illustrated in Fig. 2 the complexes adopt the trigonal-bipyramidal geometry, thus rninirnizing the 
steric hindrance between the buiky phosphine and the thiol ligands. In this respect the cornpounds are 
cornparable to the "4+1" Tc(lll) complexes formed by the tripodal ligand 2.2'.2"-nitrilotris(ethanthiol) 
and tertiary phosphines 141. 
Fig. 2. Molecular structures of Tc(lll) mixed-ligand cornplexes containing tridentatelrnonodentate thiol 
ligands and rnonodentate phosphines. 
The reaction is not limited to dimethylphenylphosphine. PPh3, PBu3 and P(CHZCH&N):, react in a 
sirnilar manner with the oxotechnetiurn(V) cornpiexes, as was shown eariier by the UWis data of the 
reaction products 151. 
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22. No Carrier Added Preparations of "3+1+1" Technetium Complexes 
S. Seifert, A. Drews, A. Gupta, H.-J. Pietzsch, H. Spies 
lntroduction 
As described in the article above, reduction of the well-known 3+1 Tc(V) cornplexes [TcO(SES/S)] with 
phosphines leads to tridentatelrnonodentate/rnonodentate coordinated "3+1+1" Tc(ll1) cornplexes of 
the general forrnula [Tc(SES/RS/P)] (E = S, NR, 0; RS = rnonothiol; P = phosphine) [I, 21. 
The preparation of these cornplexes at the no carrier added level was investigated to study their reac- 
tivity in aqueous solution and in biological rnedia in vitro as well as in vivo. At first the complexes were 
prepared at the carrier added level in a Wo-step procedure via the 3+1 Tc(V) cornplex, followed by 
reduction with phosphine. Then a rnore "kit-like" procedure was developed, which involved the reduc- 
tion of pertechnetate in the presence of all three ligands. Finally, stability studies were carried out to 
check the suitability of this type of cornplex for biological studies. 
Experimental 
No carrier added preparation of 3+1 technetiurn complexes as weil as the purification and separation 
of ligand excess were carried out according to described rnethods [3, 41. We studied the cornplexation 
reactions at n.c.a. level with the tridentate ligands 3-thiapentane-1,s-dithiol (HS-(CH2)2-S-(CH2)2-SH), 
3-rnethylazapentane-15-dithiol (HS-(CH2)2-N(CHd-(CH2)2-SH) and 3-oxapentane-1,5-dithiol (HS- 
(CH2),-O-(CH2)2-SH) and the rnonodentate ligand rnethoxythiophenol (MTP). For the following reduc- 
tion of the Tc(V) cornplex the pH of the reaction solution and the arnounts of dirnethylphenylphosphine 
and stannous chloride were optirnized. It was found that 0.2 rng of dirnethylphenylphosphine are suit- 
able for reducing the separated 9 9 m ~ ~ ( ~ )  cornplex to the Tc(ll1) cornplex at pH 3 - 4 within 1 - 2 hours 
at roorn ternperature. 
The one-step procedure for preparing 3+1+1 9 9 m ~ ~  complexes was perforrned according to the follow- 
ing route: 
A mixture of 0.5 ml pertechnetate solution (10 - 500 MBq generator eluate), 
0.25 rnl propylene glycol, 
0.25 rnl acetonitrile, 
0.50 mg rnethoxythiophenol, dissolved in ethanol, 
0.05 mg tridentate ligand (SSS, SOS or SNMeS ligand), dissolved in ethanol and 
0.02 rnlO.l M NaOH is reduced by addition of 
20 p1 SnCI, solution (1 -0 - 1.5 rng SnCld5.0 rnlO.l N HCI). 
The resulting solution is neutralized with trifiuoroacetic acid to pH 5.0 - 6.0 and after that, 0.2 rng of 
dimethylphenylphosphine (dissolved in acetonitrile) are then added. The via1 is closed and the reaction 
solution is heated at 50 - 60 "C for 20 rnin. 
Yields: 90 - 95 % ~ m ~ c ( ~ ~ ~ / ~ ~ ~ / ~ ~ e 2 ~ h ) ]  and t g m T c ( 0 ~ / ~ i ~ / ~ ~ e 2 ~ h ) ] ,  
80 - 85 % ~ g m ~ c ( ~ ~ ~ e ~ I ~ ~ ~ I ~ ~ e 2 ~ h ) ] .  
Results and Discussion 
The pssibility of preparing n.c.a. ggm~c(lll) cornplexes of the jeneral forrnula [Tc(SES)(RS)PMe2Ph] 
was evaluated. A cornparison of the chrornatographic data of 'TC reference cornplexes described in 
the article above with the ""'TC preparations confirrns the identity of SSS, SOS as well as SNMeS 
complexes (Table 1). 
Table 1. HPLC data of 3+1+1 "TC and ""'TC cornplexes 
Cornplex Hypersil ODS (MeOHlO.01 M PBS pH 7.4,80/20); R, [rnin] 
The preparation was studied using the two reaction routes shown in Scherne 1 
Scherne 1. Reaction routes to prepare the n.c.a. 3+1+1 9 9 m ~ c  cornplexes 
pmpyiene glycol (PO). pH 9 - 10 
R-SH, HS-E-SH. NaüH, SnCk. 20 min, 5OC * Me 
I 
p ' p p p e  $lYcol 
HS-E-SH 
NaOH (pH 8-9) 
*Cl, 
CFsCWH (pH 56) 
PMe,Ph 
* 
20 min. 50% 
~t first, the preparation of f @ m ~ c ( ~ ~ ~ l ~ ~ ~ l ~ ~ e 2 ~ h ) ]  was carried out via the 3+l "TC(V) complex, 
which was then reduced with phosphine. The 3+1 99m~c  complexes were prepared by direct reduction 
of pertechnetate with stannous chloride in an optirnized rnixture of arnounts of ligand and propylene 
glycol (PG) and purified by HPLC. For the following reduction of the Tc(V) cornplex the pH of the reac- 
tion solution and the quantities of dirnethylphenylphosphine and stannous chloride were optirnized. 
It was found that 0.2 rng of dirnethylphenylphosphine dissolved in acetonitrile are the uptirnum amount 
for reduction. The reduction proceeds slowly. It takes about one hour at roorn temperature to complete 
the reaction with yields of about 70 %. The reaction is pH-dependent. Under dilute a~idic onditions 
(pH 3 - 4) the Tc(V) cornplex is reduced to the desired product. The Tc(l1l) cornplex is not fomied in 
neutral or weak alkaline solutions. 
Encouraged by these results a one-pot reaction was tested to prepare the 99mTc(lli) complex djrectly 
from pertechnetate. The optirnized parameters (ligand arnounts, reducing agent, pH) found for the 
preparation of g g m ~ ~ ~ ~ )  cornplexes and the reduction to the Tc(l1l) cornplex were used for this pupse.  
The preparation of "'Tc(V) complexes is comrnonly carried out at pH 9 - 10, On the &her hand, the 
reduction to the Tc(lll) complex should take place in a weak acidic Solution, This discrepancy was 
solved by using nearly neutral conditions for preparation of the desired complex, High yields of 90 % - 
>95 % can be reached, if the addition of Iigands and other substances to tbe genefator eluate fofiowc 
the order rnentioned above. Using the optirnum parameters for preparation af the 99m~c[113) complexes, 
a reaction time >1 h is needed to cornplete the reaction, The formation of the desired ~urnplex is ac- 
celerated by heating the reaction solution to 50 - 60 "C for 20 - 30 rninuies. Higher tempemtures di- 
rninish the yield of the product. Without addition of stannous chlon'de only low yields of the dedred 
product are obtained. 
Stability studies 
The 99m~c complexes are partial1 stable in alcoholic or acetonitrilic solutions. This behaviour was also 
911 observed for the corresponding Tc complexes dissolved in acetonitrile. The blue colour of the 3+l +I 
99~c(lll) complex solution slowly turns red after standing for days due to oxidation to the 3+1 "TC(V) 
complex and small parts of other unknown products (Fig. 1) 
/.L 
, , U . , *  
0 2 4 6 8 10 12 14 16 18 
Time (min) 
Fig. 1. HPLC pattern of [ B ~ c ( ~ ~ ~ e ~ ) ( ~ ~ ~ ) ( ~ ~ e 2 ~ h ) ]  dissolved in acetonitrile, 
after 50 h at room temperature. 
The rate of transformation varies for the three investigated complexes. The following order of stability 
was determined for the "Tc complexes: 
While the "TC complex solutions are practically stable for 3 - 4 hours and longer, the 9 9 m ~ ~  complexes 
undergo a faster transformation in methanolic solution (Fig. 2). The order of stability is different from 
that determined for the "Tc complexes. 
SOS SNMeS SSS 
Fig. 2. Stability of purified [ 9 9 m ~ ~ ( ~ ~ ~ ) ( ~ ~ ~ ) ( ~ ~ e 2 ~ h ) ]  complexes, 2 h after HPLC Separation 
and dissolution in methanol. 
tn aqueouslalcoholic solutions parallel to the oxidation a rapid decomposition of the 3+i+1 complexes 
to Ihree more hydrophilic products is observed by HPLC and TLC, 
A remarkable increase in stabifity in aqueous solution was achieved by adding ß-hydroxypropyl- 
cycbdextrin (HPB) to the complex solution. According to results obtained by Goomer et al. in 1992 an 
improvement is in fact obsenred by the addition of HPB to the complex solution. Fig. 3 shows the sta- 
bility of the SSS complex in aqueous solution with and without addition of HPB. 
0 2 4 6  8 1 0 1 2  0 2 4 6 8 1 0 1 2  0 2 4 6 8 1 0 1 2  
Time (rnin) Time (min) Time (rnin) 
Fig. 3. Stabilization of [ 9 9 m ~ c ( ~ ~ ~ ) ( ~ ~ ~ ) ( ~ ~ e 2 ~ h ) ]  complex (Rt = 10.1 min) by addition of ß-hydroxy- 
propylcyclodextrin (HPB). A: cornplex solution diluted 1:10 with water after 30 min; B: cornplex solution 
in methanol after 90 rnin; C: cornplex solution diluted 1 :10 with 25 % aqueous HPB solution after 
90 min. 
GSH challenge 
Challenge experirnents with glutathione confirrn also for this class of cornplexes the exchange of the 
rnonothiol ligand as known frorn the 3+1 complexes [5]. It was found that the transchelation of 3+1+1 
complexes proceeds generally faster than for 3+1 complexes. In the case of SNMeS and SOS corn- 
plexes the rate of exchange is rnuch faster than the rate of decornposition. That allows clear studies of 
the transchelation reaction with GSH and of the reversibility of this reaction. It was possible to show 
that the reaction product of the ~ 9 m ~ c ( ~ ~ ~ e ~ ) ( ~ ~ ~ ) ( ~ ~ e ~ h ) ]  cornplex with GSH is identical in 
HPLC and TLC analyses with the prepared ~TC(SNM~S)(GS)(PM~~P~) ]  complex which was charac- 
terized by elemental analysis and rnass spectrornetry (Fig. 4). 
Besides the challenge product of the 99m~c(lll) complex also the challenge product of the correspond- 
ing 3+1 9 9 m ~ c ( ~ )  cornplex was observed. The oxidation of Tc(lll) to Tc(V) was clearly visible after ad- 
dition of MTP to the challenge sarnple. In a reversible reaction both the 3+1+1 Tc(lll) complex and the 
3+1 Tc(V) cornplex were forrned by ligand exchange of GSH against MTP (Fig. 5). 
The addition of HPB to the complex solution did not influence the rate of transchelation with GSH. 
Fig. 4. Electron Spray ionization mass spectrurn of [ g g ~ c ( ~ ~ ~ e ~ ) ( G S ) ( ~ ~ e 2 ~ h ) ]  
Fig. 5. HPLC chromatograms of ligand-exchange reaction of [gSm~~(SOS)(~7~-)(~~e2Ph)f {Aj wiEh 
GSH (B) and reversible reaction after addifion of MTP (Cf. Column: Hygrsjl ODS, Rt values: 1.9 mr'n 
( f g m ~ c ( S 0 ~ ) ( ~ ~ ) ( ~ ~ e 2 ~ h ) ] ) ,  3.1 min ( f g Q m ~ c 0 ( ~ 0 ~ ) f ~ ~ ~ ) f f  $3.9 min i(I Tc{SOS){MTP)(PMe2Ph)j. 
Surnrnarizing, it can be concluded that the no carrier added preparation of technetiurn rnixed-ligand 
complexes of the general forrnula ~c(SXS)(RS)(PMe2Ph)] (3+1+1 cornplexes) is possible in a one 
step procedure starting from pertechnetate in yields of 85 - 95 % of radiochemical purity. The identity 
of n.c.a, preparations with the fully characterized g g ~ c  complexes was confirmed by comparison of 
their chrornatographic data. 
In challenge experirnents performed with glutathione the same exchange of the monothiolato ligands 
was observed as for the 3+1 cornplexes. The exchange was also reversible but the challenge reac- 
tions proceeded faster than with the 3+1 cornplexes. The cornplexes were moreover oxidized in solu- 
tion. All these properties together do not rneet the requirernents of a radiotracer and lead to the con- 
clusion that 3+1 +I technetiurn cornplexes are not an alternative to 3+1 complexes. 
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lntroduction 
Our recent work has been largely focused on the '%I' mixed ligand Systems for oxorhenium and 
oxotechnetium containing primarily the SNSIS or the SSSIS donor atom Sets. These are neutral and 
lipophilic metal chelates adopting a distorted trigonal bipyrarnidal or Square pyramidal geornetry [l, 21. 
Despite the fact that several exarnples of such mixed ligand metal chelates coupled to pharmacophore 
groups, like tropane, ketanserin or o-rnethoxyphenylpiperatine, have been recently proposed for the in 
vivo mapping of brain receptors [3, 41, cornplications related to their in vivo instability Iimit their effec- 
tive application for such purposes [5 - 71. We have recently proposed the use of '3+2' mixed ligand 
complexes, wherein the monothiolato coligand of the '3+1' concept has been replaced by a bidentate 
c~diphenylphosphinophenolato ligand. Thus, six-coordinate octahedral complexes, instead of five- 
coordinate ones, form exhibiting a closed coordination shell and, consequently, an increased stability 
181- 
We report herein on the synthesis and characterization of two novel oxorheniurn complexes prepared 
each according to the '3+1' or the '3+2' mixed ligand approach and containing 2,6-dithiornethylpyridine 
as tridentate ligand [9]. 
ResuRs and Discussion 
Complex 1 was obtained in good yields by reaction of equimolar amounts of 2,6-dithio-rnethylpyridine 
and pmethoxybenzenethiol on the [(~I-C~H~)~N][R~OCI~] precursor (Scheme 1). 
Scheme 1. 
0 
I I 
s s 
CI I - 
iC 
0- 
s Complex 3 
As shown in the ORTEP diagram of Fig. 1, cornpfex I adopts usua! distorterl squar8-pyramidal 
arrangment of the four donor atoms (SNSIS) around the IRe=O] em?, The tfitrrdeiJ&'te limnd, repre- 
senting a novel frarnework of donor atoms capable of forrning '3+T mixd-liganii cornp~x~s, spans 
three positions in the basal plane, via the charged .thiolate S atoms and the neutraf pyridine nitruge~, 
The fourth Position is occupied b,y the prnethoxybenzenethiolsite S atorn. The Re atom Xies abW@ tht; 
basal plane towards the 0 apex (0.83 Af, 
Fig. 1. Molecular structure of complex 1 
Complex 2a, as depicted in Scheme 2, was obtained by a two step synthesis: i) equimolar amounts of 
~diphenylphosphinophenol were reacted with [(rrC4H&N][ReOC14] affording the emerald intermedi- 
ate [(n-C4H9)4N][ReOC13(PO)]; ii) the latter was then reacted with 2,6-dithiornethylpyridine affording 
complex 2a as a red solid. 
Scheme 2 
Ernerald cornplex Complex 2a 
Green cornplex Complex 2b 
Complex 2a is a six-coordinate neutral oxorhenium species, given that the two thiolate groups of the 
SNS ligand and the hydroxy group of the PO ligand are deprotonated upon coordination to the RBO& 
core. The IR spectrum shows an intense band at 951 cm- corresponding to the Re=O stretching vi- 
bration, found in good agreement with that of analogous six-coordinate oxorhenium complexes con- 
taining the Same PO ligand E8, 101. The UVNis spectrum exhibits a maximum at 313, 399 nm, like to 
that of similar oxorhenium compounds [8]. 
A complete 'W, ' 3 ~  and 3 1 ~  NMR analysic confirms the formula assigned to complex 2a. In detail, the 
Proton spectrum displays the expecteü AB Pattern for the methylene protons of the tridentate ligand 
centered at 5.29 ppm, along with signals of the pyridine ring deshielded with respect to those of the 
uncoordinated iigand. The aromatic protons of the phenyl ring interpoced between the donors of the 
PO- iigand display a four signal Pattern consistent with the coordination spanning a position on the 
equatorial plane (P) and the position trans to the 0x0 linkage (01, as previiously shown by the parent 
complex [ReOC13(POf]- [I01 and related bis-substituted P,O-oxorhenium compounds [l 11. Analo- 
gously, the 'C spectrum shows the aliphatic carbon at 53.8 ppm and all of lihe aromatic signals arising 
from both the pyridine and arylphosphine in the range 1 1 7.0 - 153.8 ppm. -Rhe 3 1 ~  spectrum exhibits a 
singlet at 13.1 ppm to be compared with the signal of uncoordinated POH which falls at - 31 -2 ppm 
Pol. 
During the synthesis of the mono-substituted emerald complex [ReOCb(PO)]-, aiways trace amounts 
of the bis-substituted [ReOCI(P0)2] green compound are recovered [10]. The latter reacts also with 
2,6-dithiomethylpyridine leading to the formation of a minor complex 2b, as depicted in Scheme 2. It 
was isolated from a silica column during the purification of the major complex 2a. Complex 2b is more 
hydrophilic as compared to 2a. The IR spectrum of 2b reveals a band at 947 cm-' attributed to the 
v[Re=O] stretching vibration [8, 101. The formulation of 2b was assessed by NMR studies. The 3 ' ~  
spectrum clearly indicates the presence of two magnetically unequivalent P nuclei giving a two dou- 
blets pattern with coupling constant of 8 Hz, in agreement with a cis-P configuration (see Scheme 2). 
These two doublets are centered at 9.6 and 4.6 ppm, values slightly different from those observed in 
the Same solvent (1 1.6 and 2.3 ppm) for the parent complex [ReOCI(P0)2], indicating the substitution 
of the chloride ligand by the thiolate function of the dithiomethylpyridine ligand. The Proton spectrum 
shows two multiplets in the methylene region, along with a series of overlapped multiplets in the aro- 
matic region in the correct 4:31 integration ratio. The coordination of a thiolate group leaving outside a 
further uncoordinated dangling thiol is precedended [ I  I]. 
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24. Synthesis and Characterization of Trigonal-Bipyramidal Technetium(lll) Com- 
plexes with Tetradendatehlonodendate NSdsocyanide Coordination: Potencies of 
the "4+1" Tc Chelate System for the Design of Neutral, Non-Polar and Lipophilic 
Complexes Stable In Vivo 
H.-J. Pietzsch, A. Gupta, R. Syhre, H. Spies 
Introduction 
To date most technetium compounds suitable for coupling to biologically active molecules, e.g. CNS 
receptor targeted agents, are tetragonal-pyramidal complexes of the 0x0 ion Tc=03+. However, the 
properties and thus the in vivo behaviour of such complexes are strongly influenced by the quite polar 
Tc=O unit offering a free position trans to the 0x0 ligand for further reaction in vivo. The stricter the 
requirements for specific agents, the more important is the question whether such a polarity is benefi- 
cial or not. Alternatives are the 0x0-free lower oxidation states, namely +1 and +3. Aiter we reported 
on trigonal-bipyramidal mixed ligand rhenium(l1I) complexes with 2,2:,2-nitrilotris(ethanethio1) und 
isocyanides as CO-ligands [ I ,  21, which are neutral and non-polar since they contain sterically well 
shielded 0x0-free Re(lll) ions, in the present Paper we describe the basic chemistry of the "TC ana- 
logues relevant for the radiotracer design. This involves the synthesis and structural analysis of "TC 
complexes with simple isocyanides serving as models for functionalized derivatives. The no-carrier- 
added preparation of the analogous 99m~c-complexes is described as well as their stability in aqueous 
solution and in plasma, and their biodistribution in rats. 
Results and Discussion 
9 9 ~ c  chemisfry 
The "TC complexes 9 c 2  - ?CS were synthesized by a two step procedure starting from pc04]- via 
the phosphine-containing precursor -CI according to Scheme 1. 
To a mixture of pertechnetate(VI1) and an excess of dimethylphen- 
ylphosphine was added as ligand exchange 
reactions of the appropriate of the complexes 
9 c 2  - 9 c 5 .  
The complexes were characterized by elemental analyses as well as by NMR-, IR- and UVNis spec- 
troscopy. X-ray structure analyses of some representatives confirm the triganol-pyramidal coordination 
geometry of this type of complexes (Figs. 1 - 5). 
Fig. 1. Molecular structure of ''TCI Fig. 2. Molecular structure of 9 c 2  
Fig. 3. Molecular structure of 9 c 3  
Fig. 4. Molecular structure of 9 ~ 4  Fig. 5. Molecular structure of 9 . ~ 5  
-TC chemistry and biodistribution studies 
No-carrier-added preparation of the 99"~c compiexes 
The no-carrier-added preparation of the complexes q ~ 2  - T c 4  was performed by rt anestep 
procedure starting from 9 9 m ~ ~ 4  with stannous chloride as reducing agent. The ylelds wert? bween 
50 - 75 % using not optimized preparation conditions. In the apprupriate reaC:Ion mlxtures a by- 
product occurs which is not eluted from the Hypersil colurnn. Therefore TLG has to W performa fos 
determining the yields of the preparation. After HPLC separation the radiochemical purity of the 
9 9 m ~ ~ ( l l l )  V+1" complexes was determined by TLC and found to be >90 % (Fig. 6). 
A) B) 
mobiliiy [rnm] 
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Fig. 6. TLC pattern of the 9 9 m ~ ~ 3  complex; TLC: aluminium sheets RP-18 F254s (Merck) developed with 
methanovwater (80120) 
A)no-carrier-added preparation of reaction mixture 
B)no-carrier-added preparation of after HPLC purification 
In order to establish the structure of the ""'TC complexes, comparison by HPLC with the well charac- 
terized "TC analogues was pursued applying parallel radiometric and photometric detection. Thus, 
after CO-injection of complexes and practically identical retention times were observed, 
while the recovery through the column was quantitative. Similarly, CO-injections of the complex couples 
9 9 m ~ & 9 ~ ~ 3  and 9 9 m ~ ~ 4 f 9 ~ ~ 4  led to identical Rt values for the respective compounds, revealing their 
structural analogy. Rt values of HPLC, % values of TLC and partition coefficients (log P) of the 9 9 m ~ c  
complexes in the System octanoikaline are given in Table 1. 
Table 1. HPLC data of "TC and 9 9 m ~ ~  complexes; Hypersil ODS: MeOHlO.01 M 
PBS pH 7.4, linear gradient 70 - 100 % A in 5 min, TLC data: TLC aluminium 
sheets RP-18 F25& (Merck) eluent: methanoliwater (80120) 
Complex R, [min] LogP R f 
(octanoiisaline) 
Gbtathione challenge experiments 
Glutathione (GSH), the most abundant thiol compound in tissues, has to be considered as a potential 
agent for transchelating reactions in v h .  GSH is also responsible for the in vivo reactivity of so-called 
"3+lV mixed-ligand -TC(V) complexes. In view of these ex~eriences it woufd be usefffl to explore also 
the behaviour of the 4+1" complexes against GSH ligand exehange reactions. 
The ""'TC compounds were diluted with a 10 mM GSH solution irnmediately after HPLC purification 
and analysed after 120 rninutes. In all cases no additional peaks, indicating Tc-GSH rnixed ligand 
species, were observed in HPLC studies as well as in TLC studies. Under the conditions described 
above practically no ligand exchange reaction occurs between the 99m~c(111) ,4+ln complexes and 
glutathione. Therefore we expect that no reactions of the complexes with thiol cornpounds in tissues 
as well as in blood will occur. 
Stability studies in plasma and in rat blood 
For stability studies the 9 9 " ' ~ ~  complexes were incubated in rat blood and rat plasrna for 120 minutes. 
After incubation the blood is centrifuged and the supernatant plasrna was separated frorn the erythro- 
cytes. The supernatent plasrna as well as the resulting hemolysate were analysed using a Supelguard 
column as described above. For the complexes m ~ c 2  - m ~ ~ 4  no additional peaks were obsewed, 
indicating some kind of decomposition, rnodification or alteration of the cornplexes in HPLC studies 
with supelgard column. There is also no tendency of these cornplexes to bind on plasrna cornponents. 
To confirm these results the plasrna sarnples as weil as the hernolysates were extracted with ethvl 
acetate. In this way approx. 85 - 95 % of the activity in the sarnples could be extracted. Analysing the 
extracts by HPLC using a Hypersil column and by TLC as described in the experimental section only 
the parent compounds were detected. These results indicate that the g g m ~ ~ ( ~ ~ l )  "4+lv cornplexes be- 
have absolutely stable in plasma and blood of rat for at least 120 rnin as shown for * T C ~  in Fig. 7. 
Fig 7. HPLC Pattern of the %'"Tc4 cornplex; Supelguard column (20 X 4.6 mrn, 10 prn, flow rate 1.0 
mllmin) using a linear gradient 95 % A to 40 % A in 15 min [A: isopropanol/O.l% trifluormcetic 
acid (TFA) (1 0190), B: isopropanol/O.l % TFA (9011 O)]. 
A: 120 rninutes incubation in rat blood, hemolysate 
B: 120 minutes incubation in rat blood, supernatant plasma 
Biodistribution studies in rats 
Biodistribution results for 9 9 " ~ c  c 0 m p l e x e s ~ ~ c 2  - '%Tc~ in rats were shown in fable 2. These neu- 
tral, lipophilic complexes Cross the blood-brain-barrier of the anirnals. They show a signlficant initial 
brain uptake up to 1 .I %, obtained for the most lipophilic cycbhexyl substikited complex 
1.7). It was obse~ed that the cyclohexyl as well as the benzyl substituted complex 
9 9 m ~ ~ 2 )  indicate rather higher brain uptake cornpared to the cornplex 9 ~ 4  (rnax. 0.6 % 1113; 2' p.i.), 
which contains a nitrogen-bearing side chain. Furthermore it was bund that all of the complexes 
( 9 4 m ~ ~ 2  - *TC~) were fast cleared from the blood and the brain of rats. Excepl. the excretoiy Organs 
liver and kidneys no prominent uptake and retention in the organisrn of rats couid be obsewed after 
injection of these tracers. They were measured to be stable in whole-bio& d rats and revded no 
affinity to protein components of rat plasrna. (Fig. 6). 
Table 2. Biodistribution Pattern of ""'TC complexes 2 - 4 in Wistar rats (% IDIorgan except for 
blood as % IDIg; means I SD; n = 5) 
Complex Time Bloodlg Brain Heart Lungs Kidneys Liver 
[min] 
Conclusion 
The tripodal, tetradendate ligand 2,2',2"-nitrilotris(ethanethiol) und isocyanides as co-ligands are able 
to form non-polar, lipophilic technetium complexes which contain sterically well shielded oxo-free 
Tc(lll) ions. The monodendate isocyanide ligand enables easy functionalization in order to fine-tune 
physico-chemical properties of the complexes or to link the chelate unit to biomolecules. ""'TC com- 
plexes can easily be prepared at no-carrier-added level in high radiochemical yield. Challenge experi- 
ments with glutathione clearly indicate that no transchelation reaction occurs in vivo. This behaviour is 
considered to be an advantage of the ""'TC thioether carbonyl complexes over mixed-ligand ""'TC 
oxocomplexes in the oxidation state +5. Therefore, we believe that the complexes may be a useful tool 
in designing of ""'TC or 186~e/188~e radiopharmaceuticals. 
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lntroduction 
The oxidation state +1 of technetium has been addressed oniy in a rninor way before a new approach 
to inert technetiurn compounds on basis of Tc(l) carbonyl complexes has been elaborated [ I  - 31. In- 
tensive investigations in the Tc carbonyl chemistry made available an organornetallic Tc(l) aqua ion, 
[TC(H~O),(CO)~]+, from Tc04 under normal pressure. So, the prerequisite ta exploit the small 
[TC(CO)~]+ rnoiety for the labeling of biomolecules is given [4, 51. Thioethers with the n-acceptor prop- 
erties of the sulfur show a great potency to coordinate at the metal(l) carbonyl centre and a couple sf 
Re carbonyl cornplexes with thioether ligands are known [6]. They rnay sewe in an alternative ap- 
proach to fully exploit the potential of the [M(C0)3]+ moiety (M = Tc, Re) for the design of radiotracers. 
In the present paper we describe the basic chemistry of the Tc(l)/Re(l) carbonyl th~ioethers as relevant 
for the radiotracer design. 
Results and Discussion 
Rhenium chemistry 
The organometallic precursors (NEt,)~[ReBr~(c0)~] and [R~(NO~)~(CO)~]~-  were reacted with bidendate 
dithioethers (L1-L5) of the general formula H3C-S-CH2CH2-S-R (R = -CH2CHpCOOH, CH&=CH) and 
R'-S-CH2CH2-S-R' (R' = CH~CHZ-, CH3CH2-OH, CH2COOH). The product patterrn depends from the 
kind of the precursor complex and the reaction conditions. 
In methanol (NEt4)2[ReBr3(CO)3] reacts with L'-L' to form stable rhenium(1) tricarbonyl complexes of 
the general composition [ReBr(CO)3L]. Under these conditions the functional groups do not participate 
in the coordination (Scheme 1). 
Scherne 1 
As a prototypic representative of this type of Re compounds the propargylic-group-bearing complex 
[ReBr(C03)(H3C-S-CH2CH2-S-CH&=CH)] Re2 was studied by X-ray diffraction analysis (Fig.1). Its 
rnolecular structure exhibits a slightly distorted octahedron with facial coordination of the carbonyl 
ligands. 
Fig. 1. Molecular structure of cornplex Re2 
The potentially tetradentate ligand HO-CH2CH2-S-CH2CH2-S-CH2CH2-OH was reacted with the trini- 
trato precursor [ R ~ ( N O ~ ) ~ ( C O ) ~ ] ~  to yield a cationic cornplex [Re(C0)3(HO-CH2CH2-S-CH2CH2-S- 
CH2CH2-OH)]N03 Re8 which shows the coordination of one hydroxy group (Scherne 2). Re8 has been 
characterized by correct elemental analysis, infrared spectroscopy, capillary electrophoresis and X-ray 
diff raction analysis. 
Fig. 2. Molecular structure of cornplex Re8 
In water and with equimolar amounts of NaOH the ligand exchange reaction of the carboxylic group 
bearing ligands H3G-S-CH2CHz-S-CH2CH~H and HOOC-CH2-S-CH2CH2-S-CH-H with 
(NEf4)2[ReBr3(C0)3] led to complexes in which the bromide is replaced by the carboxylic group. The X- 
ray structure analysis of the complex Re6 shows the cecond carboxylic group non-coordinated offering 
an ideal site for functionalization or coupling a biornolecule. 
Fig. 3. Molecular structure of complex Re6 
Technetium-99m chemistry 
The no-carrier-added preparation of the analogue 9 9 m ~ ~ ( ~ )  carbonyl thioether complexes could be 
performed using the precursor ~ ~ C - [ ~ ~ ~ T C ( H ~ O ) ~ ( C O ) ~ ] +  with yields up to 90 % (Scheme 3). In order to 
establish the structure of the ""'TC complexes prepared at tracer level, comparison by HPLC with the 
respective rhenium complexes prepared in macroscopic amounts was pursued applying parallel ra- 
diometric and photometric detection. Thus, after CO-injection of complexes Tc1 and Rel, practicaliy 
identical retention times were observed, while the recovery through the column was quantitative. Si- 
milarly, CO-injections of the complex couples Terne2 - TcWRe6 led to identical Rt values for the re- 
spective compounds, revealing their structural analogy. 
Scheme 3 
[-Tc(H~O)~(CO)$ I saline 
The behaviour of the chlorine containing 9 g m ~ ~  complex T cl  in aqueous solution at physiol~icai pff 
value was investigated. In saline the chromatographical& separaterl compound was sZable for at ieast 
120 min. However, in chloride free aqueous solution a water-coordinated cationic species Tc% WCu- 
red (Scheme 4 and Fig. 4). 
Scheme 4 
O C  ,,, TO,,\ C o  phosphate buffer 
Tc or saline 
yc,s' I 'CI 4 C + NaCl 
The cationic charge of the conversion product Tcla was confirmed by capillary and paper electropho- 
resis (Fig. 5). 
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Fig 4. Time Course of conversion of the complex 
Tc1 into the complex Tcla in a solution of 45 % 
H,0/45 %MeOH/10 % Propylene glycol 
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Fig. 5. Mobility of Tcla in the electrical field 
(paper electrophoresis) 
By the introduction of a carboxylic group into the thioether ligand as a third donor group the conversion 
is suppressed and thus the neutrality of the complex preserved. So, Tc5 and Tc6 with a coordinated 
carboxylic group were stable in all investigated solutions at least for 120 min. Capillary electrophoreti- 
cal studies of the complex couple Tc31Tc5 Support the assumption that the chloride ligand in the abo- 
vely described complexes of the general formula ~ 9 m ~ ~ ~ ~ ( ~ 0 ) ~ ~ ]  is responsible for their reactivity in 
aqueous solution. Tc3 was found to be an anionic species in the pH range of 9.3 - 7.0 and a neutral 
one at pH 2.5 indicating the protonation of the free carboxylic group. Tc5 is a neutral species over the 
whole pH range showing the Same migration time as the neutral marker acetone. 
Glutathione chailenge experiments 
Glutathione (GSH), the most abundant thiol compound in tissues, is present in almost all animal cells 
in relatively high concentrations (0.5 mM t0 12 mM). Therefore it has to be considered as a potential 
agent for transchelating reactions in vive. In fact, GSH is responsible for the in viv0 reactivity of so- 
cailed %l" mixed-ligand 9 Q m ~ c ( ~ )  complexes which consist of a monodentate thiol ligand and a tri- 
dentate dithiol. In view of these experience it would be useful to explore also the behaviour of 99m~c(l) 
thioether carbonyl complexes against GSH Iigand exchange reactions although the difference in the 
oxidation state (+1 versus +5) does not predispose these complexes for such a ligand exchange. 
Saline containing preparations of the 9 9 m ~ c  compounds were diluted with a 10 mM GSH solution im- 
mediately after HPLC purifbtion. In ail cases no additional peaks, indicating Tc-GSH mixed Iigand 
species, were observed in HPLC studies. In contrast, addition of a 10 mM GSH solution to chlorine- 
free preparations of T d  and Tc2 led to the cationic species characterized above. 
These results clearly indicate that glutathione has no negative effect on the stability of ""'TC thioether 
carbonyl complexes in solutions. Obviously, no transchelation reaction by GSH occurs in vivo. This 
behaviour is considered to be an advantage of the ""'TC thioether carbonyl complexes over mixed- 
ligand ""'TC ~x~complexes in the oxidation state +5 [7]. 
Biodistribution studies in rats 
The biodistribution of the complexes Tcl, Tc2, Tc5 and Tc6 in the rat were studied. All four com- 
pounds show similar radioactivity in blood at 5 min. p.i., which thereafter decreases within 120 min to a 
similar extent, except for anionic Tc6 with its fast clearance (Table 1). 
Complexes Tc1 and Tc2 showed significant initial brain uptake (1,031 0.25 and 0.781 0.08 % IDlorgan 
at 5 min. p.i.). This is consistent with the absence of charge of the complexes and their low molecular 
weight but astonishing in so far as the octanoVwater partition coefficients are as low as log P = 0.9 for 
Tc1 and log P = 0.7 for Tc2. The complex Tc5, which is also neutral but more hydrophilic (log P = 
0.4), and the anionic complex Tc6 (log P= -1.8) exhibit only low brain uptake. 
Table 1. Biodistribution data of complexes Tcl, Tc2, Tc5 and Tc6 in male Wistar rats 
Complex Time p.i. Blood Brain Heart Lungs Kidneys Liver 
[min] 1% I Dlg] [% ID] 
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b) An anionic ""'TC complex 4 at oxidation state +5 was formed with the tetradentate MALYG ligand 
[4] and 9 9 " ' ~ ~  gluconate as a precursor. The pendant amino group of MALYG (N-mercaptoacetyl- 
lysyl-glycine) was coupled to etomidate by a peptide bond. 
Fig. 3. 9 9 " ' ~ ~  complex 4 with the MALYG-functionalized etomidate 
(MALYG = mercaptoacetyl-lysyl-glycin) 
C) A 9 9 " ' ~ ~  complex 5 with a "Tc(C0)3" moiety at oxidation state +I was formed with 2 functionalized 
by a bifunctional thioether ligand and [TCC~(CO)~]" as a precursor. 
Fig. 4. 9 9 m ~ ~  thioether-functionalized etomidate carbonyl complex 5 
The ""'TC complexes are purified by RP-HPLC and their biological behaviour is studied in rats. As 
shown in Table 1 only a rather low accumulation of activity in the adrenal cortex was obtained. Nev- 
ertheless a difference was observed between the 99m~c complex with the MALYG-functionalized eto- 
midate (4), the 9 9 m ~ ~ ( ~ )  thioether-functionalized etomidate carbonyl (5) and the "Tc complex accord- 
ing to the "3+1" principle (3). The Tc(1) complex and the ""TC complex according to the %I'' principle 
show about a 10 times higher accumulation than the 9 9 m ~ c  complex with the MALYE-functionalized 
etomidate. Most likely, the negative charge of this complex is responsible for this behaviour* The Tc(l) 
complex shows a remarkably low uptake in the blood. 
In Summary, investigations with further ""'TC complexes are required to decide whether they have 
some potential for being significantly accumulated in the adrenals or whether the  hange in the etomi- 
date molecule by the chelate is accompanied by a complete loss of biological activity. 
Table 1. Biodistribution of ""'TC etornidate cornplexes in 5 - 6 weeks old male Wistar rats 
(means + SD, n = 6) 
Complex Time Adrenals Kidneys Brain Heart Lungs Liver 
p.i. 
[rnin] IDJ 
Blood Adrenals Kidneys 
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27. Basicity of Amine Group Containing "3+1" Re Compiexes Studied by HPLC 
R. Berger, M. Friebe, M. Glaser, H.-J. Pietzsch, T. ~aina', E. ~hiotellis', H. Spies 
'Institute of Radioisotopes - Radiodiagnostic Products, National Centre for Scientific Research "De- 
rnokritos", Athens, Greece 
The basicity (expressed by the pKa values) of protonable arnine group containing Re complexes de- 
pends on the position of the amine function and on the nature of substituents which the nitrogen atom 
bears. Here we wrnpare the pHdependent acid-base behaviour of four types of 3+1" Re complexes 
(Fig. 1). Types 1 and 2 include complexes having pendent amine groups attached either to the mono- 
dentate or the tridentate ligand, whereas the amine group as pati of the tridentate ligand SNN (type 3) 
or SNS (type 4) is assurned to be involved in coiordination to the metal. 
Fig. 1. Types 1 - 4 of arnine-group-containing Re complexes 
[X = N, 0, S; R = alkyl andlor aryl residue] 
The pKavalues of these compounds derive from turning points in lipophilicity/pH profiles determined by 
HPLC. The measured values are corrected (PK,(~)) with the aid of a calibration curve based on sorne 
amines with known pKa values as standards [I]. 
Neutral "3+lU cornplexes having a pendent amine group behave as amines, which is reflected in the 
pH dependence of the partition coefficient 12, 31. Some pKa(c) values of structure-related Re/Tc(=M) 
"3+lU cornplexes (type 1) with diethylamine, piperidine and morpholine in the monodentate chelate 
part are compiled in Table 1. For these complexes, in which the amine group is attached to the mono- 
dentate thiolate ligand, turning points between the protonated and unprotonated forms were found at 
about 7 - 10. Cornpared with the free amines, the basicity of the arnine group of the complexes is 
shifted to lower pKa values at about 1 to 2 units. The difference in basicity between diethyla- 
rninelpiperidine and morpholine is reflected in the corresponding complexes. The influence of the 
neutral donor group X on pKa(@ is relatively small and is in the sequence S C 0 C N. 
Table 1. Some pKa(@ values ') of structure-related Reflc(=M) "3+ln complexes with diethylarnine, 
piperidine and morpholine structural rnoieties 
I Piperidyl 11.12 1 9.48 9.42 9.64 9-24 3.1 2 
Morpholinyl 8.33 7.1 6 7.21 7.42 7.24 7.22 
') mean values of refering Tc and Re complexes, 4 pKa values from 141 
However, basicity decreases further in complexes of the type 2, in which the amine group is located at 
the N-atom coordinated with the tridentate ligand [5]. An example is given in Table 2. This change is 
due to the electron-withdrawing effect of the coordinated nitrogen atom of the tridentate ligand. 
In complexes of types 3 and 4 the amine group is formally Part of the coordination sphere. 
A group of "3+1" mixed-ligand Re complexes in which the tridentate ligand has an SN'N' donor Set (N2 
= diethylamine or pyrrolidinyl) (type 3 complexes) was recently described by Chiotellis et al. [6]. Three 
representatives were measured and are of the Same order as observed for complexes 2, which have 
non-coordinated amine groups. As shown below for compound 4, the coordinated amine group re- 
fuses to be protonated under the conditions used. It is therefore difficult to reconcile the pK,(„ values 
found for 3 with the formulation of a coordination of the N2 amine group. However, when we assume 
the amine group to be free, what then is coordinated at the remaining unpossessed coordination site? 
This question has yet to be answered. 
Compounds of type 3 have to be studied further because of their unexpected behaviour. 
Table 2. Comparison of the P&(,) values of type 1,2,3 complexes 
(diethylamine derivatives) 
Structure 
The neutrat complex [ReO(NH(CH2CH2S)2)(SC6H5)] 4 was measured for comparison. The complex 
was formed as a result of a reaction between [Re(0)(SPh)4]' and N(CH2CH2SH)3 [7]. Unlike the corn- 
pounds of types i, 2, 3 discussed above, the complex is neutral at low pH and becomes negatively 
charged in an alkaline medium, thus showing a dissociation behaviour like an acid. The Proton of the 
coordinated tridentate ligand obviously becomes acidic due to the N-Re coordination. The measured 
pKHPLC value was corrected to pK& by rneans of a calibration curve, using some organic acids as 
standards [B] (Fig. 2). 
fig. 2. Complex of type 4 (stntcture, dissociation, pKaIc) vaiue) 
70 cbnclude* the naWe and position of the amine group in R e h  complexes are tools for directing the 
basicity so ac to either bring about a crnalt decrease in basicity compared with that of the basic amines 
or to produce species of drastically reduced basicity, As the basicity of a tracer is an imporiant prop- 
erty that governs its in wivo tmnsport, a knowledge of structure-basicity relationships is essential in 
radiatraceir design- 
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28. lnteractions of Medicinally and Biologically Relevant Anions with Photo- and pH- 
Responsive Dendrimers 
H. Stephan, H. Spies, B. Johannsen, C. ~auffmann', F. ~ögtle' 
1 Kekul~lnstitut für Organische Chemie und Biochemie, Universität Bonn 
lntroduction 
Dendrimer chemistry is a rapidiy expanding field for both fundamental studies and applications [ I  - 51. 
Their unique structural features and properties make them ideally suited for use in diagnostic imagingl 
and therapy [5 - 131, transfection [14 - 221, and drug delivety [23 - 341. We are especially interested in1 
the efficient binding and controlled release of anionic substrates with dendrimers tailored [%I. 
In this paper we report the binding behaviour of dendrimers having the photo- and pH-switchable units, 
azobenzene and methyl orange at theasperiphery tgwards pertechnetate, and the nucleotides AMP, 
ADP and ATP. Liquid-liquid partition of TcOi and C-labelled nucleotides in a CHC13/aqueous buffer 
System was chosen to characterize the binding propefiies of dendrimers. 
Experimental 
All chemicals were reagent grade and used as obtained. Dendrimers 1 and 2 (generation 3) were ob- 
tained by reaction of poly(propylene imine)-dendrimer-(NH2)16 with 4-(pheny1azo)benzoic acid chloride, 
and 4-(p[dimethylamino]phenylazo)benzenesuIfonic acid chloride, respectively. 
The extraction studies were performed at 25 I I 0 C  in 2 ml micro centrifuge tubes by mechanical 
shaking. The phase ratio Vtd:V(,t was 1:1 (05 ml each); the shaking period was 30 min. The ex- 
traction equilibrium was achieved during this period. All samples were centrifuged after extraction. The 
anion concentration in both phases was determined radiometricaily using the P-radiation measure- 
rnents of "TCO; (Amersham), and 14~-labelled nucleotides (NEN Liie Science Products) in a liquid 
scintiliation counter (LS 6000 LL, Beckman). The aqueous solution was adjusted using 0.05 M1 
NaOAcRICf- @H 2,O ... 5.5), 4-morpholinoethanesulphonicacid (MES)/NaOH- (5 4.. 6.5) and 4-(2- 
hydroxyethyl)-piperazine-1-ethanesulphonc acid (HEPESJfNaOH-buffer (7.0 ... 8.0). 
Results and Discussion 
may quantitatively transferred into 
the organic phase using azoben- 
zene and methyl orange function- 
alized dendrimers of generation 5 
at physiological pH [36]. Espe- 
cially dendrimer 2 having methyl 
orange units at the periphery show 
an unique phase transfer behav- 
iour with respect to pH changes. 
For extraction of pertechnetate we 
found that the organic phase is 
entirely discoloured accompanying 
by formation of a reddish brown 
flocky precipitation at the aqueous 
phase in the pH range of 2.0 to 
4.5 (cf. Fig. 2). This finding points 
to a strong interaction of the posi- 
tively charged dendrimer periph- 
ery with pertechnetate anions. 
Further increase of pH leads to 
the formation of a lipophilic com- 
plex of dendrimer 2 with pertech- 
netate which is completely soluble 
The investigations periormed show that the dendrimers 1 and 2 are capable of extracting especially 
the oxyanions pertechnetate and ATP even at very low concentration of dendrimer (c,,~ = 1.10-~ M in 
CHCI,). As expected the efficacy is enhanced with decreasing pH caused by increasing protonation of 
dendrimers. Further ex~eriments revealed a clear dendritic effect and consequently pertechnetate 
Extractability [%] 
% 
AMP ADP ATP Tc04 
Fig. 1. Extractability of nucleotides and pertechnetate with 
dendrimers 1 and 2 
[nucleotide, (KTc04)] = 1.1 W4 M; [dendrirner] = 1-1 0.' M in CHCI, 
* pH = 5.4 (MESINaOH buffer); ** pH = 7.4 (HEPESiNaOH bufFer) 
in CHCI,. Obviously the pertechnetate anion migrates into the inside of the dendrimer. So, Tc08 is 
bound by tertiary amine groups of the core, and the anion is shielded by the hydrophobic periphery. A 
controlled release of pertechnetate from the dendrimer is be achieved by graduated deprotonation of 
these amino groups. A very 
interesting property of the 
dendrimers investigated is 
the possibility to alter the 
structure by photo- 
isomerization. It could be 
shown that the E form of 
azobenzene-functionalized 
dendrimers can be reversibly 
switched to their Z form by 
light excitation [37]. As ex- 
pected encapsulated spe- 
cies like the dianion eosin 
can be stronger shielded 
from the environment by the 
Z form. Investigations about 
the controlled inclusion and 
release of pertechnetate with 
methyl orange dendrimers 
by photoswitching are under 
way. 
Extractability [%I 
1 
Fig. 2. Extractability of pertechnetate with denddmer 2 as fundan of pH 
[KTc04] = 1.10~ M [21= 1-10'~ M in CHCC; PH = 2.0 ... 5.5 @b.OAdHCl buffer, - 1 
pH = 5.4 ... 6.5 (MESiNaOH buffer, -*===* 1; pH - 7.0.,8.0 (HEPESINaW buffer, - 1 ) 
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29. Binding of Pertechnetate by Novel Scorpion-Like Macrocyclic Phosphonium Hosts 
H. Stephan, H. Spies, B. Johannsen, J. ~läser ' ,  E. ~ogel', F. vögtlel 
'~ekull&lnstitut für Organische Chemie und Biochemie, Universität Bonn 
lntroduction 
Due to their unique cornplexing properties rnacrocyclic compounds like crown ethers, cryptands and 
calixarenes win increasing irnportance for effective and selective binding of technetium(Vll) species [ I  
- 61. Thus, pertechnetic acid may be directly bound in acidic rnilieu by macrokycles. On the neutral and 
alkaline-side ion pairing of rnetal cations complexed with pertechnetate anion dominates. Recently, the 
cooperative sodium cation - pertechnetate anion binding was realised using a tripodal tris(amido 
benzo.15-crown-5) ligand [6]. Knowing the exciting anion binding properties of rnacrocyclic tetralac- 
tams 173 we are especiaily interested to design a pertechnetate host on the basis of such structure. 
The present short paper outiines 
our concept and we report the 
first results on binding of per- 
technetate with scorpion-like 
phosphoniurn salts using solvent 
extraction studies. As can be 
Seen frorn Fig. 1 the tetrahedral 
anion pertechnetate may be 
stabilised in the tetralactam cav- 
ity via hydrogen bonds. The 
charge should be compensated 
by the phosphonium spine. The 
phosphoniurn moiety was cho- 
Sen owing to their suitable syn- 
thetic handling. Furtherrnore 
phosphoniurn salts are known 
as exltractants for pertechnetate 
[8-101. 
Fig. 1. Conceptual design of a scorpion-like macrocyclic 
phosphoniurn host for pertechnetate 
Experimental 
All chemicals were reagent grade and used as obtained. Macrocycles l a  and 2a were synthesized as 
descrilbed earlier [ I  1, 121. Compound I b  and 2b were obtained by reaction of hydroxy-functionalized 
l a  an~d 2a, resp., with diiododecan and subsequent treatment with triphenylphosphine. The iodide 
salts isolated were converted into the chlorides using anion exchange with serdolit AS-1 (Serva). 
The extraction studies were performed at 25 f 1°C in 2 ml micro centrifuge tubes by mechanical 
shaking. The phase ratio V(„„:V(„ was 1:l (0.5 ml each); the shaking period was 30 min. The extrac- 
tion equilibriurn was achieved during this period. All samples were centrifuged after extraction. The 
anion concentration in both phases was determined radiometrically using the ß-radiation measurement 
of ' ' ~ ~ 0 4  (Amersham) in a liquid scintillation counter (LS 6000 LL, Beckrnan). The aqueous solution 
was adjusted using 0.05 M 4-(2-hydroxyethy1)-piperazine-1-ethanesulphonic acid (HEPES)/NaOH- 
buffer (7.0 ... 8.0). 
Results and Discussion 
Preliminary investigations showed that the tetralactams l a  and 2a are not able to transfer the anions 
chloride, brornide, iodide, acetate and pertechnetate from aqueous solution (pH = 7.4) into chloroform 
(cLigad = 1-10-~ M in CHC13). At higher ligand concentration weak interaction of la and 2a with pertech- 
netate was observed. Thus, 2a (cligand = 5 . 1 ~ ~  M in CHCI3) extractc approximately 1 % T a .  A drasti- 
cally increase of efficiency is obtained using the phosphonium-functionalized macrocycles l b  and 2b, 
pertechnetate is quantitatively extracted at higher ligand concentrations. The results, shown in Fig. 2, 
reveal a linear relationship between 
the technetium concentration and the LW DT~W 
ligand concentration. The data ob- 
tained with slopes of unity were con- 4 
sistent with preferential 1 :I complex 
forrnation of pertechnetate with these 2 
ligands. It is worth rnentioning that 
compound 2a gives the highest ex- 0 
traction constant (Log K„ = 6.22) for 
anion exchanger published up to now 
-2 
[I 31. But rnolecular modeling calcula- 
tion using ZINDOI1 (Hyperchem 5.1) 
_4 [14] show that some structural opti- 
mization of the host is necessary. -4 -3 -2 -1 
The macrocyclic ring size is too large Log C~i,w(cq) 
and consequently only one hydrogen 
band beween the pertechnetate Fig. 2. btraction of pertechnetate with Iigands 1  a, 1  b, 2a Wid 2b 
technetate anion is expected if the 
macrocyclic ring size decreases. Additional the pertechnetate anion should be fixed at the macroc;ycle 
using a positively charged clamp. 
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111. SCIENTIFIC COOPERATION 
COOPERATIVE RELATIONS AND JOINT PROJECTS 
In rnultidisciplinary research such as carried out by this Institute, collaboration, the sharing of ad- 
vanced equipment and, above all, exchanges of ideas and information play an important role. Effective 
collaboration has been established with colleagues at universities, in research centres and hospitals. 
Dresden University of Technology has been a rnajor Partner in our cooperative relations. Cooperation 
with various groups in the Department of Chemistry and the Faculty of Medicine was again signifi- 
cantly extended last year. Comrnon objects of radiopharmacological and medical research link the 
lnstitute with the Dresden University Hospital, above all with its Departrnent of Nuclear Medicine (Prof. 
Franke). A joint team of staff rnernbers from both the lnstitute and the Clinic of Nuclear Medicine are 
currently working at the Rossendorf PET Centre. 
The Institute cooperates with the Department of Surgical Research (Prof. Schackert) on a project con- 
cerning gene therapy rnonitoring. The lnstitute of Analytical Chemistty (Prof. Salzer) plays not only an 
irnportant part in tracer research by performing analytical characterization (Dr. Scheller) but also coop- 
erates in turnour research. 
Very effective cooperation exists with the Federal Material Research lnstitute in Berlin (Mr. Leibnitz, 
Dr. Reck), whose staff rnembers carried out X-ray crystal structure analysis of new technetium and 
rheniurn cornplexes. The Institute of Organic Chemistry (Dr. Seichter) of the Freiberg Universiry of 
Mining & Technology also contributes to analysing coordination cornpounds. 
Our Institute is linked with the lnstitute of Pathology (Prof. Zwiener, Dr. Bauer) of Jena's Friedrich- 
Schiller University by long-standing fruitiul cooperation on the pathophysiological aspects of brain 
functions. 
In the field of PET tracers (steroid chernistry) the Institute works together with the Hans-Knöll- Institute 
for Natural Products Research, Jena (Prof. Hinnen, Dr. Kasch). 
The fruitful collaboration with the Paul Scherrer Institute (Prof. Schubiger) of Villigen, Swiberland, 
which involves bioinorganic, radiochernical and biological topics, is rnuch appreciated, PSI is also one 
of the rnain Partners in the current BIOMED2 project on tumour-affine neuropeptides. 
Our long-standing cooperation with the "Demokritos" National Research Centre for Physical Sciences 
in Athens (Dr. Chiotellis) has been continued. Various joint projects on technetiurn and rhenium 
chernistry were dealt with. 
A field of cooperation with the Department of Pharmacy (Prof. Folkers, Prof. Wunderli-Allenspach) of 
the Swiss Federal lnstitute of Technology Zurich (ETH Zürich) was the chemical and biological char- 
acterization of technetiurn and rhenium complexes. 
Based on PhD student and post doc visits, joint research into labefled steroidc was carried out with the 
Departrnent of Chernistry (Prof. Katzenellenbogen) of the University of Iiljnois, Urbana, USA, and the 
Division of Radiological Sciences (Prof. Welch) of the Washington University School of Mediciise, St 
Louis, USA. 
Cooperation on a special subject concerning bioinorganic chemistry is in Progress wjth ASTA Medica 
Frankfurt (Prof. Kutscher, Dr. Bernd). 
In the field of supramolecular chernistry, successful cooperation was established with the lnstitute of 
Organic Chemistry and Biochernistty (Prof. Schmidtchen) of Technische UnhrersilCit München and wlth 
the Kekule lnstitute of Organic Chemistty and Biochemistry (Prof. Viigtle) of the University af3onn. 
The identification of common objects in PET radiapharrnacy has led to sbllaborative research with the 
Departrnent of Nuclear Medicine (Prof. Georgi) of the Universjty of Ld@z&. 
Effective cooperation also exists with the Riga lnstitute of Organic Chernjstry@r, ZabI&kayaf, Lahria. 
Cooperation in PET tracer chemistry has been established with the Turku Medical PET Centre (Dr. 
Solin). 
The lnstitute works with the Bar-//an University in Ramat-Gan, Israel (Prof. Nudelman), with the West 
Virginia University Morgantown, USA (Prof. H. Kuwabara), the PET Centre Aarhus, Denmark (Prof. A. 
Gjedde), the Birla Institute of Technology and Science, Pilani, lndia (Dr. P. Srinivas) on the biochemi- 
cal aspects of radiotracer research. 
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B. Johannsen 
One-term course on Radiopharmaceutical Chemistry. 
H. Spies 
Laboratory course on Radiopharmaceutical Chemistry. 
OTHER ACTlVlTlES 
B. Johannsen 
Chairman of the DGN Working Group on Radiochemistry and Radiopharmacy. 
B. Johannsen 
Co-editor of the journal "Nuclear Medicine and Biology". 
B. Johannsen 
Co-chairman of the meeting: Naturwissenschaftlich-technische Beiträge zur modernen Ent- 
wicklung der Medizin. 
Meeting of the research association Wissenschaftsgemeinschaft Gotlfried Wilhelm Leibniz (WGL) 
München, October 13, 1999. 
F. Füchtner 
Expert mission for the International Atomic Energy Agency (IAEA) at the Hadassah University 
Hospital, Jerusalem, Israel. 
September 30 - Oktober 1 1, 1999. 
St. Preusche 
Chairman of the CYCLONE 1819 & 1015 User Community. 
St. Preusche 
Technical CO-operation expert mission for the International Atomic Energy Agency for the accep- 
tance tests of the CYCLONE 1819 cyclotron in PragueICzech Republic. 
November 1 - 8,1999. 
IV. SEMINARS 
TALKS OF VlSlTORS 
Dr. M. Brandsch, Biozentrum Halle 
Substrat- und Konformationsspezifität des Peptidtransporters an Darm und Niere. 
03.09.1 999. 
Prof. Golovinski, Institut für Molekularbiologie Sofia, Bulgarien 
Inhibitoren der Glucuronosyltransferase. 
03.09.1 999. 
Dr. Th. Behr, Georg-August-Universität Göttingen 
Cholecystokinin-BIGastrin-Rezeptorliganden zur Diagnostik und Therapie CCK-B-Rezeptor- 
exprimierender Tumoren. 
08.09.1999. 
Dr. Blasig, Institut für Molekulare Pharmakologie Berlin 
Oxydativer Stress in Myokard und Endothel. 
10.09.1 999. 
Prof. Dr. H.-P. Schreiber, ETH Zürich, Schweiz 
Biologie und Ethik. 
28.1 0.1 999 (FZR, Zentrumsseminar). 
Dr. G. Richter, Astrophysikalisches Institut Potsdam 
Astronomie auf "Abwegen". Fachübergreifende Aspekte der Bifdverarbeitung, 
03.1 2.1999. 
Dr. F. Wüst, Washington University, School of Medicine, St. Louis, USA 
- Produktion von Nichtstandardisotopen unter besonderer Berücksichtigung von Technetium-94m, 
- Synthese von [C-1 1 ]Fettsäuren. 
10.12.1999. 
JNTERNAL SEMINARS 1999 
P. Brust 
Serotonintransporterliganden für PET und SPECT. 
07.07.1 999. 
S. Seifert 
Reaktivität und Stabilität von 99m~c-~emischtligandkomplexen. 
A. Gupta 
Stabilität und Metabolisierung von "3+1"1-g9m~c-~emischtligandkomplexen. 
08.09.1 999. 
I. Heimbold 
Synthese und Charakterisierung von Liganden der Ketanserin-Reihe. 
29.09.1 999. 
A. Friedrich 
Transportstudien an RBE4-Zellen. 
27.1 0.1 999. 
R. Bergmann 
Tracer in Tumormodellen. 
01.12.1999. 
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